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ABSTRACT
Biological systems adapt to environmental and genetic changes via dynamic molecular expression
and regulation. During the past decade, the use of ‘omics’ technologies to take a snapshot of this
molecular behaviour has become ubiquitous. Expression quantities of a single molecular level like
the transcriptome, proteome or metabolome have been a focus of study, however this is not suffi-
cient to understand the complex intermolecular level regulations. Instead, taking a series of snapshots
of molecular levels over time allows the study of molecular expression dynamics. In addition, the
integration of multiple time course ‘omics’ experiments may result in better understanding of how
molecular interactions give rise to the functions and behaviours of that system.
The analysis of time course ‘omics’ data has various objectives. One is to identify molecules that
change expression over time or between groups to infer their contribution to biological processes.
Another is to cluster molecules with similar expression profiles. These co-expressed molecules are
believed to be co-regulated or have similar molecular functions and are hypothesised to be the result
of networks of molecule interaction. Therefore, researchers use time course ‘omics’ data to identify
co-expressed molecules and differentially expressed molecules to understand the dynamics of bio-
logical systems at the molecular level. These data can also be used to model molecular interaction
networks with the objective to understand the relationships of molecules that drive a biological sys-
tem.
Time course ‘omics’ experiments quantify thousands of molecules for each biological sample, but
those experiments often only include very few biological and technical replications. The data gen-
erated are difficult to analyse because of the high number of missing values, as well as potentially
high within and between individual variability. Furthermore, expression changes of co-expressed
molecules can occur delayed in time. Therefore, powerful statistical methods are critical for an-
swering key questions about system response and function. They need to efficiently analyse high-
dimensional data that are noisy and complex. However, so far researchers have been limited in capi-
talising on the wealth of ‘omics’ data because of the lack of powerful statistical methods. This thesis
outlines the development of novel and user-friendly statistical tools to analyse time course ‘omics’
data. It consists of two core projects: firstly, the development of a framework to analyse time course
‘omics’ data obtained from a single molecular level (e.g. proteome); secondly, the development of
statistical methods and tools to integrate and analyse time course ‘omics’ data from several functional
levels (e.g. transcriptome and metabolome).
For my first project, I developed a framework consisting of three stages: quality assessment and
filtering, profile modelling, and analysis. The quality control approach was developed to remove
molecules for which expression was highly noisy. I then further developed and implemented a lin-
ear mixed model spline approach, which optimally modelled each molecule’s expression profile as
a function of time, taking subject-specific variability into account. Finally, I proposed two types of
analysis of the modelled trajectories: clustering analysis to identify groups of co-expressed molecules,
and differential expression analysis to identify molecules whose expression changed over time and/or
between treatment groups. My framework achieves high specificity and sensitivity to detect differ-
entially expressed molecules as determined on simulated data. As a validation of these ideas, I also
showed that my framework led to meaningful biological results. For example in a kidney allograft
rejection study I identified potential predictive biomarkers.
For my second project, I developed DynOmics, a novel algorithm based on the fast Fourier trans-
form that estimates delays between co-expressed molecules and takes those delays into account while
integrating data from different molecular levels. Delays of co-expressed molecules are a known phe-
nomenon in biology, hence their inclusion in analysis gives additional insights into the molecular dy-
namics. I showed on simulated data that my algorithm performed with higher sensitive and specific to
identify delayed co-expressed molecules than existing methods. Moreover, I showed that DynOmics
unravelled meaningful biological insights from three case studies with the focus on answering vari-
ous biological questions. I could confirm that many biological processes across multiple molecular
levels or organisms are delayed. This highlighted the importance of tools that include delays while
integrating time course ‘omics’ data, as relevant information would have been missed if delays were
not taken into account. The delays and associations between pairs of molecule trajectories obtained
from applying DynOmics can further be used to model causal relationships of molecule expression. I
therefore developed a visualisation tool to model networks of delayed molecule interactions. Prelim-
inary results showed promising biological inferences in a toxicity study.
The work presented in this thesis highlights the importance of sophisticated statistical methods to
analyse time course ‘omics’ data. In addition to developing efficient tools for high-throughput time
course data analysis, I made those available to the broad research community through several freely
available, user-friendly graphical user interfaces.
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1. INTRODUCTION
1.1 Definition of the ‘omes’
The suffix ‘-ome’ is widely used to refer to the complete composition of an biological measurement
e.g. transcriptome, proteome and metabolome, while the suffix ‘-omics’ refers to a field of studying
these ‘omes’ such as transcriptomics, proteomics and metabolomics. The above mentioned ’omes’
will be addressed in this report and are defined below.
Transcriptome. The transcriptome is the entire set of RNA molecules expressed by the genome,
cell, tissue or organism and is the precursor for protein synthesis [1]. To date, the study of the whole
RNA content of the cell is the most popular method to reveal an organism’s response to a perturbation.
This is due to practical factors such as feasibility, time and technical stability, but more importantly
the integrity of the obtained information compared to other newer ‘omics’. Transcriptomics helps
to understand the disease progression, to identify differences in healthy vs diseased and to discover
potential drug targets or biomarkers. However, the inference of biochemical processes determined
by changes in the transcriptome alone can lead to many false positive discoveries, since transcripts
undergo several post-transcriptional regulatory mechanisms that can affect the translation to a fully
functional protein.
Proteome. The proteome is the set of all proteins expressed by the genome. It is an important part
of a vital organism, involving functions like reaction catalysing, metabolite and ion transport and
signal transduction. It is highly dynamic and its composition is very dependent on external signals,
the present condition, the developmental stage and other complex regulatory mechanisms. Studying
the proteome through a series of snapshots, will capture present proteins, their interactions and their
effect on phenotype over time. However, the presence of a protein will not reveal its current functional
activity. For example proteins may be post-translationally modified or require to be in a complex with
other proteins to be active. To reveal enzymatic activity we actually need to explore the products of
enzymatic reactions.
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Metabolome. The metabolome is the composition of metabolites in a cellular system, cell or com-
partment under a given condition. The chemical structure of metabolites are independent of the exam-
ined organism and its evolution. Hence, metabolomics can be seen as a universal approach spanning
the species barrier [2]. Quantities of metabolites can be considered as the final reaction of systems
to genetic or environmental changes [3]. In addition, it reflects the activity of the cell at a functional
level and is therefore the closest ‘ome’ to the phenotypic characteristic of an organism. The study of
correlated metabolites over time can help to identify metabolic networks and explore new metabolic
pathways. Alterations in metabolic changes in biochemical pathways can potentially be linked to the
involved enzymes and their underlying genetic variations [3, 4].
The ‘omes’ information flow. The theoretical ‘omes’ information flow (Figure 1.1), describes the
overall connection between the ‘omes’. It arises from the relatively static genome, which contains
information impacting the phenotype. The evolving transcriptome comprises what appears to be
happening in a cell at a given time and condition but the proteome and metabolome are the ultimate
response to genetic and environmental changes. Every information transformation step through the
central dogma is highly regulated to maintain a stable relatively, constant condition of properties
called homoeostasis.
Figure 1.1: ‘Ome’ information flow.
1.2 The importance of time course experiments
Measuring an ‘ome’ over time is a powerful tool to study stressor-induced molecular behaviour [5],
developmental processes like ageing [6] and cyclic mechanisms like cell cycle [7]. The key questions
to be answered are: what functions do different response patterns serve and what are the molecular
mechanisms that underlie the formation of each pattern [8]? Networks can be formed from correlated
trajectories, which may predict putative functions for molecules, and reveal stage- and tissue-specific
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regulators [6]. Time course transcriptomics are popular to study genetic responses to interference
factors, through these dynamic networks of gene regulation and the prediction of gene functions.
Nevertheless, this only covers one level of change in a complex cascade of on-going processes and
it only gives the baseline for potentially system wide changes. The studies of the proteome and
metabolome over time should therefore give a higher resolution of the temporal or sustained response
of the system.
Much effort has been put into the experimental determination of protein-protein interaction (PPI)
via yeast two-hybrid systems, which leads to informative interactions maps [9, 10, 11]. However,
the method limitation is that PPIs alter under different conditions and only known proteins can be
considered [12]. Hence, a comprehensive analysis of the proteome under defined circumstances can
reveal altered or new interactions. Moreover, the comparison of molecule kinetics over time in healthy
and diseased individuals or in wildtypes and knockouts [13] will increase our understanding of disease
progression, molecular functions and pathways [14].
Patterns in time course ‘omics’. The control mechanism of molecule expression in cells and or-
ganisms is remarkably flexible, constantly reconfiguring itself to respond and adapt to perturbations
[8]. These changes are apparent across a broad range of time scales, from rapid responses to envi-
ronmental signals (i.e. minutes to hours) to slower events during development and pathogenesis (i.e.
hours to days) [15]. Recent studies revealed several key classes of patterns that serve different func-
tions (Figure 1.2). Sustained changes perform a state transition and are observed in developmental
processes like sex development or disease progression (Figure 1.2 A) [16, 17]. In contrast, an impulse
response such as a temporary change is observed in molecules that help us adapt to environmental
fluctuation (e.g. heat shock, oxidative stress or pathogens; Figure 1.2 B) [18]. Finally, oscillatory
patterns (Figure 1.2 C) play integral roles in homoeostasis, such as the execution of the cell cycle or
circadian rhythm [7].
The importance of integrating multiple ‘omics’ data. An organism is a complex system that
needs to be finely tuned in order to respond to environmental changes, to develop and to maintain
the circadian clock. Homoeostasis is the result of interactions and regulation through all layers of
‘omes’ [19] and no single ‘ome’ can fully reveal this complexity [20]. For example, recent studies
have shown that just ∼ 40% of changes in the protein level can be explained by variations at the
mRNA level [20, 21]. This is the result of differences on a biological level including RNA and
protein modifications, but can also be attributed to technical limitations and data analysis. Therefore,
inferring an organism’s response on a transcription level alone, can lead to misinterpretations and
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Figure 1.2: Molecule expression model pattern: A) sustained B) temporary or C) cyclic profile.
incorrect conclusions. Chen et al. [22], analysed the transcriptome, proteome and metabolome of a
person in healthy and diseased condition. They reported that they found mechanisms in disease that
they would not have found when analysing only the transcriptome, implying that cellular systems
differences can occur on post-genomic levels.
Conclusion. Every single ‘ome’ is an important part of a vital organism and is highly dynamic.
However, studying an individual ‘ome’ is not sufficient to reveal molecule synergy and understand
the complete functional activity of the system. There is therefore an urgent need to integrate multi-
‘omes’ and also to study multiple time points in order to understand an organism on a functional level
and to model these integrated systems accordantly.
1.2.1 Challenges of time course experimental designs
Sampling rate. The number of samples and time points monitored is very important to the exper-
imental design and is dependent on the biological question of interest. While in developmental and
cyclic processes the sampling rate should be equally spaced over the entire process, experiments start-
ing with a clear signal should cover the first time points very densely to observe the effect response of
a molecule. Regardless, sampling later time points is compulsory to discriminate between transient
and persistent reaction. The use of replicated measurements is crucial as it can help to reduce the noise
and discover clear trends. It is therefore important to design experiments with multiple replicates, a
continuous representation and a dense sampling rate to overcome measurement errors at a single time
point by using the dependency to its prior and following values.
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Definitions of experimental designs with measurements over time. When analysing experiments
with a time component it is important to understand the biology behind specific jargon used to describe
experimental designs. We list a few experimental designs that are commonly applied in biological
studies and highlight their characteristics.
• A repeated measurement experiment is an experiment which samples more than once from a
single source. Typical repeated measurements are samples taken before and after treatment of
a single subject. Another important fact is that the measurements do not have to be taken over
a specific time interval but the same unit can be repetitively observed for different treatments at
different locations. Missing values are likely to happen by chance.
• In time course experiments the samples are observed over an equally spaced time interval but
do not necessarily have to come from the same source. Prominent examples are model organ-
isms that have to be sacrificed to perform the experiment. To obtain reliable results the system
should be from the same controlled experimental condition and with similar/close genotypes.
In addition, biological replicates should be taken to control for within subject variation. Usu-
ally, the sample and the number of time points are relatively small and over a relatively small
time period. Missing values are due to random events. Both the within and the between subject
variations should be relatively small. Repeated measurements and time course experimental
designs share the properties of being very controlled, they have a low inter-subject variability
and missing values are at random.
• Longitudinal experiments, in contrast, rely on a population of samples from a single subject
measured over a longer time period. Missing values occur not only by random chance alone, but
also can be due to subject non-compliance or dropout - a problem facing many clinical trials.
Moreover, by observing different subjects over time, not only intra-subject variations but also
inter-subject variations are expected.
Sources of variability. Advantages of time series are the ability to monitor dynamics and to reduce
intra-subject variability. However, a good experimental design is compulsory to successfully measure
variability correlated with the conditions of interest. An experiment can have sources of variability
due to the measurement process and the experimental material that are unwanted but unavoidable. An
excellent experimental design will let you estimate the amount of variability and account for it in the
analysis.
• An unplanned, systematic variability is the worst source of variability in an experimental
design as it introduces bias and can lead to wrong conclusions. For example, the sample prepa-
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ration of two groups by two different persons or age/gender accumulation in treatment vs non-
treatment group.
• Planned and systematic variability is good and describes e.g variability between measure-
ments due to different treatments applied.
• Non systematic variability is tolerable and includes errors in the experimental preparation or
chance error for example if a single value differs from a true population value. In longitudi-
nal experiments especially, a certain amount of subject-specific variation, even if the subjects
are treated identically is expected. This is due to environmental, life style and genetic base-
line differences. To discover systematic effects, multiple subjects must receive each treatment.
This avoids biased results due to confounding variables which would otherwise obscure true
differences between treatment groups.
1.2.2 Challenges of emergent high-throughput platforms
Challenges in the analysis of proteins and metabolites are the detection of molecules and measure-
ment of abundances. Figure 1.3 displays a typical mass spectrometry (MS) pipeline to identify and
quantify proteins or metabolites in a high-throughput manner. The first step to analyse the sample
compounds is a separation step (e.g. gas chromatography; GC, matrix-assisted laser disorption/ion-
isation); MALDI, followed by the vaporisation and ionisation of the components in a mass analyser
(e.g. time of flight; TOF). The analyser separates the molecules according to their mass-to-charge
ratios (m/z) leading to a characteristic peak pattern for the analysed sample. The peaks could then be
quantified using isobaric tags for relative and absolute quantitation (iTraq). To identify the proteins
behind the peaks in the first MS, the peaks are fragmented followed by a second MS. The resulting
spectra are like a fingerprint for the protein and matching these spectra to known data leads to the
identification of the protein. Sometimes, differences in the retention time result in shifts in pattern
thus homologous peaks across replicated samples can only be detected by aligning the spectra.
Conclusion. Difficulties in the MS data analysis lie in the heterogeneous peak landscape between
samples leading to a high amount of missing data and the identification of proteins based on their
peptides [23]. Therefore missing and noisy peaks across samples are common, so a good summary
of replicated data is crucial to provide reliable and reproducible data. However, due to technical lim-
itations, the measurement of large-scale absolute protein abundances in higher eukaryotes remains
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Figure 1.3: Mass spectrometry pipeline from sample preparation over mass detection to data analy-
sis. Abbreviations: gas chromatography (GC), liquid chromatography (LC), mass-to-charge (m/z),
electrospray ionisation (ESI), mass spectrometry (MS), database (DB)
challenging. Comparing the number of proteins detected by recent MS analysis to the ∼ 20, 199
proteins estimated to be in the full human proteome (data retrieved from UniProt, www.uniprot.org,
Date:19/04/2016), we are far away from measuring the complete proteome. For example, in a recent
study 6, 280 proteins were detected across 14 time points and two technical replicates but only 3, 731
consistently across all time points [22]. The same applies for Murphy et al. [5], who detected 899 pro-
teins in three biological replicates across five time points but detected only 269 consistently in at least
two replicates and four time points. Similar observations have been made in the metabolome analysis.
The Human Metabolome database currently contains 41, 993 metabolite entries (data retrieved from
http://www.hmdb.ca, Date:29/03/2016). This includes water-soluble and lipid soluble metabolites as
well as abundant (> 1µM ) or relatively rare (< 1nM ) metabolites. Recent experiments discovered
∼ 4, 000− 6, 000 [22] for different infection states and only 1, 020 shared metabolites.
1.3 Time course ‘omics’ data analysis to date
1.3.1 Summarising trajectory information
Changes of molecule expression quantities over time are believed to come from a systematic process,
which can be described by a smooth function. Observed quantities can be seen as a noisy realisation
of this function. Treating these quantities as a function over time provides an effective mean to reduce
noise, reduce the sample dimension, estimate missing values reliably, include non-uniformly sampled
data and predict expression quantities different to the observed ones.
Methods. A popular method for summarising quantities measured over time is smoothing splines,
which uses a piecewise polynomial function with a penalty term λ [24, 25]. The challenging part of
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this method is to determine the correct smoothness parameter λ and the number of knots, which are
very important for the function fit, but are often arbitrarily chosen.
Patterson and Thompson [26] first introduced smoothing splines in the linear mixed model (LMM)
framework in 1971. The best linear unbiased predictors (BLUP) from the extended mixed effects
model correspond to solutions of a generalised penalised regression where smoothing parameters λ
are directly related to variance components. Various authors [27, 28] have since developed models us-
ing cubic smoothing splines. Brumback et al. [27] describe computational problems associated with
subject-specific effects to be fixed. Eilers and Mark [29] defined a class of P-splines, based on reduced
B-splines, as a computationally efficient approach to the cubic smoothing spline models. B-splines
are a traditional choice of spline representation which control the smoothness of the spline by vary-
ing the number and location of knots that define the break-points between the piecewise polynomials
[30]. This form was set into the LMM framework by Eilers et al. and Currie et al. [31, 32]. Wand
[33] motivated a simple low-rank smoothing spline. He described penalised spline models, based
on reduced-knot truncated power function bases with penalties on the untransformed coefficients and
fitted it in a mixed effect model framework. Durban et. al [34] presented an approach which is a
compromise between number of knot and position dependent spline regression and computationally
intensive for large data sets smoothing splines in a LMM framework. They use low-rank smoothers
adapted from Rice et al. [35] to overcome computational problems with a penalty approach [29] to
relax the importance of the number and location of the knots. As the choice of the basis function is
dependent on the properties of the data, I enabled multiple basis functions in the LMM framework
(Section 2.2.2) and the user can select the most appropriate for their data. In this context liner mixed
model splines (LMMS) refer to smoothing splines modelled in a linear mixed model framework.
Integration of spline basis in mixed models. The fact that the penalized spline smoother corre-
sponds to the BLUP, allowed us simply to integrate splines into the mixed model framework. We
explain the concept and define different basis applied in the thesis on a simple model. More-complex
models are exemplified in Chapter 2.
We define yij(tij) as the expression for subject (or biological replicate) i at time tij , where i =
1, 2, ..., n, j = 1, 2, ...,mi, n is the sample size and mi is the number of observations for subject i.
Nonlinear response patterns are commonly encountered in time course biological data [8], hence we
model a curve that uses spline basis f.
yij(tij) = f(tij) + ij, where ij ∼ N(0, σ2 ). (1.1)
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In this thesis we adopted and applied the penalized spline basis (p-spline) as proposed by [34] for its
simplicity and performance compared to other splines as discussed above. In Eq. 2.2 f represents
a penalised spline which depends on a set of knot positions κ1, ..., κK in the range of {tij}, some
unknown coefficients uk to be estimated, an intercept β0 and a slope β1. That is,
f(tij) = β0 + β1tij +
K∑
k=1
uk(tij − κk)d+,
with (tij − κk)d+ =

(tij − κk)d if tij − κk > 0,
0 otherwise.
(1.2)
Since a spline is a composition of curve segments and the knots define the break points of the curve
segments, the choice of the number of knots K and their positions jointly influence the shape of the
curve. As proposed by [36], we estimate the number of knots based on the number of measured time
points T as K = max(5,min(bT
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c, 40)), setting knots κ1...κK at quantiles of the time interval of
interest. For more complex spline fitting we also provide the cubic p-spline with degree d = 3.
Since biological time series have often been sampled only a few times we also provide to use the
cubic smoothing spline basis as proposed by [28].
f(tij) = β0 + β1tij +
K∑
k=1
uk6Pk(tij),
with Pk(tij) =

0 if tij ≤ κk−1,
h−1k−1(tij − κk)3 if κk−1 < tij ≤ κk,
h−1k−1(tij − κk−1)3 − (h−1k−1 + h−1k )(tij − κk)3 if κk < tij ≤ κk+1,
(hk−1 + hk)(3tij − κk−1 − κk − κk+1) if κk < tij.
(1.3)
where hk = κk+1 −κk.
Application to ‘omics’ data. So far, only a few attempts have been made to apply LMMS to bi-
ological data. Luan et al. [37] introduced the mixed-effects model using B-splines to analyse time
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course gene expression data and carried out gene clustering in the framework of a mixture model.
Storey et al. [38] applied LMMS with a polynomial basis of fixed degree d calculated via singular
value decomposition (SVD) taking subject-specific scalar shifts from the mean gene expression curve
into account. Berk et al. [39] applied LMMS to metabolite time course data with a similar model but
instead of treating individual curves as scalar shift from the mean, they modelled the individual level
effects as full curves, yielding a flexible model that can more accurately describe the heterogeneous
response observed amongst replicated measurements. Berk et al. [39] also noted that their model
tended to over-smooth the profiles under specific data conditions, while Storey’s et al. [38] model
under-smoothed. I took these observations as motivation to develop a new method, where the model
selection is data-driven rather than predefined.
Conclusion. Smoothing expression profiles in the LMM framework enables not only the repre-
sentation of molecule expression as a function of time, but also the removal of noise, prediction of
expression values to time points not measured in the experiment itself, and information about rate of
change. Moreover, compared to smoothing splines it estimates the smoothness of the data, hence the
user is not left with the arbitrary choice of parameters influencing the model. Still, the method of
modelling subject-specific random effects can have an impact on the model fit to the data. I addressed
this issue in Chapter 2 of my thesis.
1.3.2 Clustering
With minimal prior knowledge of how molecular responses group together, clustering is often the
first step in data mining knowledge discovery as it provides easy visualisation and interpretation of
the data. Below, I review some general algorithms, some approaches specifically developed for time
course data, and some methodologies which reduce the sample dimension prior to clustering.
Generic clustering algorithms are algorithms that are invariant to time ordering as they are not
specifically developed for the purpose of analysing time data. Widely used methods for cluster-
ing time course data are hierarchical clustering (HC) [22], kmeans (KM) [24], self-organizing maps
(SOM) [40] and model based clustering (mclust) [25]. HC is popular because of the easy visualisation
and the resulting information of the data structure. The partition based algorithm KM is popular as
it is fast and easy to apply to high-dimensional data. SOMs are based on learning neural networks.
They are preferred because, when given a predefined grid, the method selects by itself the number of
partitions based on the data structure. Moreover it delivers a two-dimensional representation of the
data after clustering. Model based clustering (mclust) assumes that the data come from a set of mix-
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ture distributions. A Bayesian information criterion (BIC) score can be used to automatically find the
best number of partitions in the data. Datta et al. [41, 42] validated a wide range of generic clustering
approaches (HC, SOM, KM, mclust) to time course gene expression data. They concluded that none
of the clustering algorithms outperformed the others as the quality of every single algorithm is highly
depend on the properties of the data.
Some time course clustering algorithms for transcriptome data provide a graphical user interface
(GUI) such as the short time-series expression minor (STEM) [43], graphical query language (GQL)
[44] and TimeClust [45]. STEM is the implementation of the method developed by Ernst et al. [46]
and allows for the analysis of short time series (limited by three to eight time points). The algorithm
first defines a set of model profiles, which are data independent and then classifies the measurements
accordingly to the similarity of the model profiles. The user needs to choose the number of profiles
and the maximum unit change in model profiles between the time points. GQL provides two tools,
GQLQuery and GQLCluster. With GQLQuery the user can define a hidden Markov model (HMM)
and can query the gene expression profiles to find genes correlating the model profile. The second
method GQLCluster is to estimate clustering. Models can be predefined by the user, randomly gener-
ated or estimated from the data using BIC score. Both programs STEM and GQL provide a validation
of the cluster significance via gene ontology (GO) term enrichment analysis. TimeClust implements
four different clustering algorithms: HC and SOM, a Bayesian clustering (BC) [47] and a temporal
abstraction clustering (TAC). BC assumes that a cluster is characterised by a typical profile and that
each gene profile of the cluster differs from the typical one due to random effects (individual variabil-
ity). All the profiles are described by random walk processes, one of the simplest stochastic models
capable to fit ‘regular’ curves. The BIC scores are used to perform the partitioning using an agglom-
erative method like in HC. The main burden of this method, as stated by the author himself [45],
is the computational cost and hence only feasible for clustering of no more than 100 gene profiles.
TAC transforms the original time series into a series of intervals in which increasing, decreasing or
steady conditions hold. Trends are defined using a linear model with a sliding window approach and
a threshold to define these trends. Finally the trends are clustered using an agglomerative method.
The main limitation stated by the author is the difficulty in tuning the parameters in the algorithm and
a possible large number of clusters with long time series. Moreover, they do not provide a method to
biologically validate the clusters.
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Limitations. The major drawback I have identified with all these methods is the lack of appropriate
handling of replicated measurements per time point. As both biological and technical replicated
measurements come with a certain amount of variation, simply taking the mean of expression values
as proposed in Ernst et al. [43] can be prone to outliers and can therefore lead to misinterpretation.
Smoothing and clustering. Two clustering algorithms that incorporate smoothing and clustering
are implemented in the R package SSCLUST [48] and the standalone application CurveSOM [40].
SSCLUST unifies linear mixed effect model splines with a cubic basis with the Expectation Max-
imization algorithm for clustering. However, the algorithm is computationally costly and was out-
performed by a range of algorithms like SOM and KM on simulated data [49]. CurveSOM [40] is
using smoothing cubic splines and SOM. The issue with smoothing cubic splines is determining the
smoothness of the curve with the tuning of the smoothness parameter λ. This parameter can have an
immense impact on the clustering result [24]. We refer to Section 1.3.1 for further reading about the
challenges arising when smoothing expression profiles.
Conclusion. All clustering algorithms specifically developed for time course data provide a user-
friendly GUI, and most of them assess the biological significance of the clusters obtained [43, 44].
Nevertheless, the methods are limited by the number of time points [43], suffer from a high number of
parameters to tune, require a large number of model estimations [44, 45] or are computational costly
[44, 45]. The largest concern about these methods is that they are semi-supervised: the user has to
define model profiles and the data are matched to the predefined profiles accordingly. Consequently,
the danger is to miss important and novel patterns.
Generic clustering algorithm, in contrast, are completely unsupervised, hence they will not miss any
patterns but depend on the selection of number of clusters and were therefore used in Chapter 2-3.
A ‘wrong’ number of clusters might merge distinct patterns into one cluster. Thus, the challenge of
most generic clustering algorithms is the selection of the number of clusters (HC, Kmeans) or the grid
shape and size (SOM). Moreover, it was shown that the performance of those clustering algorithms
is highly dependent on the data itself [41, 42]. Methods that validate the cluster performance and
compare the cluster quality amongst different type of clustering algorithms are therefore desirable
and are discussed in the following section.
Assessing cluster quality
The choice of the clustering algorithm and the number of clusters are difficult to determine with-
out a priori knowledge of the data structure. To understand and assess cluster quality of biological
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data, three different aspects of clusters are investigated: the cluster stability, biological relevance and
compactness.
Stability. The first aspect to assess cluster performance is stability. To do this clustering of the full
data set is compared with the classification from the averaged iteratively leave-one-out (LOO) data
sets. Ideally, predictions should not vary between the full and the reduced data sets. Measurements
evaluating the robustness are the average proportion of non-overlap (APN), the average distance (AD)
of the observations placed in the same cluster, and the mean error of an observation to its cluster mean
(figure of merit, FOM) [50]. The drawback of the latter two measurements is that the use of different
distance metrics between clustering algorithms can lead to misinterpretation of the performance of the
algorithm. Hence, we can only use APN to compare clustering algorithms based on different metrics.
Biological relevance. In a biological context, we can examine cluster performance based on the
algorithm’s ability to predict biological homogeneity. This is based on the strong belief that co-
regulated molecules and molecules involved in similar biological processes show correlated response
patterns and are therefore likely to cluster together. The biological homogeneity index (BHI) pre-
sented in [41] simply counts similarities within cluster divided by the number of comparisons made.
The drawback is that the index does not account for context information, such as how many obser-
vations of each type are in the data and how likely it is to see particular samples in the same cluster
by random chance alone. However, we can assess biological enrichment in clusters by computing an
exact p-value from the hypergeometric distribution. Therefore, I will perform an enrichment analysis
on the selected algorithm to validate the biological significance of the chosen partition.
Compactness. Finally, the compactness of a cluster is based on the metric applied (e.g Euclidean,
Pearson). Popular methods to validate compactness are the Silhouette width [51] and the Dunn index
[52]. Both indices work on minimising distances; hence, a problem arises when comparing algo-
rithms with different metrics (e.g. dissimilarity or distance). It is clear that distance measurements
on different scales are not comparable. Therefore, neither Silhouettes nor Dunn Index are suitable to
compare the quality of clustering algorithm quality with different distance measurements.
Conclusion. The application of cluster validation methods to different algorithms and different
numbers of clusters can help reveal the characteristics of the data structure and the appropriate num-
ber of clusters. It also helps identify the algorithm of choice for a particular data set. I identified some
limitations with these criteria:
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• methods that assess the compactness of cluster cannot be applied to compare algorithms with
different metrics,
• methods that average over all cluster validation results (presented in Datta et al.) facilitate
interpretation but restrict information regarding the performance of each single cluster.
To avoid these issues and to better assess the performance of each clustering algorithm I implemented
the non-averaged version of the APN (Chapter 3).
1.3.3 Differential expression
In most biological experiments the aim is to compare molecule expression of two or more groups (e.g.
before and after treatment, knockout vs wildtype, healthy vs sick) to, for example explore drug activ-
ity, reveal molecular functions or select biomarkers. Time course experiments can explore whether
changes are temporal or sustainable, can catch late or causal responses and can reveal responses in
a single system. None of these patterns would be revealed if measuring a single time point. Trying
to adapt statistical methods from static differential expression (DE) analysis and treating every time
point separately performs poorly due to loss in power or incorrect calculation of significance [38].
Therefore, the challenge is to take the entire trajectory into account.
Methods taking the complete trajectory into account include significance analysis of microarrays
(SAM) [53] which uses a modified t-test to identify differences in the slope or the area under the
curve. SAM is available in two R packages (samr [54] and siggenes [55]) and as an Excel add-in.
Storey et al. [38] developed a method to summarise time course data via LMM splines and used an
F-type test statistic to test for DE. The framework was implemented and is known as extraction and
analysis of differential gene expression (EDGE) [56]. A Bayesian method called BETR was devel-
oped by Ayree et al. [57] to estimate the probability of differential expression for each molecule given
the data. Further analysis methods use Gaussian processes [58, 59, 60] or two step regression (maSig-
Pro [61]). A very popular method is LIMMA (R package limma [62]), which fits linear models for
contrasts of interest and tests the estimated coefficients for differences using an empirical Bayes ap-
proach [63, 64]. Similarly, linear mixed model (LMM) (R package nlme [65]) coefficients can be
used to test for different trends in different groups.
Limitations of these developed methods are that some only allow for a particular number of repeats
per time point [53, 57] or number of molecules [53] while others require a continuous representation
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before analysis [53, 56]. Furthermore, methods that define a fixed variance structure for their data
[56] will likely under- or over-smooth some of the molecule profiles [39].
Conclusion. Characteristics of methods inferring DE of molecules are quite diverse in their re-
quirements for the data and the statistic calculated. I therefore developed an approach based on linear
mixed model splines (LMMS) without limitations on missing values or balanced design. More im-
portantly my approach is data-driven and selects the appropriate variance structure of the model on
a molecule to molecule basis (Chapter 2). This will help to avoid under- or over-smoothing of the
data compared to methods using a fixed variance structure in their data [56]. My developed approach
was compared to LIMMA in terms of specificity and sensitivity to detect differentially expressed
molecules on simulated data.
1.3.4 Integrating time course ‘omics’ data obtained from multiple platforms
In order to understand an organism’s response to environmental changes on a system level, we need
to understand the interplay of multiple molecular levels. For example shifts in the environmental
condition of an organism effects a clear hierarchy of molecular events. First, the metabolome reacts
as it is the most sensitive ‘ome’ to perturbations and almost immediately changes its abundances.
Then, in order to adapt to the altered environmental condition, gene expression changes to guarantee
homoeostasis and kick starting a cascade of molecular processes. To date, gene regulatory processes
caused by metabolites have been well studied in procaryotes [66] with the prominent lac operon, as
well as in Saccharomyces cerevisiae [67]. Recent studies have shown that there is often a measurable
time delay from signal introduction through the multiple layers of ‘omes’. Metabolite changes and
transcriptional reprogramming after sudden relief from glucose limitation react with a time delay
of 120-210 s indicating the required time for the glucose signal transduction to the final activation
of transcription [68]. In addition to transcript-metabolite (TM) and metabolite-transcript (MT) time
lags, we also need to account for regulation of gene transcription [69] or enzymatic reactions, when
integrating multiple ‘omes’.
Analysis. The earliest attempts to analyse multiple ‘omes’ were based on Pearson correlation and
not taking time shifts into account [70]. Takahashi et al. [66] studied only TM shifts using time lagged
profiles and Pearson correlation, not taking MT shifts into account. Redestig et al. [71] developed
a combined approach using hidden Markov models (HMM) and time-lagged Pearson correlation to
identify MT and TM shifts but their method can only infer positive correlated profiles. Gulati et al.
[72] used a bootstrap based ANOVA, SOM and time-lagged Pearson correlation to find time delayed
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positive correlated TM profiles. Cavill et al. [73] use Dynamics Time Warping algorithm to associate
metabolite marker with gene expression.
Conclusion. Some methods take time delays of only one ‘ome’ into account [66, 72]. Other meth-
ods are limited to the identification of positive correlated profiles [71, 72, 73]. Moreover, data arising
from different platforms will be measured on different scales and Pearson correlation is sensitive to
time delayed, non-linear relationships. Just investigating time lags comes with the disadvantage of
not taking into account differences in the rate change. But the major limitation identified is that none
of the methods for ‘omes’ integration are available as comprehensive, user-friendly framework.
1.3.5 Networks
Biological processes are driven not by a single component but by networks of interacting molecules.
The global goal of network analysis is to understand the causal relationships and interactions that
drive a biological system. The hypothesis is that observed correlations of molecule expression on all
levels of metabolism are the result of network interaction. In the following I describe recent proposed
network algorithms.
Definition of networks. A network is a graph G = (V,E) consisting of sets of V nodes and E
edges. An edge connects two nodes x, y and is introduced as edge (x, y). In undirected graphs edges
have no orientation, i.e. edge (x, y) is identical to edge (y, x), while in directed graphs these edges
are distinct [74].
Network reconstruction algorithms (NRA) to date have focused on gene interaction networks (GIN)
with genes as nodes and edges as association between nodes.
NRA for static GINs integrating knowledge like PPI and transcription factor-gene regulatory inter-
actions complementing gene expression data has shown to be beneficial for the construction and in-
terference of networks. For example the algorithm ‘passing messages between biological networks to
refine predicted interactions’ (PANDA) [75] outperformed methods based on semi-supervised learn-
ing [76], model reconstruction methods [77] and methods using data-driven mutual information in
gene expression to predict regulatory networks [78, 79].
NRA for GINs with time course data can be discriminated into three different types of networks:
A) Networks with temporal association, B) dynamic networks with temporal nodes and C) dynamic
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networks with transition of nodes. I focus on methods developed for type A) and refer the reader to
Yongsoo et al. [80] for further information about type B) and C) networks. The network algorithms
developed to generate type A) networks infer temporal association from time course gene expression
data. We can discriminate between Bayesian networks (BN) [81], dynamic Bayesian networks (DBN)
[82, 83, 84] and relevance networks (RN) methods incorporating networks inferred by correlation or
mutual information of the nodes [78, 85, 86]. While BN and DBN suffer from high computational
cost, RN methods are very efficient and hence used for a large number of nodes. A major issue with
RNs is that they cannot discriminate between indirect and direct links leading to a high number of
false positive (FP) predicted interactions.
Directed and undirected dynamic networks. The directionality of edges in a network represents
the causal relationship between nodes. This is important to infer regulation, metabolic cascades and
feedback and feed-forward loops. BN and DBN are capable of assessing this causal relationship
while the RN algorithm cannot predict directions. The issue can be resolved by using the time delay
information of the correlation to infer the causal relationship [86, 87, 88, 89] or using interaction
information from signalling pathways in like in KEGG pathway database.
Networks interference from the integration of multiple static ‘omes’. Methods that incorporate
metabolite or genomic data to infer causes of co-regulation have been presented in multiple studies
[90, 91, 92, 93]. Inouye et al. [90, 91] tested for linear association between gene expression and
metabolites using associated single nucleotide polymorphism information to build the network. Ya-
manishi et al. [92, 93] developed a kernel canonical correlation analysis (kCCA) for the integration
of genomic, pathway and gene expression data and simultaneously extracting the main component of
correlation to infer causality. These methods’ main limitations are that they are developed for static
data and would need to be extended for time course data.
Assessment of network structure. The validation of a built network is important to assess whether
the inferred network models a real process. The first property to test for is scale-free behavior. Scale-
free means the number of connecting edges for each node is not uniform but follows a power-law
distribution (Figure 1.4) [94]. Formally, the probability that a node V has edges E follows P (E) ∼
E−V . This power-law distribution relationship between nodes and edges is observed across many
networks that that are derived from not only biological, but also other, e.g. social and semantic data
[94, 95]. The second property is to test for the biological enrichment of highly connected nodes
(hubs) and the probability of seeing this distribution by random chance alone given the data. A
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permutation test where the labels are permuted and the functional enrichment is calculated to get the
null distribution is a widely used method to assess functional enrichment significance.
Figure 1.4: A Network modelled from a random process,B Network derived from real data along with
the histogram of the node connectivity. For random networks the number of edges for each node is
uniform while for networks derived by a real process the number of edges for each node follows a
power-law distribution.
Conclusion. Given the high dimensionality of data obtained from high-throughput platforms the
NRAs have to work with a high number of nodes. As reviewed RNs were therefore most appropriate
for my analysis. However, RNs alone, as opposed to BN and DBN, could not provide directionality
of interactions between molecules. I therefore used the time delay as estimated by the DynOmics
algorithm in Chapter 4 to reconstruct networks and to infer causality of molecule expression (Chapter
5).
1.4 Research questions
It is now feasible and practical to measure multiple layers of metabolism over time in a high-throughput
manner. The comprehensive analysis of these multiple ‘omics’ is an important step towards under-
standing molecular mechanisms and malfunctions. Despite the fact that time course ‘omics’ data
contain a wealth of information, the analysis of these data remains challenging. Typically ‘omics’
experiments quantify thousands of molecules at a time, however noise and missing data occur. The
high-dimensionality and complexity of the data makes the extraction of relevant information difficult
for the biologists who designed and performed the experiment. Consequently, there is an urgent need
to facilitate a comprehensive and convenient framework. Tools developed for time course so far has
only focused on transcriptomics data and address one aspect of the analysis, differential expression
or cluster analysis. Furthermore, most approaches only allow a single observation per time point
or equally spaced time intervals. This leaves the molecular biologist who conducted the experiment
alone with the challenge of reducing the sample dimension to obtain population representative tra-
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jectories. Due to these limitations, I aimed to develop a framework for the pre-processing and the
analysis of time course ‘omics’ data. We need to reliably summarise repeated measurements in order
to reduce the sample dimension and the noise, and predict values for time points different from those
observed, to enable the integration of unequally sampled ‘omes’.
Detecting regulatory relationships between different biological entities is not a trivial task. Even for
the analysis of interacting molecules on a single ‘omes’ level it was shown that correlating response
patterns do not overlap directly [89, 96, 73]. This can be the result of differences in the kinetics of
trajectories between molecules that leads to time delayed corresponding profiles. Hence, several au-
thors who integrated transcript and metabolites observed time delayed response patterns [66, 68, 71]
and the incorporation of time shifts has shown to increase biological inference [66, 71]. Discovering
the intricate patterns of different biological entities will be a challenging task as the quantities are
from multiple platforms that come with their own scale and noise components. Therefore I aimed to
develop an approach for identifying correlated and anti-correlated time delayed trajectories.
Biological inferences based on networks derived only from gene expression data can lead to mis-
interpretation, as there are numerous regulatory mechanisms involved in turning a transcript into a
fully operative protein. The integration of experimentally obtained protein-protein interactions (PPI)
[9, 97, 98] with gene expression data, has been shown to increase specificity of networks built [75].
However these PPI maps are considered incomplete [99] and more importantly PPIs were found to
alter under specific conditions [100]. It is therefore important to create and analyse condition-specific
molecular interaction networks to gain new insights and discover condition-specific correlating tra-
jectories. This is particularly relevant for perturbation experiments, where environmental conditions
change dramatically; or in patients with disease.
Regulation of metabolic pathways occurs on all functional levels [19], hence I aimed to integrate sev-
eral ‘omics’ data from the same source under a defined condition with a sound framework to increase
the understanding of drug sensitivity, disease progression, metabolism and developmental processes.
The final output of these ‘omics’ networks will be visualised in order to improve the understanding
of analytical results.
1.5 Objectives
The overall objective of my PhD thesis was to provide statistically sound and efficient frameworks for
the integration and analysis of multiple time course ‘omics’ data. In order to achieve this objective I
had two key aims. The first aim was the development of methods and associated tools to analyse time
course ‘omics’ data derived from a single platform or molecular level. The second aim was to develop
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statistical methods and associated tools to analyse co-expression across multiple time course ‘omics’
data when integrating multiple molecular levels, organisms or data derived from multiple platforms.
The more specific aims of the thesis are outlined below:
1. Development of statistical methods and associated tools to analyse single time course ‘omics’
data.
(a) Development of a quality control approach for filtering non-informative molecule tra-
jectories prior to downstream analysis to remove noise and therefore increase biological
interference.
(b) Development of a modelling approach for flexibly taking noise levels into account that are
caused by genetic and environmental factors to improve model fitting.
(c) The enabling of clustering approaches to identify clusters of co-expressed molecules.
(d) Development of differential expression analysis approach flexibility taking noise levels
into account.
(e) Development of a graphical user interface to allow non programmers the use of state-of-
the-art statistical time course analysis methods to answer their key biological questions.
2. Development of statistical methods and associated tools to integrate and analyse multiple time
course ‘omics’ data.
(a) Development of an efficient approach for estimating time delays between pairs of associ-
ated molecule trajectories.
(b) Development of a visualisation to analyse intermolecular level interaction networks.
(c) Development of a user-friendly tool to integrate and visualise multiple time course ‘omics’
data.
1.6 Thesis outline
The first part of the thesis, described in Chapters 2 and 3 focus on the development of methods and
associated tools to analyse time course ‘omics’ data. Chapter 2 describes the design and implementa-
tion of a unified approach. This framework incorporates filtering of non-informative trajectories based
on standard deviation ratios and modelling of molecular trajectories using data-driven linear mixed
model splines (LMMS) for clustering and differential expression analysis. Through simulations I
showed that my developed differential expression analysis is more sensitive and specific in identify-
ing differentially expressed molecules with small fold changes and noisy expression values compared
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to commonly used methods based on linear models. I also demonstrated that clustering on modelled
trajectories using my data-driven modelling approach is superior to identify biological relevant pat-
terns compared to modelling approaches that make prior assumptions about the noise structure in the
data. When performing exploratory analysis, usually little is known about the data structure and thus
the number of clusters of expression patterns. For that reason, I provided an evaluation method to
find the number of distinct clusters in the data that will aid to understand the structure of the data.
Moreover, I enabled clustering of the first derivative of the trajectory information as it can lead to new
biological insights.
I obtained confidence that the approach is suitable to analyse data obtained from both microarray and
mass spectrometry platforms, by applying the framework to proteomics and transcriptomics data sets
and obtaining results in line with the experiments performed. The framework is implemented as an R
package called lmms and freely available on the CRAN repository https://cran.r-project.org/.
Having established a statistically sound framework for the analysis of time course ‘omics’ data from
different platforms, the next step was to provide the framework to the broader research community.
Therefore, Chapter 3, was dedicated to develop a simple and easily accessible graphical user inter-
face called TimeOmics. TimeOmics uses the shiny web application framework and enables to easily
apply the statistical methods I developed for time course ‘omics’ data. Results of the analyses can
be explored in interactive tables and can be further investigated in high quality graphical outputs.
My developed tool enhances the research community with user-friendly and state-of-the-art statistical
methods for mining and understanding time course ‘omics’ data. The tool includes a user guide and
is available on github https://github.com/JStrau/TimeOmics.
The second part of the thesis, described in Chapter 4-6 focuses on the development of tools to integrate
and analyse time course ‘omics’ data obtained from multiple molecular levels of a single organism
or from multiple organisms. The challenge was to identify molecules with similar expression pat-
terns in order to infer regulatory relationships or functional similarities. The additional challenge to
the complexity and high-dimensionality of these data was that expression changes of functional re-
lated molecules could occur delayed in time. Chapter 4 describes the development of an algorithm
to integrate multiple time course ‘omics’ data. The algorithm called DynOmics is based on the fast
Fourier transform. The approach estimates delays between two molecule trajectories and uses these
delay estimation to realign the profiles to determine the degree of association. In simulation studies,
I showed that this approach was more sensitive and specific compared to methods based on dynamic
time warping and (lagged) Pearson correlation to identify delayed associated trajectories on simulated
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data. In addition, DynOmics could accurately estimate the simulated delays. As DynOmics required
a single measurement per time point I applied my developed LMMS approach (Chapter 2) prior to
applying DynOmics, which could also increase biological findings by removing noise. Using LMMS
and DynOmics together, I identified relevant molecular interactions between levels of metabolism
that also showed differences in timing of expression changes. I further applied DynOmics to time
course ‘omics’ data sets obtained from multiple organisms in comparable developmental stages. I
identified conserved molecular mechanisms that showed differences in expression timing across the
studied organisms. These conserved mechanisms would have been missed if not taking time delays
into account. The framework is implemented as an R package called dynOmics and freely available
on bitbucket https://bitbucket.org/Jasmin87/dynomics.
To complete that body of research, I further investigated whether I could use the DynOmics results to
model networks of molecular interactions (Chapter 5). The importance of visualising and analysing
molecular networks is that molecular behaviour is driven not by a single molecule but by networks
of molecule interactions across all levels of metabolism. To date, networks reconstruction algo-
rithm have focused on gene expression data. I hypothesised that the integration of multiple layers
of metabolism would increase understanding and confidence in the modelled networks. For this pur-
pose Chapter 5 describes the development of a graphical user interface called NetOmics. NetOmics
enables the integration of multiple time course ‘omics’ data using DynOmics and then uses DynOmics
results to model relevance networks. The network reconstruction algorithm was altered to specifically
highlight and analyse DynOmics results. I implemented functionalities to display sub-networks (e.g.
negative/positive correlation or delay) to answer specific biological questions. The preliminary results
of this network visualisation showed first promising insight in a toxicity study (Chapter 6). The tool
is available on bitbucket https://bitbucket.org/Jasmin87/netomics.
22
Part I
Development of statistical methods and
associated tools to analyse single time course
‘omics’ data.
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2. A LINEAR MIXED MODEL SPLINE FRAME-
WORK FOR ANALYSING TIME COURSE ‘OMICS’
DATA
ABSTRACT
Time course ‘omics’ experiments are becoming increasingly important to study system-wide dynamic
regulation. Despite their high information content, analysis remains challenging. ‘Omics’ technolo-
gies capture quantitative measurements on tens of thousands of molecules. Therefore, in a time course
‘omics’ experiment molecules are measured for multiple subjects over multiple time points. This re-
sults in a large, high-dimensional dataset, which requires computationally efficient approaches for
statistical analysis. Moreover, methods need to be able to handle missing values and various levels of
noise. We present a novel, robust and powerful framework to analyse time course ‘omics’ data that
consists of three stages: quality assessment and filtering, profile modelling, and analysis. The first
step consists of removing molecules for which expression or abundance is highly variable over time.
The second step models each molecular expression profile in a linear mixed model framework which
takes into account subject-specific variability. The best model is selected through a serial model se-
lection approach and results in dimension reduction of the time course data. The final step includes
two types of analysis of the modelled trajectories, namely, clustering analysis to identify groups of
correlated profiles over time, and differential expression analysis to identify profiles which differ over
time and/or between treatment groups. Through simulation studies we demonstrate the high sensi-
tivity and specificity of our approach for differential expression analysis. We then illustrate how our
framework can bring novel insights on two time course ‘omics’ studies in breast cancer and kidney
rejection. The methods are publicly available, implemented in the R CRAN package lmms.
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2.1 Introduction
Over the past decade, the use of ‘omics’ to take a snapshot of molecular behaviour has become
ubiquitous. It has recently become possible to examine a series of such snapshots by measuring an
‘ome’ over time. This provides a powerful tool to study stressor-induced molecular behaviour [5],
developmental processes (e.g. ageing; [6]) and cyclic mechanisms (e.g. cell cycle; [7]).
Robust and powerful analysis tools are critical for capitalising on the wealth of data to answer key
questions about system response and function. In addition to addressing the high-dimensionality of
the data, such tools must account for a high number of missing values, and also variability within
and between studied subjects. Many methods are limited by scale, and are unable to handle either a
large number of time points, a varying number of time points per subject [57] or a very large number
of molecules [45]. Hence there is an urgent need for filtering and modelling these time course data,
not only to decrease the number of profiles analysed, but also to collapse subject-specific profiles to a
summary thereof.
The benefit of decreasing the number of profiles analysed via filtering is evident when considering the
scale of typical time course ‘omics’ experiments. Tens of thousands of molecules can be measured at
different time points, requiring multiple hypothesis tests to determine differential expression. While
the false positive rate can be controlled using multiple testing corrections (e.g. FDR; [101]), these
are frequently accompanied by an increase in the false negative rate. Hence identifying and removing
non-informative molecules prior to testing can help to increase statistical power. This drives a need
for accurate approaches to remove a large number of non-informative profiles. Indeed, estimates
are that only 30 − 40% of the genes are expressed at array-detectable levels [102], increasing up to
60 − 70% for newer technologies like RNA sequencing [103]. Furthermore, modelling can provide
considerable benefits by summarising the remaining, informative profiles. Our aim in this study is to
model the systematic process from which expression levels derive, as a smooth function over time, so
that observed measurements can then be seen as a noisy realisation of this function.
A popular modelling approach for time course data is smoothing splines, which use a piecewise
polynomial function with a penalty term [24]. The two main drawbacks are the arbitrary selection
of the penalty and the computational burden, both of which have received extensive attention. For
example, [26] re-parametrised smoothing splines in a linear mixed model spline framework to address
the arbitrary choice of penalty. However, the smoothing splines models developed in this framework
are still computationally challenging to fit with an increasing number of time points [27], [28]. The
standard smoothing splines approach faces similar challenges, which can in part be mitigated using
spline regression. There the computation-limiting factor is the number of polynomial pieces rather
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than the number of time points. Since splines can be calculated using linear mixed models, a wide
range of methods have been proposed to improve computational efficiency of such models [29],[32].
More recently, [34] presented a tradeoff between spline regression and the linear mixed model spline
framework by combining low-rank smoothers adapted from [35] with the penalty approach of [29].
The hybrid approach results in a truncated lines basis which improves computational efficiency and
relaxes the importance of initial parameters choices.
After the filtering and modelling steps, the resulting summarised profiles can be clustered to gain
biological insight from their similarities. Indeed, clusters of correlated activity patterns may predict
putative functions for molecules and reveal stage- and tissue-specific regulators [6]. To that end,
several spline-based clustering methods have been proposed in the literature [37], [40]. However,
common limitations include additional assumptions on the distribution of the data, computational cost
and dependency of the resulting clusters on the initial parameters. To our knowledge, no approach
currently incorporates subject-specific random effects in a spline model in order to accurately model
subject-specific variation before clustering.
Hypothesis testing can also be performed within the mixed effect model framework to gain biological
insight from differences between groups and across time. Several methods have been proposed which
can all handle missing data and different numbers of replicates per time point, but are often limited
when only a few time points are observed, as is typically the case for costly high-throughput experi-
ments. Approaches such as linear models for microarray data (LIMMA; [62]) test contrasts of interest
in a spline framework using an empirical Bayes approach [64], but do not account for subject-specific
variation in the model. extraction and analysis of differential gene expression (EDGE; [38]) does
model subject-specific effects as scalar shifts from the mean population response but lacks flexibility
and has been reported to not adequately model data in simulated scenarios [39]. A more flexible ap-
proach is smoothing splines mixed effects (SME; [39]), which models subject-specific effects as full
curves, but with the risk of over-smoothing profiles in some cases.
In this paper we propose a novel framework for time course ‘omics’ studies which is summarised in
Fig. 2.1). First, we extend a quality assessment and filtering approach to time course data to identify
and remove non-informative molecular profiles. Second, we propose a serial modelling approach
which avoids both under- and over- smoothing by allowing the data to drive the complexity of the
curve in order to fit the appropriate model. These modelled and summarised profiles can then be
analysed for clustering and differential expression analyses. We illustrate the use of our framework in
simulation and real time course ‘omics’ case studies.
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Figure 2.1: Overview of the analysis framework. The proposed framework consists of three stages:
quality control and filtering; serial modelling of profiles; and analysis with clustering to identify
similarities between profiles or with hypothesis testing to identify differences over time, between
groups, and/or in group and time interactions.
2.2 Material and Methods
2.2.1 Material
We first applied the filtering and modelling stages of our framework to two publicly available tran-
scriptomics datasets, which are briefly described below. The main analyses and biological inter-
pretations were then performed on two proteomics datasets from breast cancer and kidney rejection
studies.
S. paradoxus evolution data (GSE36253). The evolutionary principles of modular gene regulation
in yeast were investigated by [104]. They tracked growth on glucose in real-time by measuring the
growth rate, glucose, and ethanol levels. Expression of 5,503 genes was measured at six physiologi-
cally comparable time points. Samples were hybridised to microarrays with the reference chosen to
be the same physiological phase in all cases. In this study we selected a single species (S. paradoxus)
with two to four biological replicates per time point.
M.musculus chemoimmunotherapy data (GSE27440). The anti-tumour efficiency of a chemother-
apeutic drug on bone marrow in mice was investigated by [105]. Expression of 13, 443 genes was
measured pre-treatment, 1, 2 and 5 days after chemotherapy of tumour-bearing mice. At each time
point five biological and two technical replicates were assayed.
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iTraq breast cancer data (PRD000178). Proteomic changes in MCF-7 cells resulting from insulin-
like growth factor 1 (IGF-1) stimulation were investigated by [5]. As impairment of the IGF-1 recep-
tor signalling network is involved in tumour growth and chemotherapy resistance, the study of proteins
involved in this network may help to understand the underlying mechanisms and to identify potential
drug targets. iTraq liquid chromatography followed by a two-dimensional mass spectrometry scan
(LC-MS/MS) was used to quantify proteins at 0 h (no IGF-1), 6, 12 and 24 h after IGF-1 stimulation.
This procedure was repeated in three separate cultures. In total 899 proteins were identified. Sample-
wise scaled log2 fold changes for time points 6, 12 and 24 h relative to baseline (0 h) were reported for
264 proteins with minimum two measured replicates. We applied our full data-driven modelling ap-
proach to this dataset, finishing with cluster analysis to explore patterns of protein response to IGF-1
stimulation.
iTraq kidney rejection data. The PROOF Centre of Excellence performed a longitudinal study to
identify diagnostic biomarkers in blood plasma to predict acute renal allograft rejection [14]. The
iTraq kidney rejection dataset is a subsample thereof which includes 10 acute rejection patients (AR)
and 20 non-rejection patients (NR). In this discovery study, iTraq MALDI-TOF MS/MS technology
was used to quantify plasma protein relative concentrations in blood samples tracked prior to (0
weeks) and post transplant at 0.5, 1, 2, 3, and 4 weeks. In total, 140 proteins were quantified from
blood samples. We applied our full data-driven modelling approach to this dataset, finishing with
differential expression analysis to identify proteins whose profiles differed between the two groups.
Simulated data. For each of six different scenarios varying noise levels and fold changes, we sim-
ulated 100 datasets, each consisting of 140 profiles, 50 of which were differentially expressed. For
each dataset, we applied our differential expression approach and LIMMA [62], and compared their
sensitivity and specificity to differential expression over time, between groups and in group*time
interactions. A detailed description of the simulation procedure can be found in the Supporting Infor-
mation files, with examples of simulated profiles (Figure S2.1 A).
2.2.2 Methods
Quality control and filtering.
Filtering on the overall standard deviation of molecule expression is a common approach in static
gene expression experiments to remove non-informative molecules prior to analysis [106]. The justi-
fication is that low standard deviations indicate little molecular activity, and so molecules which vary
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more are of more interest. In time course experiments however, molecules can vary both over time
and between subjects. Therefore, an increase in the overall standard deviation does not necessarily
indicate interesting molecular behaviour and the additional time dimension of the data needs to be
accounted for.
Rather than the overall standard deviation, defined below as sM , we considered two filter ratios based
on the standard deviations across time and subjects. These estimates can be used to identify low
quality and/or non-informative profiles. Let T be the number of time points and n the total number of
subjects. For each molecule, we denote by yi(t) the expression for subject i at time t, with i = 1, ..., n
and by sT the average of standard deviations (SD) computed per time point with
sT =
1
T
T∑
t=1
√√√√ 1
n− 1
n∑
i=1
(yi(t)− µt)2, where µt = 1
n
n∑
i=1
yi(t).
Similarly, sI is the average of SDs computed per subject, with
sI =
1
n
n∑
i=1
√√√√ 1
T − 1
T∑
t=1
(yi(t)− µi)2, where µi = 1
T
T∑
t=1
yi(t),
and sM is the SD for each molecule, over all subjects and time points:
sM =
√
1
Tn−1
T∑
t=1
n∑
i=1
(yi(t)− µM)2, where µM = 1Tn
T∑
t=1
n∑
i=1
yi(t).
Missing values were excluded from the relevant sums. We then define the filter ratios RT and RI as
RT =
sT
sM
and RI = 1− sI
sM
.
Our filter ratios are motivated by the expectation that the SD values for profiles consisting purely of
noise are different compared to those with a true signal over time. Fig. 2.2 illustrates some example
profiles to motivate the use of one of the ratios, RT , for quality control. The first type of profile
consists purely of noise, resulting in sT ≈ sM and therefore RT ≈ 1. The second type of profile has
a true signal over time, resulting in sM greater than sT and RT < 1. Hence, RT provides one means
of discriminating between non-informative and informative profiles. We generally expect subject-
specific profiles to be close to the mean molecule profile, resulting in RI ≈ 0, as would also be true
for noisy profiles over time. Therefore, on its own, RI is only a good discriminator of unambiguously
flat profiles, for which sI may often be smaller than sM , resulting in RI > 0. Nevertheless, the
combination of both RT and RI can provide additional insights into the variance structure of the
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molecules and can guide the user to make more informed choices about filter ratio thresholds as
illustrated in our case studies.
Figure 2.2: Examples of ‘noisy’ and differentially expressed profiles. Profiles changing over time
(blue) have a mean of the standard deviations per time point (sT ) smaller than the mean of the standard
deviations per molecule (sM ), while these means have similar values for noisy molecules (brown). In
both cases the mean of the standard deviations per subject (sI) is similar to sM .
During our filtering stage, we first removed molecules with more than 50% missing data and applied
model-based clustering (R package mclust [107]) on the filter ratios RT and RI by specifying two
clusters. Based on the rationale described above, we expect the cluster of profiles with low RT and
RI to be informative and propose to discard profiles in the cluster with high RT and RI . In the
specific case where a time course study includes the comparison of multiple conditions or treatments,
it is important to avoid filtering profiles which may be non-informative within a condition but are
differentially expressed between conditions. Therefore, we propose to apply the filtering approach to
each condition separately, with the additional requirement that profiles must be found non-informative
in all conditions in order to be removed.
Modelling
In high-throughput experiments, thousands of molecule profiles need to be modelled in an efficient
manner. Biological variability both between and within subjects must be accounted for, and experi-
mental procedures typically result in different numbers of replicated measurements per molecule and
time point. The combination of all of these factors requires a flexible, robust model-fitting procedure
which can easily accommodate different sources of variation.
Model fit with linear mixed model splines (LMMS). For each molecule, we determine an appro-
priate model via a serial model fitting approach. This avoids under- or over-fitting by allowing the
data structure to drive the model complexity, rather than relying on a priori assumptions such as in
[62],[38]. We make comparisons between successive models using a goodness of fit test, retaining a
more-complex model only if it fits the data better than a simpler model. The goodness of fit is assessed
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with the log likelihood ratio test as implemented in the anova function of the nlme package. The four
models considered in this process are described below, listed in order of increasing complexity.
The first model assumes the response is a straight line and is not affected by subject variation. For
each molecule, we denote by yij(tij) its expression for subject (or biological replicate) i at time tij ,
where i = 1, 2, ..., n, j = 1, 2, ...,mi, n is the sample size and mi is the number of observations for
subject i. We fit a simple linear regression of expression yij(tij) on time tij , where the intercept β0
and slope β1 are estimated via ordinary least squares:
yij(tij) = β0 + β1tij + ij, where ij ∼ N(0, σ2 ). (2.1)
As nonlinear response patterns are commonly encountered in time course biological data [8], our
second model replaces the straight line in Eq. 2.1 with a curve that is modelled using a spline truncated
line basis as proposed by [34]:
yij(tij) = f(tij) + ij, where ij ∼ N(0, σ2 ). (2.2)
In Eq. 2.2 f represents a penalised spline which depends on a set of knot positions κ1, ..., κK in the
range of {tij}, some unknown coefficients uk to be estimated, an intercept β0 and a slope β1. That is,
f(tij) = β0 + β1tij +
K∑
k=1
uk(tij − κk)+,
with (tij − κk)+ =

tij − κk if tij − κk > 0,
0 otherwise.
(2.3)
Since a spline is a composition of curve segments and the knots define the break points of the curve
segments, the choice of the number of knots K and their positions influences the shape of the curve.
As proposed by [36], we estimate the number of knots based on the number of measured time points
T asK = max(5,min(bT
4
c, 40)), setting knots κ1...κK at equidistant time points of the time interval
of interest.
In order to account for subject variation, our third model (Eq. 2.4) adds a subject-specific random
effect Ui to the mean response f(tij). Assuming f(tij) to be a fixed (yet unknown) population curve,
Ui is treated as a random realisation from an underlying Gaussian distribution independent from
the previously defined random error term ij . Hence, the subject-specific curves are expected to be
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parallel to the mean curve as we assume the subject-specific random effects to be constant over time:
yij(tij) = f(tij) + Ui + ij, where Ui ∼ N(0, σ2U). (2.4)
A simple extension to this model is to assume that the subject-specific deviations are straight lines.
Our fourth model therefore fits subject-specific random intercepts ai0 and slopes ai1:
yij(tij) = f(tij) + ai0 + ai1tij + ij,
with ij ∼ N(0, σ2 ) and (ai0, ai1)T ∼ N(0,Σ).
(2.5)
We assume independence between the random intercept and slope, and therefore the covariance ma-
trix for the random effects Σ is diagonal.
Derivative information for Linear Mixed Model Splines (DLMMS). The derivative of expres-
sion profiles contains valuable information about the rate of change of expression over time [24, 25].
We consider the derivative of the mean population curve f(t) from Eq. 2.3. Note that for profiles
modelled using only Eq. 2.1 the derivative is constant and is equal to the estimate of the slope.
Otherwise, the derivative at any time point t in the relevant time interval is:
f ′(t) = βˆ1 +
K∑
k=1
uˆkI(t, κk) with I =

1 if t− κk ≥ 0,
0 otherwise,
where βˆ1 and uˆk denote the estimates of the intercept and spline coefficients. The derivatives of
the LMMS profiles can then be used instead of the modelled profiles to gain new insights in the
downstream cluster analysis.
Clustering
Clustering of time profiles allows insight into which molecules share similar patterns of response,
which may in turn indicate a shared biological basis. Similarities between trajectories may be seen
not only in terms of shape and magnitude, but also rates of change, or speed. However, detecting these
similarities can be challenging due to noise and missing values in subject-specific measurements.
Hence, the choice of modelling approach often has critical impact on the ability to identify clusters of
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biologically similar molecules.
We compared our modelling approaches LMMS and DLMMS to two single-step models using the
workflow shown in Fig. 2.3. As a basic comparison, we first calculated the mean at each time
point for each molecule as it is arguably the most common way of reducing subject dimension. As
a more sophisticated alternative, we applied the R package implementation of the recently proposed
modelling approach smoothing splines mixed effects (SME) [39], which uses a single model that
treats each subject-specific trajectory as a smooth function of time.
For clustering, we compared the performance of five algorithms using the Dunn index [52] from the
clValid R package [108]. The Dunn index is the ratio of the smallest inter-cluster distance to the
largest intra-cluster distance. A large index value indicates a good separation of the clusters, and is
our criterion of choice to determine both the appropriate number of clusters and the best performing
clustering algorithm.
We selected clustering algorithms for comparison based on representatives of different classes of
standard techniques: a model-based algorithm (mclust; [107]), hierarchical clustering, k-means,
partitioning around medoids (cluster; [109]), and self-organizing maps (kohonen; [110]). The
last four algorithms utilise a dissimilarity metric to cluster profiles derived from SME, mean and
LMMS and the Euclidean distance metric for DLMMS.
A size-based gene ontology (GO) term enrichment analysis was then performed to validate the biolog-
ical relevance of each cluster, using the hypergeometric distribution based on the number of molecules
in the domain of interest [43]. We specifically examined the molecules’ spatial link (cellular compart-
ment), basal activity (molecular function) and involvement in a series of molecular events (biological
process). All annotations were obtained from the org.Hs.eg.db R package [111].
Differential expression analysis
While cluster analysis can provide valuable insight into behaviour patterns common to groups (clus-
ters) of molecules, differential expression analysis in a time course experiment can highlight signifi-
cant responses to perturbations of each molecule. Our LMMS framework enables assessment of the
significant differences over time or between individual groups based on the whole molecular trajec-
tory instead of analysing individual time points.
LMMS for differential expression analysis (LMMSDE). We extended the LMMS modelling
framework to test between groups, across time, and for interactions between groups and time as
follows. Suppose we have R different groups of subjects, with hi denoting the group for each subject
i. Further, we define hir to be the indicator for the rth group, that is, hir = 1 if hi = r and 0 otherwise.
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Figure 2.3: Workflow for the profile cluster analysis. Trajectories derived from linear mixed model
spline (LMMS) and derivative linear mixed model spline (DLMMS) were compared to trajectories
derived either from the mean or smoothing splines mixed effects (SME) models. Five clustering
algorithms - hierarchical clustering (HC), kmeans (KM), self-organizing maps (SOM), model-based
(model) and partitioning around medoids (PAM) were then applied on modelled trajectories using a
range of two to nine clusters. The performance of each algorithm was assessed using the Dunn index.
Gene ontology (GO) term enrichment analysis was performed on each of the obtained clusters.
Starting from the model in Eq. 2.3 which is fit for a single group, we can extend our formulation to
allow for variations to the mean curve depending on which group contains each subject. Thus the
mean curve for each group fhi in the full LMMSDE model is given by:
fhi(tij) = β0 + β1tij +
K∑
k=1
uk(tij − κk)+
+
R∑
r=2
hir(α0r + α1rtij) +
R∑
r=2
hir
{
K∑
k=1
vrk(tij − κk)+
}
.
(2.6)
For each r = 1, . . . , R, α0 = α0r are the differences in intercept between each group and the first
group; α1 = α1r are the differences in slope between each group and the first group; and vrk are the
differences in spline coefficients between each group and the first group.
We can test different hypotheses depending on which parameters are equal to zero. Firstly, for a
single group, ∀r > 1, we have hir = 0, and time effects will be detected only if the goodness of fit of
this model is better than the null model which fits only the intercept. Secondly, to detect differences
between groups, we set α1 = 0 and β1 = 0, and test a goodness of fit against the null model which
also has hir = 0. Finally, if we include all parameters we can model the group * time interactions,
by allowing different slopes and intercepts in the different groups. We compare this to the null model
where the effects over time do not differ between groups. For each case we compared the fit of the
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expanded model from Eq. (2.6) with the corresponding null model using the likelihood ratio test as
implemented in the anova function from the R package nlme [65].
Comparisons with LIMMA. We compared our approach to LIMMA [62], which is a set of meth-
ods for microarray data analysis integrating empirical Bayes approaches with linear models. We
tested for differences over time and between groups using the following two-step process. First, lin-
ear spline models were fitted over time for every group. Second, contrasts of coefficients from the
fits were tested for significance. Correction for multiple testing was applied for both methods for a
significance level of 0.05 using the FDR approach from [101]. Note that no filtering was performed
before differential expression analysis for two reasons: first, we wanted to compare the results based
only on differences between models, and not on differences in filtering approaches; second, p-values
derived from LIMMA are based on the spread of the genewise variance estimates and the removal of
non-informative profiles, based on the genewise variance, will change the distribution of the variance
and hence will decrease sensitivity and specificity.
2.3 Results
2.3.1 Quality control and filtering
We considered the performance of our filtering procedure in both proteomics and transcriptomics
datasets. On the iTraq breast cancer (Fig. 2.4 A) and iTraq kidney rejection data (Figs. 2.4 B, C) we
obtained one cluster with low RT and RI ratios, and a second cluster with high values for the two
ratios. The molecules from the second cluster were removed for further analysis. Similar types of
clusters were observed for all transcriptomics datasets.
In total, between 35% and 76% of the data were removed (Table 2.1). As our filtering process is based
on identifying high signal to noise ratios over time, we expected the remaining profiles to be enriched
for those differentially expressed over time. In Fig. 2.5 we present the relationship between the filter
ratios and p-values obtained from performing a differential expression analysis over time using the
new LMMSDE approach. We highlight the decrease in p-values when there is a decrease in filter
ratios in the M. musculus data (similar results were obtained in the other datasets). However, contrary
to our expectation we also observed for some low RT values large p-values. We can explain the large
p-values for low RT in Fig. 2.5 A by the presence of a large number of missing values (> 50%) in
the raw data (Fig. 2.5 B). Subsequently, the removal of profiles with more than 50% of missing data
resulted in the expected previously described trend of decreasing p-values with decreasingRT and RI
values (Fig. 2.5 C).
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Figure 2.4: Clustering of filter ratios on proteomic datasets. Scatterplots of filter ratios RT on the
x-axis against RI on the y-axis for A) iTraq breast cancer dataset and B) and C) the iTraq kidney re-
jection dataset for group allograft rejection (AR) and non-rejection (NR) respectively. Colors indicate
clusters from a 2-cluster model-based clustering, with red squares indicating molecules that cluster as
‘informative’ and will remain in the analysis and blue circles indicating ‘non-informative’ molecules
that will be removed prior to analysis.
Figure 2.5: Filtering ratios of the Mus musculus data. The filter ratios RT and RI were calculated
for every molecule. Colors in A) indicate the -log10(p-values) for differential expression over time
and in B) the proportion of missing values. C) is after discarding profiles with > 50% of missing
values, with colors as in A).
2.3.2 Modelling
The power of our LMMS modelling lies in its ability to adaptively fit the complexity of the data.
Since some molecules are more prone to subject-specific variations than others, we generally expect
that a single model will be insufficient to appropriately model all types of trajectories. We illustrate
our point through the application of LMMS to datasets with increasing biocomplexity. Biocomplex-
ity in this context is defined as diversity in the genetic markup and/or environmental factors that lead
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to nonlinear interactions of active biological molecules. Here as example we define an in vitro cell
line less-complex because molecular changes are measured in a controlled environment and are ge-
netically identical compared to H. sapiens with varying genetic and environmental factors. Table 2.1
shows that the proportion of complex models required to summarise molecule profiles increases with
biocomplexity.
Table 2.1: Types of models used to summarise profiles. The number (proportion) of profiles mod-
elled with each model selected by our proposed LMMS approach. Models are abbreviated as linear
(LIN), spline (SPL), subject-specific intercept (SSI), and subject-specific intercept and slope (SSIS).
Models were applied to cell line breast cancer data (Cell), Saccharomyces paradoxus evolution data
(Yeast), Mus musculus chemotherapy data (Mouse), and Homo Sapiens kidney rejection non-rejection
(NR) data (Human). The row ’Removed’ indicates the percentage of filtered profiles using the 2-
cluster model-based clustering on RT and RI .
Model Cell Yeast Mouse Human
LIN Eq. 2.1 93 (.55) 125 (.035) 205 (.1) 3 (.091)
SPL Eq. 2.2 75 (.45) 3,427 (.95) 1,769
(0.87)
3 (.091)
SSI Eq. 2.4 30 (.008) 56 (.028) 10 (.3)
SSIS Eq. 2.5 2(.0005) 3 (.002) 17 (.51)
# Modelled 168 3,584 2,033 33
% Removed 36 35 67 76
2.3.3 Clustering
We compared clustering of profiles from the iTraq breast cancer dataset which had been modelled with
mean, SME, LMMS and DLMMS (Fig. 2.6). For each method, performance of different algorithms
and optimal number of clusters (from two to nine) was assessed using the Dunn index.
This criterion resulted in different selections for these two quantities for the four modelling ap-
proaches (Figure S2.3). This in turn led to different shapes of profiles being represented in the clus-
ters selected for each modelling approach. The LMMS modelled profiles could be grouped into the
largest number of clusters, which allowed better discrimination between temporary changes and linear
increases/decreases over time when compared to the other approaches (Fig. 2.6 A).
We subsequently assessed the biological relevance of the proteins identified within each cluster with
a GO term enrichment analysis. After removal of GO terms that contained only one molecule, we
identified 62 unique enriched GO terms (adj. p-value ≤ 0.05, Table S2.1) across all clusters and
methods. Most of the methods identified some specific and unique GO terms: 9 for LMMS, 10 for
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Figure 2.6: Clustering of the iTraq breast cancer dataset. Clustering was performed on the sum-
marised profiles obtained from A) linear mixed model spline (LMMS), B) derivative linear mixed
model spline (DLMMS), C) mean and D) Smoothing Splines Mixed Effects (SME). The best clus-
tering algorithm and the best number of clusters were chosen according to the Dunn index. In A),
B) and D) we used hierarchical clustering and in C)partitioning around medoids (PAM) clustering.
The x-axis represents time (in hours) and the y-axis intensity in terms of log2 transformed protein
abundance.
mean and 1 for DLMMS (Fig. S2.4 B ). Clustering profiles using the methods mean and SME re-
sulted in the enrichment of the intrinsic apoptotic signaling pathway (GO:0097193) which was found
to be altered under IGF-1 stimulation [112]. Both LMMS and DLMMS found enriched biological
function for programmed cell death (GO:0012501) and negative regulation of programmed cell death
(GO:0060548), which were also shown to be altered under IGF-1 stimulation [113].
Interestingly, among the enriched GO terms identified by LMMS or DLMMS we observed biologi-
cal processes involved in glucose metabolic processes (GO:0006006), glycolysis (GO:0006096) and
gluconeogenesis (GO:0006094). These processes play an important role in cancer progression [114],
indicating that growth of the cancer cells may be stimulated by IGF-1. The small cluster numbered
3 for the LMMS profiles was the only cluster in any of the methods that identified profiles with
monotonically increasing expression. These profiles were involved in biological processes such as
gluconeogenesis (GO:0006094), G-protein coupled receptor binding (GO:0001664) and phosphory-
lation (GO:0016310), which have all been shown to be an important part of the IGF-1 signalling
cascade in association with cancer [115],[116], [113] (Table S2.2).
2.3.4 Differential expression analysis
Simulated data. We compared the proposed LMMSDE with LIMMA on the unfiltered simulated
data with varying expression patterns and levels of noise. For each scenario, we recorded how many
of 50 differentially expressed molecules were detected as significant after correction for multiple test-
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ing and calculated average sensitivity and specificity over all 100 replicates (Table 2.2). Overall,
LIMMA and LMMSDE performed very well at a noise level similar to what was observed in real
data (Noise = 1), with both specificity and sensitivity higher than 0.96 for fold change (FC) lev-
els above 1.5. For lower fold changes (FC = 1.25), differences between the two methods became
more apparent. LMMSDE was still very sensitive (0.98) to group differences, but the performance
of LIMMA (0.85) dropped. With increased variability, the difference between methods became more
dramatic, as LMMSDE was much more sensitive compared to LIMMA except for the lowest FC. Sim-
ilar trends were observed for all differential expression tests performed and LMMSDE consistently
outperformed LIMMA for low FC and high variability.
Table 2.2: Simulation results. Averaged sensitivity for LMMSDE and LIMMA after 100 simula-
tions. Differential expression between groups and/or time was tested with increasing noise and fold
change (FC) levels.
Effect Noise FC LMMSDE LIMMA Effect Noise FC LMMSDE LIMMA Effect Noise FC LMMSDE LIMMA
1.25 0.877 0.793 1.25 0.98 0.85 1.25 0.96 0.927
1 1.5 0.981 0.963 1 1.5 0.997 0.976 1 1.5 0.993 0.987
time 2 0.997 0.992 group 2 0.999 0.995 group 2 0.999 0.998
1.25 0.044 0.019 1.25 0.66 0.053 ∗ time 1.25 0.347 0.124
3 1.5 0.667 0.354 3 1.5 0.943 0.494 3 1.5 0.845 0.703
2 0.939 0.838 2 0.986 0.881 2 0.965 0.938
iTraq kidney rejection data. We performed a differential expression analysis on the iTraq kidney
rejection dataset to illustrate our LMMSDE analysis on complex and real data. In addition to ap-
plying the differential expression approaches LIMMA and LMMSDE on the full data set as in the
simulated case study, we also applied our filtering approach for multiple conditions and removed pro-
files that were identified as non-informative in both conditions (64% of profiles were removed) before
LMMSDE analysis. Filtering before differential expression analysis was only applied for LMMSDE,
since removal of non-informative profiles should increase statistical power without biasing results. In
contrast, filtering before LIMMA analysis affects posterior estimates and can bias p-values.
We compared LMMSDE and LIMMA in terms of the number of proteins declared as differentially
expressed between the two groups and investigated their biological relevance with respect to the
biological questions from the study. Two analyses were performed: to identify the molecules with
significant differences between groups, and to identify molecules showing significant group*time
interactions leading to different trends between the two groups over time. While no differentially
expressed molecules were identified by LIMMA for either group or interaction effects, LMMSDE
identified 35 differentially expressed proteins with a group effect and 12 proteins with a significant
39
interaction effect (FDR adjusted p-value < 0.05). On the filtered dataset LMMSDE identified 13
molecules with a significant group effect and nine molecules with a significant interaction effect.
Note that these differentially expressed proteins were also identified in the analysis of the full dataset.
The effect size of differential proteins identified with both group and interaction effects tended to be
small, with a magnitude of average fold change of < 1.5.
For the 13 (three not annotated) molecules that were declared as differentially expressed between
groups, the top enriched biological process (Table 2.3) was the negative regulation of endopeptidase
activity (GO:0010951). This is of interest since an increase in the activity of serum neutral endopep-
tidase has been shown to play an important role in acute renal graft rejection [117]. An additional
enrichment observed in the complement activation (GO:0006956) is also of biological relevance as in-
nate immune responses are major causes of graft rejection [118]. Therefore, these molecules present
good candidate biomarkers for the prediction of allograft rejection. Some differentially expressed
molecules were also present in biological processes involving platelet degranulation (GO:0002576)
and platelet activation (GO:0030168), which have been shown to contribute to hyperacute rejection
of both allografts and xenografts [119].
Out of the nine molecules (1 not annotated) with a significant interaction between group and time, the
most promising protein differentially expressed was IQ calmodulin-binding motif-containing protein
1 (IQCB1). This protein is particularly relevant to this study, as it is a nephrocystin protein localised to
the primary cilia of renal epithelial cells. Mutations in this gene were shown to be strongly associated
with Senior-Løken-Syndrome Type 5, a disorder causing nephronophthisis and renal failure [120].
2.4 Discussion
Thus far, very few methods have been developed to analyse high-throughput time course ‘omics’
data. Statistical analysis is challenging due to the high level of noise relative to signal in such data,
and the time measurements add an extra dimension of variability both within and among subjects.
Our data-driven approach focuses on magnifying the inherent signal, by removing non-informative
profiles that potentially interfere in downstream analysis, and by using a linear mixed model spline
framework to account for subject-specific variability. This procedure provides clearer signals in both
clustering and differential expression analysis.
The filtering of non-informative profiles is an important first step in analysis, as such profiles other-
wise introduce noise and reduce statistical power in downstream clustering and differential expression
steps [121], [106], [122]. We have extended the standard deviation filter for static microarray exper-
iments proposed by [106] and introduced a computationally fast approach accompanied by useful
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Table 2.3: iTraq kidney rejection dataset: Gene ontology (GO) term enrichment analysis. GO
term enrichement analysis based on the proteins identified by LMMSDE as differentially expressed
between allograft rejection (AR) and non-rejection (NR) patients after filtering using a 2-cluster
model-based clustering based on RT and RI . The top GO biological processes are listed along with
their FDR adjusted p-value and log odds ratio (OR).
GO GO Description adj. p-value log(OR)
GO:0010951 negative regulation of endopeptidase activity 4.30e-03 5.57
GO:0006956 complement activation 6.40e-03 6.45
GO:0006958 complement activation, classical pathway 6.40e-03 6.36
GO:0002576 platelet degranulation 8.30e-03 5.67
GO:0045471 response to ethanol 8.30e-03 5.55
GO:0042593 glucose homeostasis 8.80e-03 5.43
GO:0006935 chemotaxis 1.00e-02 5.14
GO:0007596 blood coagulation 1.00e-02 3.84
GO:0030168 platelet activation 1.70e-02 4.30
visualisations (see Figs. 2.4, 2.5). We demonstrated that our filtering approach was effective at dis-
criminating informative from non-informative profiles by comparing the values of our filter statistics
RT and RI with the test statistics from differential expression analysis over time.
For multiple treatment groups, we filtered separately for each group, removing only molecules iden-
tified as non-informative in both groups. An alternative option would be to calculate the ratios for
each group separately, but apply the model-based clustering on all ratios from all groups. We found
very little differences compared to a filtering approach applied on each treatment group. Using one
of these approaches, it is possible that molecules that vary between groups, but show little change
over time could be removed. However, these molecules, though differentially expressed, would be
detected in a cross-sectional study, and are most likely not of primary interest in time course studies
where the focus is on molecules changing expression over time.
In spite of the clear relationship between differential expression and filter ratios, we found the selec-
tion of thresholds to be challenging. Threshold choice can be affected by a variety of issues such as
level of missing data and the number of replicates at each time point. In our analysis, we applied
2-cluster model-based clustering on the ratios to discriminate informative from non-informative pro-
files. However, we suggested guidelines to address these issues and our R package lmms allows the
user to set their own thresholds. A drawback of our proposed filtering method is the requirement of
the same sampled time points across subjects, and the need for at least three replicates per time point.
If these do not hold, it may be necessary to collapse time points into bins prior to analysis to have
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sufficient density of data. Further investigation of filters allowing for less constrained sampling could
be very useful for adaptive sampling designs.
Current modelling approaches for time course data fit the same statistical model to each molecule, al-
lowing for either subject-specific intercepts [38] or subject-specific intercepts and slopes [39]. How-
ever, we expect that effects of environmental and/or genetic factors on expression vary for individual
molecules. Therefore, as acknowledged by [39], the use of only one model for all molecules has
the serious limitation of under-smoothing or over-smoothing the representative profiles. Our method
improved upon existing methods by allowing the data to drive the complexity of the models rather
than having a single fixed model. Our analyses showed that model flexibility was necessary, and that
not only was the choice of model molecule-dependent, but also the proportion of complex models
increased with biocomplexity. Our LMMS modelling approach was applied to a range of typical time
course transcriptomics and proteomics experiments with different numbers of replicated measure-
ments (3 to 20 per time point) and time points (4 to 6), and we expect the approach to be scalable and
highly valuable for larger experiments.
To identify the best model fit of one of the proposed models we used a likelihood ratio test with a
significance level of 0.05. Other model selection criteria like the Akaikes information criterion (AIC)
[123] or the Bayesian information criterion [124] which penalise the likelihood measurement to pre-
vent over or under-fitting could have been considered. Both criteria are based on various assumptions
and asymptotic approximations and while AIC tends to select more-complex models, BIC tends to
select less-complex models [125]. Another difficulty when using AIC or BIC is to define a threshold
to determine if a more-complex model is more appropriate than the less-complex model. Often these
thresholds are based on rules-of-thumb or are established via simulation which with this many num-
ber of molecules can be particularly computational challenging. The advantage of AIC and BIC as
opposed to a likelihood test is that these measurements can be used to compare non-nested models;
however we compare only nested models. Further it was found that comparison of two models using
information criteria can be viewed as equivalent to a likelihood ratio test, with the different models
representing different alpha levels [125], [126]. Hence, we decided that the log likelihood test with a P
value threshold of 0.05 presents a sensitive choice to select the best model to fit molecular trajectories.
In this study we clustered time course data based on their summarised profiles to identify groups of
molecules representing relevant molecular processes. We did not consider here clustering of subjects
to identify groups with similar sub-phenotypes. However, similar approaches can be applied to this
alternate biologically interesting question [127].
Clustering analysis relies not only the choice of algorithm, but also on the number of clusters and
the distance metric. There are a variety of options available for all of these, but we have focused
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on common choices in this study, and expect that other options would produce similar results. We
observed that application of different modelling approaches (e.g. mean, SME, LMMS) resulted in
different input data structure to the clustering algorithms. As clustering outputs are highly dependent
on the input data structure [42], it was not surprising that the clustered patterns and the optimal number
of clusters varied across algorithms and consequently led to differences in biological interpretation
between clusters. We showed that applying LMMS prior to clustering allowed the identification of a
cluster of biologically interesting co-expressed genes. This highlights the importance of accurately
modelling before clustering.
Differential expression analysis is often based on an underlying model of the data which attempts to
explain changes over time, between group, and through interactions while simultaneously accounting
for noise in the data. We compared an approach based on linear models, LIMMA, with our approach,
LMMSDE, which is based on our linear mixed model spline framework. An alternate spline-based
approach is EDGE [38], but a comparative analysis was not feasible with the current version of
their package. In our simulation study, we showed that LMMSDE gave superior results as it led
to higher sensitivity, particularly for small fold changes and high noise levels. Consequently, in a
real biological data setting, LMMSDE identified highly relevant differentially expressed molecules
while LIMMA identified none. We note that for both LMMSDE and LIMMA, the choice of spline
basis can have a major effect on differential expression analysis. We have focused here only on the
linear penalised spline basis, but there are many alternatives available, including the smoothing spline
and penalised cubic spline, which we have implemented as options in our R package lmms. Higher-
degree polynomials may provide additional power for detection of differential expression over time
when the profiles display nonlinear behaviour, as in cluster 1 (Fig. 2.6) for the breast cancer data.
An additional benefit of LMMSDE was the ability to first perform filtering, which reduced the number
of tests performed and increased our ability to detect truly differentially expressed molecules. The
same type of analysis could not be performed with LIMMA, as its test statistic is based on an empirical
Bayes approach using posterior estimators for degree of freedom and standard deviation. Therefore,
a filtering of low variance molecules would affect posterior estimates [106] and bias the results. By
proposing a unified framework we thus achieve gains throughout the entire statistical analysis process.
2.5 Conclusion
We proposed a novel framework for analysing time course ‘omics’ data, unifying quality control and
filtering, modelling, and analysis in a linear mixed model spline framework. The first step ensures
the reproducibility and interpretability of the data. The second step is a highly flexible data-driven
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approach aimed at modelling high-throughput data with potentially different noise levels and trajec-
tories over time. It can handle missing values, has low computational burden, and avoids arbitrary
input parameters. In the third step, similarities between profiles can be assessed through clustering,
or differences over time and between groups can be assessed through LMMSDE. The unification of
our modelling with clustering led to the identification of biologically relevant profile clusters. The
unification of our modelling with differential expression analysis outperformed LIMMA in the situa-
tions of high noise levels and low fold changes. In application of LMMSDE to real data, this higher
sensitivity resulted in novel identification of differentially expressed molecules biologically relevant
to kidney rejection. The LMMS framework is implemented in the R package lmms and is freely
available for download from CRAN.
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SUPPORTING MATERIAL
GENERATION OF SIMULATED DATA
We simulated 100 datasets with different case scenarios including three different fold changes (FC),
three types of differential expression (DE) profiles and two different noise levels. Each simulated
dataset consisted of 140 profiles measured on six time points and 40 individuals. Using the NR
patients from the iTraq kidney rejection dataset, we first extracted the individual variance σ2U and
error variance σ2 from the individual-specific random intercepts and slopes from our fourth LMMS
model (Eq. 5 in the main paper). From these estimates, we generated DE profiles as described below.
Let yij be the simulated expression of a molecule for individual (or biological replicate) i where
i = 1, 2, ..., n, j = 1, 2, ...,mi with n = 40 is the sample size and mi = 6 is the the number of
time points observed for each individual i. Starting from flat (null) profiles, we added a randomly
assigned individual effect called subject.effectij ∼ N (0, σ2U) as well as a molecule-specific error,
ij ∼ N (0, σ2 ). We then randomly assigned to 50 molecules different types of differential expression
depending on the fold change levels (referred to as de.effectj) and noise levels ij . The remaining 90
molecules were modelled with no differential expression effect (i.e. de.effectj = 0).
Each simulated expression trajectory yij can be written as:
yij ∼ 0 + subject.effectij + de.effectj + ij,
with
• subject.effectij ∼ N (0, σ2U) is the stochastic subject-specific noise,
• de.effectj = 0 if the the molecule is not differentially expressed between the two groups other-
wise it can take different values depending on the intended test:
– Time effect: de.effectj takes values between log(1) and log(FC) depending on the time
point with FC=1.25, 1.5 or 2,
– Group effect: de.effectj takes the value log(FC) with FC=1.25, 1.5 or 2,
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– Group*Time effect: de.effectj takes values between log(1) and log(FC) depending on
the time point, the fold change FC=1.25, 1.5 or 2 and the group to which the individual
belongs.
• ij ∼ N (0, σ2 ) is the stochastic noise and can take the following values:
– Noise 1: ij ∼ N (0, σ2 )
– Noise 3: ij ∼ N (0, 3 ∗ σ2 ).
Fig. S2.1 illustrates some simulated profiles for the time, group and group * time interaction cases.
Figure S2.1: Example of simulated profiles with a time effect (Fig. A), a group effect (Fig. B) and
a group and time interaction (Fig. C). The noise level is equal to that in the kidney rejection data and
the groups of each individual are indicated in grey full lines (group 1) or black dashed lines (group
2). In Fig. A the expression increases over time with a fold change of log(2) from the first to the last
time points, in Fig. B the fold change between the two groups is equal to log(2), in Fig. C the profiles
measured on individuals from group 1 (group 2) increase (decrease) over time with a fold change of
log(2).
QUALITY CONTROL AND FILTERING
High quality input data is crucial for reproducibility and interpretability, particularly in time course
‘omics’ where there are a large number of molecules, often observed across relatively few individuals
and time points.
Motivation for our definition of filter ratios. In the main paper, we have defined sT as the average
standard deviation (SD) per time point, sI the average SD per individual and sM as the SD for the
molecule over all individuals and time points. We introduced the definitions of the two filter ratios,
RT =
sT
sM
and RI = 1− sIsM to quickly assess the profile quality and filter out ‘noisy’ profiles prior to
analysis. The accompanying R package lmms provides an example, and gives the user the flexibility
of choosing the RT and RI threshold values.
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Figure S2.2: Relationship between filter ratios, differential expression and presence of missing
values in multiple datasets. Filter ratios RT (x-axis) and RI (y-axis) are shown for: simulated data
(Fig. A); iTraq breast cancer data (Fig. B); Saccharomyces paradoxus evolution data (Fig. C);
iTraq kidney rejection Allograft Rejection (AR) data (Fig. D). Molecules are coloured according to
−log10 p-values for linear mixed model spline for differential expression analysis (LMMSDE) test for
differential expression over time (first column) and the proportion of missing values (second column).
Relationship between filter ratios, differential expression and presence of missing values. To
characterise the behaviour of the filter ratios on different datasets, we consider their relationship with
differential expression over time (using our approach LMMSDE) and proportion of missing data.
Our first observation is that lower filter ratios typically correspond to more significantly expressed
molecules, so our choice of thresholds is unlikely to remove molecules differentially expressed over
time (column 1 in Fig. S2.2). Our second observation is that molecules with large amounts of missing
data may not be excluded using the filtering thresholds (column 2 in Fig. S2.2 and especially case
study Fig. B2 in Fig. S2.2). Hence we removed profiles with more than 50% missing values.
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CLUSTERING
Selection of cluster algorithm. We have compared several clustering approaches: one model-based
algorithm (R package mclust; [107]) and four algorithms based on a distance metric: hierarchical
clustering (HC), kmeans (KM), partitioning around medoids (PAM, R package cluster; [109]),
and self-organizing maps (SOM, R package kohonen; [110]). We assessed the performance of the
five clustering algorithms with an internal consistency criterion, the Dunn index, while varying the
number of clusters from two to nine (Fig. S2.3).
Figure S2.3: Internal stability of iTraq breast cancer clusters: using the mean (Fig. A); smooth-
ing splines mixed effects (SME) (Fig. B); linear mixed-effect model spline (LMMS) (Fig. C) and
derivative LMMS (DLMMS)(Fig. D) for summarising the profiles across the biological replicates.
Dunn indices are displayed for a number of clusters varying from two to nine with the five different
cluster algorithms: hierarchical clustering (HC), kmeans (KM), partitioning around medoids (PAM),
model-based (model) and self-organizing maps (SOM). Higher Dunn indices indicate better clustering
performance.
Cluster GO enrichment analysis. GO term enrichment analysis as described in the main manuscript
was used to gain additional insight into the biological relationships between molecule profiles belong-
ing to the same cluster. We calculated p-values using the hypergeometric distribution based on the
number of molecules in the domain of interest. Fig. S2.4 shows the overlap of enriched GO terms
identified by clustering the different modelling approaches on the iTraq breast cancer dataset (mean,
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SME, LMMS and DLMMS) before and after removing GO terms that contained only one molecule.
Table S2.1 lists the common enriched GO terms in at least two of the mean, SME and LMMS and
DLMMS clusters, while Table S2.2 lists the enriched GO terms uniquely identified by each set of
clusters.
Figure S2.4: iTraq breast cancer cluster gene ontology (GO) term enrichment analysis. Venn
diagram of significantly enriched GO terms identified by clustering of the mean, smoothing splines
mixed effects (SME) , linear mixed model spline (LMMS) and derivative LMMS (DLMMS) before
(Fig. A) and after (Fig. B) removing GO terms that contained only one molecule.
Table S2.1: iTraq breast cancer dataset: overlapping enriched gene ontology (GO) terms.
Shown are the GO terms identified concordantly by clustering of at least two of the modelling ap-
proaches (linear mixed model spline (LMMS), derivative LMMS (DLMMS), mean or smoothing
splines mixed effects (SME)).
GO GO Description Method
GO:0045095 keratin filament LMMS, DLMMS, Mean, SME
GO:0005882 intermediate filament LMMS, DLMMS, Mean, SME
GO:0044822 poly(A) RNA binding LMMS, DLMMS, Mean, SME
GO:0005634 nucleus LMMS, DLMMS, Mean, SME
GO:1900740 positive regulation of protein insertion into
mitochondrial membrane involved in apop-
totic signaling pathway
LMMS, DLMMS, Mean, SME
GO:0005200 structural constituent of cytoskeleton LMMS, DLMMS, Mean, SME
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GO:0005198 structural molecule activity LMMS, DLMMS, Mean, SME
GO:0005719 nuclear euchromatin DLMMS, Mean, SME
GO:0005615 extracellular space DLMMS, Mean, SME
GO:0005515 protein binding DLMMS, Mean, SME
GO:0005737 cytoplasm DLMMS, Mean, SME
GO:0005829 cytosol LMMS, Mean, SME
GO:0031982 vesicle LMMS, DLMMS, Mean
GO:0030529 ribonucleoprotein complex LMMS, DLMMS, Mean
GO:0006096 glycolytic process LMMS, DLMMS, Mean
GO:0031012 extracellular matrix LMMS, DLMMS, Mean
GO:0004743 pyruvate kinase activity LMMS, DLMMS, Mean
GO:0023026 MHC class II protein complex binding LMMS, DLMMS, Mean
GO:0003725 double-stranded RNA binding LMMS, DLMMS, Mean
GO:0097193 intrinsic apoptotic signaling pathway Mean, SME
GO:0001895 retina homeostasis Mean, SME
GO:0031490 chromatin DNA binding Mean, SME
GO:0021762 substantia nigra development Mean, SME
GO:0097110 scaffold protein binding Mean, SME
GO:0005925 focal adhesion Mean, SME
GO:0070062 extracellular vesicular exosome Mean, SME
GO:0019904 protein domain specific binding Mean, SME
GO:0072562 blood microparticle Mean, SME
GO:0004601 peroxidase activity Mean, SME
GO:0006605 protein targeting Mean, SME
50
GO:0014069 postsynaptic density Mean, SME
GO:0071901 negative regulation of protein serine/threo-
nine kinase activity
Mean, SME
GO:0042470 melanosome DLMMS, Mean
GO:0031093 platelet alpha granule lumen LMMS, Mean
GO:0008285 negative regulation of cell proliferation LMMS, Mean
GO:0000790 nuclear chromatin LMMS, Mean
GO:0008544 epidermis development LMMS, DLMMS
GO:0006006 glucose metabolic process LMMS, DLMMS
GO:0005929 cilium LMMS, DLMMS
GO:0030955 potassium ion binding LMMS, DLMMS
GO:0012501 programmed cell death LMMS, DLMMS
GO:0060548 negative regulation of cell death LMMS, DLMMS
GO:0005975 carbohydrate metabolic process LMMS, DLMMS
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Table S2.2: iTraq breast cancer dataset: unique identified gene ontology (GO) terms. Enriched
GO terms uniquely identified by clustering of the profiles modelled by the different approaches con-
sidered. For each enriched term, the cluster number (Cluster), the number of molecules with GO
terms in that cluster (Counts), the number of molecules in the data with that GO term (NMol), the
number of molecules in the cluster (Size), the GO description, ontology (Ont), false discovery rate ad-
justed p-value (adj. p), and log odds ratio (OR) are given. The table is sorted by p-value within each
cluster. Linear mixed model spline (LMMS); derivative LMMS (DLMMS) and smoothing splines
mixed effects (SME) use hierarchical clustering while the mean uses PAM clustering. For LMMS
three clusters were identified, while two clusters were identified for DLMMS, mean and SME.
Method ClusterCountsNMol Size GO GO Description Ont adj. p log(OR)
LMMS 3 7 19 51 GO:0005681 spliceosomal complex CC 1.50e-03 3.55
3 6 16 51 GO:0006094 gluconeogenesis BP 4.20e-03 3.56
3 6 19 51 GO:0000287 magnesium ion binding MF 9.10e-03 3.18
3 3 4 51 GO:0001664 G-protein coupled recep-
tor binding
MF 1.50e-02 5.79
3 3 4 51 GO:0016234 inclusion body CC 1.50e-02 5.79
3 5 15 51 GO:0016310 phosphorylation BP 1.80e-02 3.26
3 3 5 51 GO:0031072 heat shock protein bind-
ing
MF 3.00e-02 4.79
3 3 5 51 GO:0031397 negative regulation of
protein ubiquitination
BP 3.00e-02 4.79
3 3 5 51 GO:0042623 ATPase activity, coupled MF 3.00e-02 4.79
DLMMS2 3 3 130 GO:0001890 placenta development BP 0.047 Inf
mean 2 2 11 2 GO:0008285 negative regulation of
cell proliferation
BP 3.00e-03 Inf
1 49 195 166 GO:0016020 membrane CC 6.20e-03 1.11
1 31 109 166 GO:0005886 plasma membrane CC 1.10e-02 1.27
1 13 33 166 GO:0005856 cytoskeleton CC 2.20e-02 1.90
1 8 16 166 GO:0030018 Z disc CC 3.70e-02 2.49
1 12 26 166 GO:0019901 protein kinase binding MF 9.80e-03 2.30
1 6 9 166 GO:0008092 cytoskeletal protein bind-
ing
MF 2.20e-02 3.48
1 6 9 166 GO:0044325 ion channel binding MF 2.20e-02 3.48
1 9 20 166 GO:0003674 molecular function MF 4.40e-02 2.21
1 13 36 166 GO:0019899 enzyme binding MF 4.80e-02 1.69
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3. TIMEOMICS: AN INTERACTIVE TOOL FOR
TIME COURSE DATA ANALYSIS
ABSTRACT
Time course ‘omics’ experiments give valuable insights into a system’s molecular behaviour after
perturbation or during developmental processes. The analysis of these data is not trivial due to their
complexity and high-dimensionality. Thus there is a demand for user-friendly and sophisticated sta-
tistical analysis tools to analyse these data. To meet these needs, we developed TimeOmics, an inter-
active application providing a novel comprehensive framework for researchers without programming
experience. The framework includes quality control, time course modelling and statistical analysis
for ‘omics’ data. Numerous visualisations enable the quality assessment and interpretation of each
analytical step. TimeOmics advantages are that it has a graphical user interface and is based on par-
allel implementation, therefore it makes time course data analysis fast, simple and easily accessible.
TimeOmics is a shiny application using a web application framework for R. The source code is avail-
able under https://github.com/JStrau/TimeOmics.
3.1 Introduction
Time course ‘omics’ data analyses aim to identify molecules reacting to perturbation or driving de-
velopment. However, the identification of these relevant molecules amongst thousands of molecules
measured is challenging due to technical or biological noise and missing samples or measurements.
In a previous study we showed that quality filtering and modelling of the molecule trajectories prior
to clustering and differential expression (DE) analysis improves the robustness of the biological re-
sults [128]. Researchers are in need of user-friendly applications to answer their biological questions,
but current supported tools that provide easy to use time course ‘omics’ data analysis methods via a
graphical user interface (GUI) have limitations. These tools focus on either clustering [43, 129, 44]
or DE analysis [130] and some of them require the data to have one measurement per time point.
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However, most studies carry out experiments with many biological replications.
We introduce TimeOmics, a comprehensive application implementing the different crucial steps for
biological time course data analysis: filtering, modelling, clustering and DE analysis. The quality fil-
tering removes molecules prior to analysis to reduce the noise in the data and modelling summarises
biological replicates. Interactive graphs and tables make data mining and interpretation straight-
forward and are exportable for further use. The web-application is an extended and user-friendly
interface from the R package lmms [131], besides visualisation it adds clustering assessment mea-
surements, gene ontology (GO) enrichment analysis and interactive tables. TimeOmics performs
state-of-the-art analysis techniques and makes them easily accessible to scientists from many disci-
plines. The statistical approaches are suitable for normal distributed data obtained from microarray
and mass spectrometry platforms.
3.2 Methods
3.2.1 Implementation
TimeOmics enhances our recently developed CRAN R package lmms [131] with a GUI and ad-
ditional functionalities using the web application framework shiny [132] to enable the interface
between R programming language and non-expert R users. The analyses run efficiently on high-
dimensional data using parallelisation. For example modelling of 5, 836 molecules with four biolog-
ical replicates and 11 time points carried out in R (version 3.2.2) took approximately two minutes to
process, on a Dell XPS (Intel dual core i7, 2.1 GHz, 8 GB RAM). TimeOmics is fully cross-platform
compatible and the only requirements are installation of RStudio and the R package shiny.
3.2.2 Data requirements
TimeOmics functions are established and tested on data from microarrays and mass spectrometry
platforms. Data are assumed to follow a normal distribution and TimeOmics is therefore not suitable
for data derived from RNA sequencing platforms. TimeOmics does not provide tools for normalising
and transforming the data. Appropriate normalisation methods are technology and platform depend.
For example, Affymerix microarray data can be normalised using the R package affy [133] and
Illumina microarray data using the R package lumi [134] both available on Bioconductor. Data
should always be appropriately normalised and transformed prior to analysis. In addition, the user
needs to be aware of any batch effects that may effect the analysis. Batch effect removal tools are like
the R packages ber and sva are available on CRAN or Bioconductor. Access to the full functionality
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of TimeOmics requires the data to have a minimum of four time points and a minimum of three
biological replicated measurements per time point.
3.2.3 Filtering
‘Omics’ experiments measure the intensity of thousands of molecules at the same time. However, only
a few molecules will respond to treatment or perturbation. Molecules that do not change expression
over time or are noisy (non-informative) can be removed prior to analysis.
The method provided is specifically developed for time course data. It is based on the time to molecule
standard deviation ratio (RT ) and the subject to molecule standard deviation ratio (RI) as described in
Chapter 2 and implemented in the lmms R package [131]. High filter ratios indicate non-informative
molecules. However, filter ratios can be affected by high number of missing values. Therefore, the
filter ratios are visualised along with the proportion of missing values and enable to filter molecules
with a lot of missing data. We suggest to first remove molecules with a high number of missing values
prior to filtering on the filter ratios.
3.2.4 Modelling
In Chapter 2 I showed that data-driven modelling of trajectories is superior to using the mean or
using fixed models, for clustering and differential expression analysis. Therefore, I enable to use our
data-driven method linear mixed model splines (LMMS) from Chapter 2 in TimeOmics. TimeOmics
offers a range of splines to be selected by the user namely ‘cubic’, ‘p-spline’ and ‘cubic p-spline’.
The difference between these splines is the basis function and the way they select the knots or break
points. The ‘cubic’ spline basis as proposed by [28], uses all inner time points of the measured
time interval as knots. Both p-spline and cubic p-spline basis, use the equidistant time points of the
measured time interval as knots as proposed by [36]. Cubic splines are preferred if the number of time
points is small. However, with increasing number of time points this basis can get very computational
expensive. The alternative is to use either the ‘p-spline’ or the ‘cubic p-spline’. Furthermore, if
clustering on the derivative information is of interest it is required to select the the ‘p-spline’ or ‘cubic
p-spline’ basis. The models applied to the data are a linear model (0), a LMMS (1), a LMMS with
subject-specific random intercept (2) and a LMMS with subject-specific random intercept and slope
(3). The minimum number of time points that is required to model the trajectories is four.
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3.2.5 Clustering
Clustering of the molecule trajectories can give valuable insights into a systems molecular behaviour.
Molecule trajectories with the same pattern are believed to be co-regulated, have similar functions or
are involved in the same biological processes. The analysis of the individual clusters for biological
enrichment can therefore be more informative than analysing all differentially expressed molecules
over time. I provide a range of cluster algorithms for the analysis. I found that the performance of the
clustering algorithms is dependent on the data structure. Since little is known about the data structure
prior to analysis I advice to compare the performance using a cluster assessment measurement. The
cluster assessment measurement will help to identify the best performing algorithm and also helps to
find an optimal number of clusters. Clustering can be performed on the LMMS modelled trajectories
Euclidean distance or on the Pearson correlation dissimilarity matrix. Clustering on the Pearson cor-
relation may perform better to group trajectories according to their shape. Clustering on the euclidean
distance will rather lead to clustering on the distance and same shaped trajectories with different ex-
pression levels may not be clustered together.
The data used for the clustering input is either modelled trajectories using the ‘Model’ tab provided
functions, alternatively it can be a single sample experimental design. The following clustering algo-
rithms are provided: hierarchical clustering (HC) with Ward agglomeration method [135], Kmeans
[135], partitioning around medoids (PAM) [109], self-organizing maps (SOM) [110] , model based
clustering (Mclust) [136]. The cluster proportion of non-overlap (CPN) is provided to assess cluster
stability via leave-one-out cross-validation. I modified the implementation of the average proportion
of non-overlap (APN) as proposed by [108] to obtain one CPN per cluster. The CPN measures the
proportion of observations not placed in the same cluster with a clustering based on the full data and a
clustering based on the data with a single time point removed. Let Ci represent the cluster containing
observation i using all of the available data and Ci,−t represent the cluster containing observation i,
where the clustering is based on the dataset with time point t removed. Then T is the number of
different time points, and N is the number of different observations in the data, the CPN is given by:
CPN =
1
TN
N∑
i=1
T∑
t=1
1− C
i,−t ∩ Ci
Ci
The CPN is in the interval [0; 1], with values close to zero corresponding to highly robust clustering
results.
The gene ontology enrichment is computed using the hypergeometric distribution based on the num-
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ber of molecules in the set of interest. Let p be the total number of unique molecules observed in
the experiment, pf the total number of molecules that are in the GO category of interest, and gc the
number of molecules assigned to a given cluster C. Based on the hypergeometric distribution the
p-value of seeing pGO molecules in the intersection of the category of interest and cluster C can be
computed as
min(gc,pf )∑ (pf
i
)(
p−pf
gc−i
)(
p
gc
)
Differential Expression
Differential expression analysis is a mean to identify differentially expressed molecules between
groups and/or over time. Here I enable to use the linear mixed effect model spline differential ex-
pression (LMMSDE) approach as described in Chapter 2 and implemented in the lmms R package
[131].
The spline basis can be selected as described in Section 3.2.4. Given two groups the ‘Type’ of differ-
ential expression analysis to be performed can be selected, either over time, between groups or time
and group interaction or all three at the same time. Given only one group in the data only the test for
differential expression over time is available.
Moreover, the type of ‘Experiment’ can be restricted to use one model for each measured molecule
to save time. I discriminate between ‘Time course’, ‘Longitudinal 1’ and ‘Longitudinal 2’ mod-
els. ‘Time course’ models each molecule with a spline. This model is selected if there is not much
variation across biological replicates expected (e.g. cell cultures). ‘Longitudinal 1’ models a subject-
specific intercept. This model is selected if subject-specific expression levels are expected. ‘Lon-
gitudinal 2’ models each molecule with a random intercept and slope. This model is selected if
subject-specific molecule expression is expected to vary in expression levels and speed of expression
change. However, each molecule expression can be differently affected by environmental or genetic
factors. Choosing one model for all molecules may lead to over- or under-smoothing of the data. A
solution is to let the data drive the modelling process. TimeOmics provides this functionality when
selecting ‘All’ in the ‘Experiment’ drop down menu. All three models are considered and for each
molecule the model that has the best goodness-of-fit is selected. The analysis returns p-values as well
as false discovery rate (FDR) adjusted p-values as proposed by [101].
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3.3 Results
3.3.1 Workflows
TimeOmics can analyse data with either a single biological sample or multiple biological samples.
Figure 3.1 displays the different analysis workflows.
Upload
Model
Cluster
Differential 
Expression
Filter
Multiple samples time course
with filteringA
Upload
Model
Cluster
Differential 
Expression
Filter
Multiple samples time courseB
Upload
Model
Cluster
Differential 
Expression
Filter
Single sample time courseC
Figure 3.1: Workflows. Presented are the possible workflows using TimeOmics. Workflow A and B
are for multiple samples time course experiments. In workflow A after uploading the data, filtering
is performed prior to modelling the expression trajectories and clustering or analysing for differential
expression. In workflow B modelling, clustering and analysing for differential expression is per-
formed without filtering. Workflow C is for single sample time course experiments, where only the
upload and the clustering functions are provided.
Multiple samples time course experiment
In time course studies multiple biological replicates are measured at multiple time points and the
experimental design looks similar to Table 3.1. With these kind of experiments all functions of
TimeOmics are enabled. The analysis can be performed using workflow A or B from Figure 3.1.
Single Sample time course experiment
In the case where only one source is measured or a different approach is used to summarise and model
the trajectories (e.g. using the median or the mean), the experimental design looks like in Table 3.2.
The only functionalities provided are in the ‘Upload’ tab and ‘Cluster’ tab.
3.3.2 Functionalities
The application contains six different tabs: ‘Upload’, ‘Filter’, ‘Model’, ‘Cluster’, ‘Differential Ex-
pression’ and ‘Example and Help’ with customisable main functionalities and are described briefly
below. A built-in example is available for demonstration.
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Sample ID Time Group
1 1 1
1 2 1
1 3 1
1 4 1
2 1 1
2 2 1
2 3 1
2 4 1
3 1 1
3 2 1
3 3 1
3 4 1
Table 3.1: Workflow A or B: Multiple samples experimental design.
Sample ID Time Group
1 1 1
1 2 1
1 3 1
1 4 1
Table 3.2: Workflow C: Single sample experimental design.
The Upload tab not only provides the interface to upload data but also gives first data quality insights
through graphical outputs. TimeOmics requires the upload of the following information: expression
data, sampling time points, source of the sample, and if applicable, the treatment or conditions of each
sample. Optionally, an annotation file for the measured molecules can be provided to be used in the
downstream cluster analysis. Graphical outputs are then produced and help to identify potential batch
effects or sample outliers that could impact the statistical analysis (Figure 3.2). The plots generated
when uploading the files aid the user to check the quality of the uploaded data. The first plot generated
is a histogram plot of the whole uploaded expression matrix (combining all samples and molecules,
Figure 3.2 B). Optionally, the data can be visualised as density distribution by ticking the check box
above the histogram plot ‘Show density’. Data should appear bell shaped (normally distributed) since
samples are assumed to be normalised. If strong deviations from a normal distribution are observed,
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we recommend to normalise the data prior to using TimeOmics. If the data is not normally distributed
TimeOmics may not produce valid results.
On uploading group information the histogram plot will change appearance if more than one group
is available. The histogram and density will display multiple histograms coloured by the according
groups in the sample.
The second plot displays the sample wise boxplot (Figure 3.2 C). Optionally, the density for each
sample can be displayed by ticking the ‘Show density’ check box above the sample boxplot. The
data distribution should be roughly the same for all samples (homogeneously distributed). If sample
boxes show strong deviations it may indicate technical difficulties or batch effects and analysis should
proceed with caution.
Filter tab provides an overview of the quality of each molecule’s trajectory using filter ratios as
detailed in Chapter 2. These filter ratios are visualised with respect to missing values, fold change and
classification information and the filtering thresholds can be set by the user based on those graphical
outputs (Figure 3.3). Given two groups molecules are only filtered if they do not pass the defined
criteria (proportion of missing values, fold change or classification of model based clustering) for
both groups. Filtering is optional, but once applied the consecutive analysis steps will be performed
on the filtered data.
The Model tab provides methodologies to model each molecule’s trajectory using a data-driven lin-
ear mixed effect model spline framework as proposed in Chapter 2. This method fits the best model
on each molecule, namely: a linear fit, spline fit, spline fit modelling subject-specific intercepts and
spline fit modelling subject-specific intercept and slope. The analysis is customisable by selecting
from various spline bases as described in the method section (Figure 3.4 I). Interactive tables (Fig-
ure 3.4 A) enable to explore the modelling results and on selection visualise a molecule’s expression
along with the modelled trajectory (Figure 3.4 B). The modelled trajectory can also be visualised
smoothed or with the mean trajectory.
The Cluster tab enables to cluster molecules and interpret these clusters’ biological function. The
input is either the modelled trajectories from the Model tab, or the expression data from the Upload
tab, in the case where there is a single measurement per time point and molecule. The user can
select amongst five clustering algorithms to be applied on the trajectories themselves or their Pearson
correlation matrix (Figure 3.5 I). As the choice of an optimal algorithm and number of clusters is
challenging, TimeOmics guides the user through graphical outputs of the stability of the clustering
results (Figure 3.5 A). A clustering algorithm and number of clusters can be selected to visualise
clustered trajectories (Figure 3.5 B). Moreover, GO term enrichment analysis can be performed if an
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annotation file containing gene symbols or IPI identifiers is provided. This is currently only available
for human data using the R package org.Hs.eg.db [111] but can be easily augmented for other
identifiers or background databases.
The Differential Expression tab tests each molecule for expression changes over time, between
groups and for group and time interaction, using the built-in linear mixed effect model spline frame-
work from Chapter 2. The analysis returns an interactive table with p-values and can be explored by
sorting columns or searching for molecules. Each molecule in the table can be visualised on selection
displaying the original expression data in addition to the modelled trajectory (Figure 3.6 AB). Given
differential expression analysis was performed including all types, all models can be visualised at
once by clicking the ‘Show plot’ radio button ‘All’. Alternatively, only the ‘Time’, ‘Group’ or ‘Group
and time interaction’ fit can be visualised. Moreover, the raw expression data and the LMMS fitted
data can be visualised along with the mean trajectory or a smoothed fit by selecting the according
check boxes.
The Example and Help tab automatically uploads example data to easily explore TimeOmics func-
tionalities and links to our comprehensive user guide.
3.4 Conclusion
Time course ‘omics’ experiments are becoming increasingly important to understand the dynamics of
biological processes. Our web-interface TimeOmics gives users the unmatched opportunity to make
sense of their complex data through quality assessment, identification of molecules that change ex-
pression over time and exploration of clusters of co-expressed molecules to study their biological
function. This novel tool is using state-of-the-art statistical analysis methods for high-dimensional
time course ‘omics’ data in an interactive, user-friendly and computationally effective way. The
unique comprehensive framework and analysis capabilities combined with its interactive visualisa-
tions places TimeOmics as application of choice to analyse time course ‘omics’ data.
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Figure 3.2: Upload. TimeOmics requires the following data input: I: expression matrix , II: a vector
indicating the sample time point, a vector indicating the sample source, IV: a vector indicating the
grouping and V: optionally the molecule annotation. Select the groups to be analysed A. In B: the
data histogram and C: the sample boxplot are visualised upon uploading the data.
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Figure 3.3: Filter. The ‘Filter’ tab allows to I: filter for proportion of missing values and fold changes.
Moreover, II: filtering can be based on molecules filter rations. The filter ratio plots help to identify
appropriate threshold for A: the proportion of missing values or B: the fold changes. C: Filter ra-
tio plot shows the classification using a model based clustering algorithm and helps to discriminate
between informative and non-informative trajectories.
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Figure 3.4: Model. The ‘Model’ tab (Section 3.2.4) enables the modelling of multiple samples time
course experiments. I: the spline basis used to model the data can be selected. II: after modelling is
completed a summary is obtained with the number of models used to model the data. Moreover, A: a
table is obtained with each molecule and the model used. B: modelled trajectories can be visualised
in addition to the measured data and the mean.
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Figure 3.5: Cluster. The ‘Cluster’ tab enables I: the stability assessment of clusters given different
algorithms and number of clusters. A: a boxplot is visualised to help to choose the algorithm and
number of clusters that predicts the most stable clustering. Then II: the cluster algorithm can be
chosen and the number of clusters to B: visualise the clustered trajectories.
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Figure 3.6: Differential expression. The ‘Differential Expression’ tab enables the differential ex-
pression analysis. I: the basis of the spline, II: the type of differential expression analysis and III:
the kind of experiment performed can be selected. Once the analysis is done a table appears for each
molecule with p-value and FDR adjusted p-value A. By clicking on the molecule in the table B: the
expression data with the modelled trajectories and the mean are visualised.
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Part II
Development of statistical methods and
associated tools to integrate and analyse
multiple time course ‘omics’ data.
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4. DYNOMICS TO IDENTIFY DELAYS AND CO-
EXPRESSION PATTERNS ACROSS TIME COURSE
EXPERIMENTS
ABSTRACT
Dynamic changes in biological systems can be captured by measuring molecular expression from dif-
ferent levels (e.g., genes and proteins) across time. Integration of such data aims to identify molecules
that show similar expression changes over time; such molecules may be co-regulated and thus in-
volved in similar biological processes. Combining data sources presents a systematic approach to
study molecular behaviour. It can compensate for missing data in one source, and can reduce false
positives when multiple sources highlight the same pathways. However, integrative approaches must
accommodate the challenges inherent in ‘omics’ data, including high-dimensionality, noise, and tim-
ing differences in expression. As current methods for identification of co-expression cannot cope with
this level of complexity, we developed a novel algorithm called DynOmics. DynOmics is based on the
fast Fourier transform, from which the difference in expression initiation between trajectories can be
estimated. This delay can then be used to realign the trajectories and identify those which show a high
degree of correlation. Through extensive simulations, we demonstrate that DynOmics is efficient and
accurate compared to existing approaches. We consider two case studies highlighting its application,
identifying regulatory relationships across ‘omics’ data within an organism and for comparative gene
expression analysis across organisms.
4.1 Introduction
High-throughput ‘omics’ platforms such as transcriptomics, proteomics, and metabolomics enable the
simultaneous monitoring of thousands of biological molecules (transcripts, proteins, and metabolites),
typically through a single static experiment [137]. The recent decrease in cost of such technological
platforms has made possible the study of dynamic biological processes by instead quantify molecules
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at several time points. This allows deeper insight into the behaviour of the molecules in situations
ranging from developmental processes to drug response. These time course ‘omics’ experiments en-
able the identification of regulators, and may give a better understanding of the structure and dynamics
of biological systems.
The statistical analysis of dynamic ‘omics’ experiments is difficult. Applying traditional statistical
methods for static experiments is limited, since each time point will be treated as independent, ig-
noring potentially important correlations between sampling times. Indeed, realising the potential
power offered in time course studies to investigate a wide variety of changes is nontrivial. Analyti-
cal challenges are further complicated by noise, small sample sizes per time point, and few sampled
time points. In the past decade, several methods have been proposed to analyse time course ‘omics’
data, with a particular focus on microarray and RNA-Seq data. These methods perform differential
expression analysis using spline fitting [38, 128], Bayesian methods [63, 57, 138, 139], Gaussian
processes [58, 59, 60], and a two-step regression approach (maSigPro [61]). Other methods focus
on clustering expression profiles to identify co-expressed trajectories, e.g., a subset of molecules for
which expression changes occur simultaneously across time [24, 37, 46, 140, 128, 139, 141]. Tar-
geted co-expression analysis can also be performed using various model-based applications to retrieve
data sets from databases given specific query data [142, 143, 144]. Finally, a third category of meth-
ods was proposed based on biological pathway analysis [145, 146] see the detailed review of Spies
et al. [147]. Co-expression analysis can provide valuable insight into the role of molecules during
biological processes [68, 73, 71], but faces significant challenges in dealing with different types of
‘omics’ and their variation in molecular response times. These timing differences or delays in the
initiation or suppression of molecule expression are a common phenomenon in biology and occur
across both different molecular levels and organisms. For example, the study of regulatory processes
after environmental changes has revealed that there is often a measurable delay from the time of sig-
nal introduction to molecular response [96, 148, 68, 66, 73]. This can result from differences in the
reaction kinetics between an enzyme and its substrate, presence of an inhibitor, or altered binding
affinities of transcription factors. Such processes can be studied through time course miRNA and
mRNA data, since miRNAs play an important role in gene translation regulation in many organisms,
through either mRNA translation inhibition or mRNA degradation [149]. This ability of miRNAs
to fine tune gene expression and translation in a broad range of important biological processes is of
broad interest in medicine [150, 151, 152]. While correlation analysis is frequently used to analyse
miRNA-mRNA time course data [153, 154], it may have limited power in situations where delayed
dynamic expression changes of miRNAs relative to mRNA have been observed [150, 155].
Delays can also hinder gene expression comparisons across organisms, since even highly conserved
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processes may vary in timing. The pre-implantation embryonic development (PED) is a highly con-
served process across mammals, reflected through the progression of the same morphologic stages
[156]. Nevertheless, attempts to compare PED in mammals based on gene expression data have faced
challenges due to differences in timing of genome activation and regulatory processes [157]. Hence
ignoring these delays in co-expression analysis can mask true associations; the first step should in-
stead be to detect and quantify the time delay between molecules. This will enable identification of
functionally related molecules regardless of the differences in the timing of expression changes, as
well as allowing quantification of similarities and differences between the observed responses in more
detail.
To date, very few methods for time course ‘omics’ data account for time delay between molecule
expression levels. Aijo et al. [60] recently proposed DynB, a set of methods based on Gaussian
processes, to quantify RNA-Seq gene expression dynamics. This allows rescaling of time profiles,
but only between replicates (i.e., at the sample level) rather than at the molecule expression level. The
most commonly used approach for molecules is to consider the Pearson correlation [70, 154], despite
its obvious limitations for detecting co-expressed molecules when their expression change occurs
at different time points. Lagged Pearson correlation, a.k.a. Pearson cross-correlation for lagged
time series, circumvents this limitation by introducing artificial delays or lags in the time expression
profiles for every possible time shift. The method eventually applies the delay that maximises the
correlation with the original profile, but can be prone to overestimation of delay.
More sophisticated approaches for time course ‘omics’ data come at the expense of computational
cost. Shi et al. [158] proposed an probabilistic model based on multiple datasets tabular combi-
nations to identify pairwise transcription factor and gene (TF-G) pairs under different experimental
conditions. This approach has shown to reduce false positive predictions but requires a time con-
suming learning step on existing and known TF-G pair data [158]. Dynamic Time Warping (DTW)
[159, 160, 161] is an algorithm that aligns the time points of two trajectories to minimise the distance
between them. It can therefore identify similarities between trajectories which may vary in phase and
speed. One variation, DTW4Omics [73] identifies co-expressed molecules with a permutation test,
but this can be computationally expensive. An alternate approach [71] utilises a combined statistic
based on Hidden Markov Models (HMM) and Pearson correlation. HMMs are trained on a set of tra-
jectories where a distribution of values is considered for each time point. This generates a probability
to observe a trajectory under the trained model that can tolerate small delays. While promising, this
approach cannot detect large delays. Additionally, both it and DTW4Omics can only identify posi-
tively correlated trajectories, requiring heavier computational costs to exhaustively explore potential
associations.
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While integrating time course experiments from different ‘omics’ functional levels is the key to iden-
tifying dynamic molecular interactions, its challenging nature has thus far prevented much method-
ological development. Difficulties lie not only in the computation required by complex algorithms,
but also in variation in types of correlation, levels of noise in the expression profiles, and the delays
themselves.
We present DynOmics, a novel algorithm to detect, estimate, and account for delays between ‘omics’
time expression profiles. The algorithm is based on the fast Fourier transform (FFT) [162], which
has already been shown to successfully detect periodically expressed genes in transcriptomics ex-
periments [163, 164, 165]. By combining the FFT angular difference between reference and query
trajectories with lagged Pearson correlation, we are able to characterise the direction and magnitude
of delay, whether the reference and query are positively or negatively correlated. After account-
ing for the estimated delays, similar profiles can be clustered for further insight. Simulation results
show that DynOmics outperforms current methods to detect time shift, both in terms of sensitiv-
ity and specificity. We apply it to two biological case studies: one focusing on the integration of
miRNAs and mRNAs in mouse lung development, and one on the conservation of gene molecular
processes across multiple organisms (mouse, bovine, human) during PED. In both cases, DynOmics
is able to unravel timing differences between ‘omics’ functional levels, demonstrating its wide ap-
plicability. DynOmics is implemented in the open source programming language R and is freely
available via CRAN [166]. Our repository and user manual are also available at the following link
https://bitbucket.org/Jasmin87/dynomics.
4.2 Material and Methods
The expression changes of molecules monitored in time course experiments often form simple tem-
porary, sustainable or cyclic patterns that can be modelled as mixtures of oscillating/cyclic patterns
using the discrete Fourier transform (FT) [167]. We introduce DynOmics, a novel method that first
converts trajectories to the frequency domain using the FFT, from which it extracts the frequency of
the main cyclic pattern. Condensing the trajectory to information on the main frequency is then used
to identify whether two trajectories are related or associated, while ignoring the noise in each time
expression profile.
4.2.1 Fourier Transform
We first describe the Fourier transform components as depicted in Figure 4.1. For a given time series
x = (x1, . . . , xt, . . . xT ), measured at time points t = 1, . . . T , the FT decomposes x into circular
71
components or cyclic patterns for each frequency k = 1, . . . , T − 1 as:
Xk =
1
T
T−1∑
t=0
xte
−i2pik t
T . (4.1)
As the amplitude at frequency k = 0 simply describes the y-axis offset (i.e., the global differences
of expression levels), this frequency is not included in our analysis context. Equation (4.1) can be
written with polar coordinates with real part a and imaginary part b as Xk = ak + bki (Figure 4.1 A).
For each frequency k = 1, . . . , T − 1 we can calculate the amplitude rk of the component as rk =√
a2k + b
2
k. The amplitude reflects the contribution of the k
th cyclic pattern to the overall trajectory,
and the pattern with maximum amplitude r˜k describes the main shape of the time series (Figure 4.1
B). The argument Arg(Xk) is the offset of the cyclic pattern, defined as:
Arg(Xk = ak + bki) =

2arctan
√
a2k+b
2
k−ak
bk
, if ak > 0 or bk 6= 0,
0, if ak > 0 and bk = 0,
pi, if ak < 0 and bk = 0,
undefined, if ak = 0 and bk = 0.
We can transform the argument to the phase angle (delay) φk in degrees by:
φk =
180 ∗ Arg(Xk)
pi
.
Together, the amplitude and phase angle describe each frequency component, and the set of these
quantities is known as the frequency domain representation.
ak
bk*i
𝑟𝑘 = 𝑎𝑘
2 + 𝑏𝑘
2
ϕ𝑘 =
180 ∗ 𝐴𝑟𝑔(𝑋𝑘)
𝜋
Frequency (k)
0 1 2 3
𝑒𝑖𝐴𝑟𝑔(𝑋𝑘)
r k
a b
Figure 4.1: Diagram of Fourier transform components. a) represents the amplitude r of the circle
and the phase angle φ for a given frequency. b) represents the decomposition of the signal for different
frequencies k, and how many times the decomposed signature is ‘spun’ around the circle(e.g. once
when k = 1, twice when k = 2, etc.) When k = 0, the amplitude represents the y-axis offset of the
data (blue line).
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4.2.2 DynOmics algorithm
We describe DynOmics, a novel method to estimate delays between a reference x and query y given in
frequency domain representation. First, we identify K as the frequency of the pattern with maximum
amplitude for x, i.e., the main reference pattern frequency. Then, for both x and y, we extract phase
angles at this frequency φx = φxK , φy = φyK and define ∆xy = φx − φy as the difference between
the phase angles. In FFT literature, ∆xy is often expressed in the range of [−180, 180]. To simplify
representation in DynOmics, when ∆xy < 0, we add 360 so that ∆xy is in the range of 0 to 359. ∆xy
indicates both the sign of the correlation between x and y and the sign of the delay, as seen in Figure
4.2. The trajectories x and y can be either positively (Figure 4.2 abf) or negatively correlated (Figure
4.2 cde), with a delay that we refer to as negative, i.e., the reference x is prior to the query y (Figure
4.2 be) or positive, i.e., the reference x is delayed with respect to the query y (Figure 4.2 cf). Specific
angular difference cases include when ∆xy = 0 (positive correlation, but no delay, Figure 4.2 a) and
when ∆xy = 180 (negative correlation, no delay, Figure 4.2 d). We can estimate the delay between
two trajectories based on the FT frequency, the length of the time series and ∆xy as
δxy =
∆xy
(360/ T
K
)
,
where δxy ranges from 0 to TK . In order to keep delay estimates and hence signal shifts as small
as possible, we collapse these values to the range of [− T
4K
, T
4K
] by setting δxy = δxy − TK when
270 ≤ ∆xy ≤ 359, and δxy = δxy − T2K when 90 ≤ ∆xy ≤ 270. We note that for query profiles either
positively or negatively correlated with the reference, this means that δxy < 0 represents positive
delay, and δxy > 0 represents negative delay.
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Figure 4.2: Relationship between angular differences, correlation and delay for a reference tra-
jectory x (red dots) and a query trajectory y (green line). The trajectories are a) positively correlated
with no delay (∆xy = 0); b) positively correlated with negative delay (0 < ∆xy ≤ 90); c) negatively
correlated with positive delay (90 < ∆xy < 180); d) negatively correlated with no delay (∆xy = 180);
e) negatively correlated with negative delay (180 < ∆xy < 270); f) positively correlated with positive
delay (270 ≤ ∆xy < 360).
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Using lagged Pearson correlation to increase accuracy in delay estimation. The delay estimate
based on the angular difference presented above is based on approximating both the reference and
query by the pattern at the main frequency for the reference. This approximation works well when
the signals from both query and reference are dominated by that main pattern and relatively ‘noise-
free’. However, when multiple frequencies have substantial contributions to the overall signal, we can
improve the estimate by maximising the lagged Pearson correlation coefficient over small perturba-
tions in the delay.
Specifically, let δ0 = bδxye denote our initial delay estimate, rounded to the closest integer. Let L be
a set of lags {l} representing perturbations to this initial delay estimate. For each lag, we construct
trajectories xl and yl by shifting the original trajectories so that if l < 0, xl = x1+|l|, . . . , xT and
yl = y1, . . . , yT−|l|; if l > 0, conversely, xl = x1, . . . , xT−|l| and yl = y1+|l|, . . . , yT . The (lagged)
Pearson correlation coefficient between the two trajectories xl and yl is defined as:
cor(xl, yl) =
1
T
∑T−|l|
t=1 (xlt − x¯l)(ylt − y¯l)√
1
T
∑T−|l|
t=1 (xlt − x¯l)2
√
1
T
∑T−|l|
t=1 (ylt − y¯l)2
, (4.2)
where x¯l (y¯l) is the sample mean across time points for each trajectory. We determine the optimal
delay for a given set of lags as that for which the Pearson correlation coefficient is maximised:
δ∗ = argmax
l∈L
|cor(xl, yl)|, (4.3)
with c∗ = cor(xδ∗ , yδ∗) then used to assess the strength and direction of the association.
We consider two sets L1,L2 of lags which represent perturbations of δ0:
L1 = {δ0,−δ0}
L2 = {δ1 − 1, δ1, δ1 + 1},
where δ1 is the result of the optimization over l ∈ L1. These two optimisations thus allow us to
compare the initial estimate with that in the opposite direction, and then with delays in a local neigh-
bourhood. While the optimisations do increase the computation required, our restriction to local
perturbations minimises the additional computation while improving the estimate in the presence of
noise.
Time course experiments with several samples measured at each time point. So far, we pre-
sented the simplest case scenario where the reference trajectory x and the query y are measured on
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a single biological sample (individual subject). In most time course experiments however, multiple
individual subjects are measured over time and a representative trajectory needs to be modelled in
order to estimate time delays between molecules. Such modelling can be performed by calculating
the mean or the median of the expression values across all subjects for each time point, but that naive
approach is sensitive to outliers and missing data. We propose instead to model expression trajectories
as a smooth function of time, using linear mixed model splines (LMMS) that we previously developed
[128]. LMMS is advantageous as it can handle unbalanced designs - when the number of observa-
tions per time point is unequal, and missing data. We showed that LMMS modelling reduced noise
in the data compared to using the mean or the median modelling. Furthermore, LMMS takes into
account the variance structure of the measured subjects, thereby preventing over or under smoothing
of the profiles. The LMMS framework also enables to perform hypothesis testing and assess whether
modelled trajectories are significantly differentially expressed over time. In the case studies presented
below, we applied the LMMS modelling using a cubic spline basis to model the time trajectories of
the molecules measured in several subjects.
Implementation and computation time DynOmics is implemented in R and uses the FFT imple-
mented in the function fft() from the stats R package [166] for the decomposition of the time
series. DynOmics utilises the R package parallel to perform calculation on CPUs in parallel
where possible. DynOmics’ computation time was tested and compared to DTW4Omics on simu-
lated datasets with seven time points and the Lung Organogenesis study described below with 14
time points. On simulated data with one reference and 100 queries DynOmics required two seconds,
while DTW4Omics required 30 seconds. On the Lung Organogenesis study the association of 50
references and 50 queries took DynOmics four seconds compared to 600 seconds for DTW4Omics.
4.2.3 Simulated data
Simulated data generation. We simulated data to evaluate and compare DynOmics to other meth-
ods to identify associations between trajectories. Data were generated based on similar scenarios
to [71] with different parameters. Specifically, five reference levels were obtained using an impulse
model and either 7 and 14 time points [168]. For each modelled reference, P = 50 queries with intro-
duced time delay−2, 1, 0, 1, 2 (ten for each delay), were created. Moreover, we modelledN = 50 flat
trajectories for each reference as negative control. Then different levels of normal distributed noise
were added N (0, σ2);σ = 0.1, 0.2, 0.3, 0.5. Each combination of varying number of time points
and noise level was generated ten times. Table 4.1 presents an overview of the different parameters
used for the simulated data. Figure 4.3 displays example references (black) and queries with different
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introduced noise σ = 0.1, 0.5, delays (color coded) and the random trajectories (grey).
Table 4.1: Simulated data schema. Presented is the number of time points, the number of different
reference and query trajectories, the introduced delays, the number of flat trajectories, and the added
noise per generated dataset.
Time
points
# of different expres-
sion trajectories
Delays for each trajec-
tories
# of flat tra-
jectories
Noise # of generated
datasets
7 5
-2, -1, 0, 1, 2 each
repeated 10 times
50
0.1
10
0.2
0.3
0.5
14 5
-2, -1, 0, 1, 2 each
repeated 10 times
50
0.1
10
0.2
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Figure 4.3: Examples of simulated trajectories. Presented are examples of simulated trajectories
for 7 and 14 time points with different added normal distributed noise (σ = 0.1, 0.5). The reference
(black) is displayed in concordance with the delayed query trajectories ranging from−2 to 2 coloured
in green (−2), light blue (−1), dark blue (0), red (1), orange (2). The randomly generated expression
trajectories are coloured in grey.
Methods compared to DynOmics. We compared DynOmics with correlation methods namely
(lagged) Pearson correlation and a dynamic time warping (DTW) method DTW4Omics [73], de-
scribed briefly below.
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Since the Pearson correlation as defined in Equation 4.2 cannot identify relationships between two
trajectories if there is a time delay, we can overcome this issue by introducing time lags into x and y
and choose the lag l that maximises the correlation between x and y. Let the lagged Pearson corre-
lation be defined as in Equation 4.3 and the optimal delay l that maximises the Pearson correlation is
defined as l = b−T
2
c, · · · , bT
2
c. The trajectories were restricted to be lagged half of the trajectories’
number of time points, since lagged Pearson correlation tended to maximise the delay to maximise
correlation.
DTW4Omics obtains two trajectories and seeks for an alignment that minimises the Euclidean dis-
tance (d) via inserting, deleting or matching the trajectories time points. The algorithm to minimise
the distance between two trajectories x and y (DTWDist), with length Tx, Ty respectively, is defined
as follows:
function DTWDIST(x,y)
DTW = array [0 . . . Tx, 0 . . . Ty]
for i = 1 to Tx do DTW[i, 0] =∞
end for . initiation of infinite values to align each time point
for i = 1 to Ty do DTW[0, i] =∞
end for
DTW[0, 0] = 0
for i = 1 to Tx do
for j = 1 to Ty do
cost = d(xi, yj)
DTW[i, j] = cost + minimum(DTW[i-1, j ], . insertion
DTW[i , j-1], . deletion
DTW[i-1, j-1]) . match
end for
end for
return DTW[n, m]
end function
To determine if an alignment occurs by random chance a permutation test is used. The proposed test
by Cavill et al. [73] independently permutes xperm and yperm then calculates the DTW distance as
defined above,
p− value =
(
100∑
k=1
(DTWDist(xperm, yperm)k < DTWDist(x, y))
)
/100. (4.4)
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As DTW4Omics generates p-values as measurement of association, we also used the Pearson cor-
relation of the DTW4Omics alignment (DTW4OmicsCor) for comparison. The estimated delay for
DTW4Omics was the absolute maximum number of aligned time points to a single time point in ei-
ther reference or query sequence.
A benchmark was created by realigning reference and query trajectories using the introduced delay
and the Pearson correlation as a measurement of association. We referred to this benchmark as ‘Real
delay’. We set a fixed threshold of 0.9 for correlation values and 0.05 for p-values adjusted by False
Discovery Rate (FDR) [101].
Sensitivity and specificity. The methods’ sensitivity and specificity were used to assess and com-
pare the methods’ ability to identify associated reference-query trajectory pairs and disregard reference-
random trajectory pairs on the simulated data. For each simulated dataset we counted the number of
true associated trajectories (true positives; TP), which was defined as a reference-query pair that is
greater/smaller than the defined correlation (cor > 0.9) or p-value threshold (p− value < 0.05). The
number of true not associated or rejected trajectories, was a reference-random trajectory pair (true
negative; TN) that was not greater or smaller than the defined correlation (cor > 0.9) or p-value
threshold (p− value < 0.05). We then calculated the sensitivity defined as the ratio of the TP and the
number of truly associated trajectories (P) for each dataset,
Sensitivity =
TP
P
. (4.5)
The specificity was accordingly calculated for each simulated dataset and was defined as the the ratio
of the TN and the number of truly not-associated trajectories (N),
Specificity =
TN
N
. (4.6)
Both measurements ranged between 0 and 1 with higher values indicating high sensitivity/specificity.
4.2.4 Lung organogenesis
Description of the study The study of Dong et al. [154] investigated the dynamic regulation of
miRNAs in mouse lung organogenesis by measuring the expression of 516 miRNAs and 45, 105
mRNAs on two biological replicates at seven time points (embryo day 12, 14, 16, 18; postnatal day
2, 10, 30) in lungs (GSE21053, Affymetrix Mouse Genome 430 2.0 Array). The data we analysed
were pre-processed in the original study. Subsequently, a linear mixed effect model splines (LMMS)
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modelling approach developed previously [128] was used to obtain representative trajectories over
14 equally spaced time points between embryo day 12 and postnatal day 30. In addition to allowing
interpolation to even out spacing between time points, LMMS can handle unbalanced designs - when
the number of observations per time point is unequal, or if there are missing data. Smoothing prior to
analysis will also help reducing the noise in the data and will prevent the detection of high-frequency
random noise. We further filtered the data to retain only miRNAs and mRNAs declared as differ-
entially expressed over time using lmmsDE [128] (FDR ≤ 0.05). The final dataset analysed with
DynOmics included 105 miRNAs and 11, 326 mRNAs.
Analysis strategy. We compared associations detected between miRNA and mRNA pairs for both
raw and LMMS modelled trajectories, using either classical Pearson correlation (on raw and LMMS
modelled data) or DynOmics (on LMMS modelled data). MiRNAs are known to be able to target
transcription regulators and therefore lead to the indirect expression of many mRNAs downstream
[150]. In this study, however, we focused on direct targets of miRNA, and therefore sought to identify
negative correlations between miRNAs and mRNAs, i.e., increased miRNA expression levels associ-
ated to a decreased (inhibited) mRNA expression levels, or vice versa. Associations were declared
for all miRNA-mRNA pairs whose Pearson correlation coefficient was < −0.9. The mRNAs associ-
ated to a given miRNA were compared with miRNA targets predicted from sequence similarity from
microRNA.org (GoodmirSVRscore, Conserved miRNA, release August 2010) [169], TargetScan (re-
lease 6.2) [170] and miRDB (Version 5) [171]. We only compared database entries with an exact
identifier match to the analysed 105 miRNAs, leaving 14 miRNAs for miRDB, 33 for TargetScan
and 86 for microRNA.org. Pathway enrichment analysis was performed using QIAGEN’s Ingenuityr
Pathway Analysis (IPAr, QIAGEN Redwood City, www.qiagen.com/ingenuity).
4.2.5 Mammalian pre-implantation embryonic development
paragraphDescription of the study.
Xie et al. [156] investigated the dynamic expression of human, mouse and bovine transcripts during
PED. The expression levels in human (30, 283 mRNAs), mouse (19, 607 mRNAs) and bovine (13, 898
mRNAs) were monitored during six to eight comparable cell stages (oozygote (only bovine), zygote,
two-, four-, eight-, 16-cell (bovine only), morula and blastocyte) in two (human, mouse) and three
(bovine) embryo replicates (GSE18290, Affymetrix mircoarrays: Mouse Expression 430A Array,
Human Genome U133 Plus 2.0, Bovine Genome Array).
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Analysis strategy. We first converted the cell stages (zygote to blastocyte) into quantitative time
points (one to seven) for input into modelling. For each organism, expression trajectories were mod-
elled using LMMS with 14 regularly spaced time points. Human transcripts were taken as references,
with reference-query pairs restricted to orthologous sequences with mouse and bovine as specified in
the Affymetrix file HG-U133 Plus 2.na26.ortholog.csv. Seven human transcripts did not match any
identifier in the orthology file and were removed. A total of 81, 966 orthologous transcript pairs were
analysed (48, 566 mouse, 33, 400 bovine), where references and/or queries may have been included
in multiple pairs. We applied DynOmics to every orthologous transcript pair to assess delays in ex-
pression levels between organisms and declared association when the absolute correlation exceeded
0.9. Pathway enrichment analysis was performed using IPA.
4.3 Results
4.3.1 Simulated data
To assess and compare DynOmics performance with current available methods we used the measures
of sensitivity and specificity while identifying associations in simulated data. Generally, sensitivity
performance decreased for all methods when noise increased. In terms of sensitivity DynOmics out-
performed every method, when the number of time points was small (Figure 4.4 A; 7 time points).
DynOmics’ average sensitivity ranged from 0.97 to 0.59. The next best performing algorithm was
lagged Pearson correlation and DTW4OmicsCor, which identified at least 8% less true associated
trajectories (sensitivity ranging from 0.89 to 0.51 and 0.82 to 0.46, respectively). The Pearson cor-
relation that did not take time delays into account performed the worst with a sensitivity between
0.36 and 0.16 showing that ordinary correlation measurements is not sufficient to detect associations
when trajectories are delayed. The specificity of DynOmics was slightly lower than the DTW meth-
ods (0.95-0.97) and Pearson correlation (1), however it was still greater than 0.94 which is a high
specificity (Figure 4.4 B; 7 time points). The method with the lowest specificity was lagged Pearson
correlation (0.91).
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Figure 4.4: Sensitivity and specificity on simulated data. The graphs show each method’s per-
formance for 7 and 14 time points and different noises in terms A) sensitivity and B) specificity.
The x-axis represents the variance of the introduced noise (σ = {0.1, 0.2, 0.3, 0.5}) of the analysed
simulated data and the y-axis the mean (dot) and 95% confidence interval (error bar) of the respec-
tive performance measure. The proposed DynOmics approach (black) is visualised in comparison
to the ‘Real delay’ used as benchmark (green), Pearson (light blue), lagged Pearson (dark blue),
DTW4OmicsCor (red) and DTW4Omics (yellow).
For a large number of time points sensitivity was extremely high (1−0.95) for all methods accounting
for delays with noise σ = {0.1, 0.2, 0.3} (Figure 4.4 A; 14 time points). The only method that does
not account for delays, Pearson correlation, identified only 47 to 40% of all truly associated simulated
trajectories. All methods performance dropped dramatically when the noise in the data increased
(σ = 0.5). DTW4Omics the only method not based on Pearson correlation measurement was the
only method that maintained high sensitivity (0.87) and was also better than the benchmark (0.6).
Specificity was overall very high for all methods and noise levels ranging from 1 to 0.96 (Figure 4.4
B; 14 time points).
Furthermore, we investigated the methods’ ability to estimate the simulated time delay. DynOmics
outperformed the other methods in estimating the simulated delays for low number of time points
(Table 4.2). Correct delay estimates for DynOmics ranged between 95 to 76%, while for lagged
Pearson correlation and DTW4Omics they only ranged from 86 to 53% and 63 to 65%, respectively.
For 14 time points DynOmics and lagged Pearson correlation performed similar with 99 to 90%
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and 100 to 94%, respectively, while DTW4Omics percentage of correct estimations was low (60 −
42%). The separation of correct estimates by delay revealed that both, lagged Pearson correlation and
DTW4Omics were inaccurate with increasing delay, while DynOmics estimates remained accurate
for noise σ = {0.1, 0.2, 0.3} (Figure 4.5).
Table 4.2: Percentage of correct estimated delays. The percentage of correct estimated delays is
presented for DynOmics, lagged Pearson and DTW4Omics over all 500 generated associated trajec-
tories per time point and noise combination.
Percentage (%) correct estimated delays
Time points Noise DynOmics Lagged Pearson DTW4Omics
7
0.1 95 86 63
0.2 91 73 60
0.3 85 61 58
0.5 76 53 65
14
0.1 99 100 60
0.2 98 97 48
0.3 93 88 42
0.5 90 94 53
4.3.2 Lung organogenesis
Firstly, focusing on the miRNAs as reference trajectories, we compared the performance of Pearson
correlation on the raw and LMMS modelled data. We defined the average agreement as the number
of associations identified in common between the two methods divided by the number of associations
observed by one method averaged over all miRNAs (Supporting Table S3). We found that modelling
representative trajectories using LMMS substantially increased the number of associations, by over
80% compared to raw data. This is likely due to the removal of noise when modelling the trajectories
[128]. We next compared the performance of Pearson correlation with DynOmics for the LMMS
modelled data. DynOmics identified on average 18% more associations, indicating that the simple
correlation analysis was not sufficient to detect all delays in expression between miRNA and mRNA.
Secondly, we analysed the overlap of these putative miRNA targets with the miRNA targets pre-
dicted from sequence similarity. Supporting Tables S4.2-S4.4 summarise for each miRNA and each
method the number of putative targets and the overlap with the predicted targets from TargetScan, mi-
croRNA.org and miRDB. For the raw data, we observed low overlap between predicted and putative
targets (ranging from 0 to 0.4% miRDB, 1.8% microRNA.org, and 4.8% TargetScan). The number of
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Figure 4.5: Proportion of correct estimated delays separated by simulated delay. For each
combination of time points (7, 14) and noise (σ = {0.1, 0.2, 0.3, 0.5}) the proportion of the correct
estimated delays is displayed on the y-axis (dot) against the originally simulated delay on the x-axis
(−2,−1, 0, 1, 2). Colours represent the results for the different methods, namely DynOmics (black),
Lagged Pearson (dark blue) and DTW4Omics (orange).
overlaps increased for the LMMS modelled data with the majority of miRNA-mRNA pairs changing
expression simultaneously (i.e., a delay of 0). However, the percentage of overlap was still small
(ranging from 0 to 3% miRDB, 3.5% microRNA.org, and 4.8% TargetScan; Supporting Figure S4.1.
Finally, we investigated whether the putative delays were of biological relevance for miRNA-mRNA
pairs. Three miRNAs in particular, mu-miR-429, mmu-let-7g, and mmu-miR-134, were associ-
ated with a large number of negatively delayed mRNAs, represented in Figure 4.6 1-3. Analysis
of these delayed mRNAs using IPA identified for mmu-miR-429 enrichment of the ‘Phospholipase
C Signaling’ pathway (P = 1.21 × 10−14), for mmu-let-7g the ‘Axonal Guidance Signaling’ path-
way (P = 4.0 × 10−11), and for mmu-miR-134 the ‘Mitotic Roles of Polo-Like-Kinase’ pathway
(P = 1.29 × 10−8). These pathways have been described as being involved in either embryonic or
lung development. Phospholipase C was associated with fetal lung cell proliferation in rats [172] and
plays an important role in organogenesis and embryonic development [173]. Some axonal guidance
molecules like netrins have been suspected to play a role in lung branching [174], while EphrinB2 or
semaphorin 3C were found to be involved in alveolar growth and development [175, 176]. Finally,
polo-like-kinases (PLKs) are highly conserved in mammals and are important for early embryonic
development [177]. PLKs are known to regulate cell cycle progression but little is known about their
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role in lung development. However, over-expression of PLKs has been associated with malignancy
and poor prognosis in lung cancer, and PLKs are therefore a target for therapy [178].
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Figure 4.6: MiRNA and mRNA expression associations in Lung Organogenesis study. Scaled
LMMS modelled expression levels (y-axis) are depicted over time in 14 equally spaced time units
from embryo day 12 to postnatal day 30 (x-axis) for the miRNAs mmu-miR-429, mmu-let-7g, and
mmu-miR-134 (red lines). Solid lines depict actual scaled expression levels, while dashed lines de-
pict inverted scaled expression levels to account for the negative correlation with mRNA. Modelled
expression levels of the mRNAs identified as associated with each miRNA using DynOmics are dis-
played (DynOmics correlation < −0.9, delay < 0) a) before and b) after shifting the trajectories
using the DynOmics estimated delay. The blue color gradient reflects the amount of delay.
4.3.3 Mammalian pre-implantation embryonic development
We applied DynOmics to identify delays in orthologous transcript expression of mouse and bovine
relative to human during PED. For an absolute correlation threshold of 0.9, we identified 32, 329
(67%) orthologous pairs as being associated between human and mouse, and 26, 769 (80%) between
human and bovine, summarised in Table 4.3 with respect to the different types of delay. Of the
transcripts displaying association, we observed that the majority of the mouse (56%) and bovine
(67%) transcripts were not delayed compared to the orthologous human transcripts. Interestingly, 20%
of mouse transcripts (compared to 10% in bovine) changed expression prior to the human orthologous
transcript. This could reflect timing differences in the zygote genome activation of mouse PED at the
gene expression level [156, 157].
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Table 4.3: Orthologous transcripts identified as associated by DynOmics. Number (percentage)
of mouse and bovine transcripts identified as associated with orthologous human transcripts at an
absolute correlation threshold of 0.9. The number of associations are divided according to different
types of delay, indicating whether changes in expression levels of the mouse and bovine transcripts
occurred prior to (delay> 0), simultaneously to (delay= 0), or after (delay< 0) expression changes
of the orthologous human transcript.
Delay Mouse vs Human (%) Bovine vs Human (%)
> 0 6,582 (20) 2,766 (10)
0 18,065 (56) 17,906 (67)
< 0 7,682 (24) 6,097 (23)
Total 32,329 26,769
Pathway analysis using IPA was performed on the human orthologs for the three types of delay (neg-
ative, no delay and positive) relative to mouse or bovine orthologs. Table 4.4 lists the top three
canonical pathways identified as enriched for each type of delay and organism. The majority of tra-
jectories whose expression levels changed in mouse prior to human were involved in EIF2 Signaling
(P = 7.94 × 10−18), mTOR Signaling (P = 5.64 × 10−12) and regulation of eIF4 and p70S6K Sig-
naling (P = 5.72× 10−11). EIF2 Signaling and eIF4 and p70S6K Signaling play an important role in
translation regulation and mTOR Signaling is an important pathway in embryonic development [179].
These same pathways were also highlighted in a recent study using RNA-Sequencing technologies
[180] on human during early embryonic development (4-cell, 8-cell, morula, and blastocyte stages).
EIF2 Signaling (P = 1.75× 10−25) and the regulation of eIF4 (P = 3.48× 10−0.9) were also found
to be enriched in bovine; however, the genes involved in these pathways changed expression after
human expression changes.
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Table 4.4: IPA enrichment analysis of human orthologs for three types of delay relative to
mouse/bovine transcripts. The top three IPA enriched pathways are listed. Associated transcripts
were analysed separately with respect to the delay: positive (negative) delay indicates that the mouse
or bovine ortholog’s expression changes occurred prior to (after) the human expression changes. No
delay indicates that all expression changes occurred simultaneously. P values were obtained from a
right tailed Fisher’s Exact Test as implemented by IPA.
Delay com-
pared to
human
Organism Pathway (# Transcripts identified/# Transcripts in path-
way)
P value
> 0
Mouse
EIF2 Signaling (79/173) 7.94× 10−18
mTOR Signaling (71/183) 5.64× 10−12
Regulation of eIF4 and p70S6K Signaling (60/143) 5.72× 10−11
Bovine
Protein Ubiquitination Pathway (54/254) 6.28× 10−09
Amyloid Processing (19/50) 4.36× 10−08
Glucocorticoid Receptor Signaling (51/272) 1.03× 10−06
0
Mouse
Role of Macrophages, Fibroblasts and Endothelial Cells
in Rheumatoid Arthritis (196/286)
1.84× 10−31
Role of Osteoblasts, Osteoclasts and Chondrocytes in
Rheumatoid Arthritis (149/213)
6.88× 10−27
Axonal Guidance Signaling (115/157) 1.29× 10−22
Bovine
Protein Kinase A Signaling (199/370) 7.11× 10−16
Thrombin Signaling (116/187) 1.44× 10−15
Acute Phase Response Signaling (106/168) 4.51× 10−15
< 0
Mouse
Ephrin Receptor Signaling (76/172) 8.39× 10−13
Molecular Mechanism of Cancer (128/359) 5.26× 10−12
B Cell Receptor Signaling (71/171) 1.54× 10−10
Bovine
EIF2 Signaling (91/173) 1.75× 10−25
Regulation of eIF4 (55/143) 3.48× 10−09
Protein Ubiquitination Pathway (83/254) 5.11× 10−09
> 0, 0, < 0
Mouse, EIF2 Signaling (32/173) 1.59× 10−17
Bovine Regulation of eIF4 (21/143) 5.25× 10−10
Acetyl-CoA Biosynthesis I (Pyruvate Dehydrogenase
Complex) (4/6)
8.71× 10−06
As an illustrative example we display the trajectories of the orthologous transcripts involved in EIF2
Signaling in human and mouse with respect to the type of delay (Figure 4.7).
We also performed enrichment analyses for human orthologs for all transcripts identified as associ-
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Figure 4.7: EIF2 Signaling. Modelled transcripts expression levels (scaled for each time point for
visual purposes, y-axis) with respect to time (x-axis) involved in EIF2 Signaling a) in human with
b) their orthologs in mouse (DynOmics correlation > 0.9, delay > 0). Hierarchical clustering was
performed on the human transcripts to extract three main expression patterns in EIF2 Signaling (a;
1-3). The three main patterns of expression in humans a) were visualised in separate plots (1-3). The
mouse expression profiles in b) were separated by the classification of their human orthologs (1-3)
and were coloured according to the DynOmics estimates of delay.
ated, across all three types of delay. We highlight the conserved process of Acetyl-CoA Biosynthesis I,
since it has not occurred in the enrichment looking at the delayed orthologs individually. Acetyl-CoA
levels were found to play a role in the acetylation of proteins and may play a role in regulation of em-
bryogenesis [181]. Using DynOmics, we identified different response dynamics across organisms for
four out of six transcripts (dihydrolipoamide branched chain transacylase (DBT), dihydrolipoamide
s-acetyltransferase (DLAT), dihydrolipoamide dehydrogenase (DLD) and pyruvate dehydrogenase
(Lipoamide) beta (PDHB)) that are conserved and involved in this process (Figure 4.8; Table 4.5).
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Table 4.5: Acetyl-CoA Biosynthesis I orthologous transcripts. Presented are the DynOmics iden-
tified associated orthologous transcripts in the Acetyl-CoA Biosynthesis I. The name of the gene is
presented with the transcript ID of human (‘TranscriptID Human’), and bovine and mouse (‘Tran-
scriptID Organism’)along with the species (‘Organism’), DynOmics identified delay (‘Delay’) and
the Pearson correlation of trajectory after indrocuding the DynOmics estimated delay (‘Delay’).
Gene name TranscriptID Human TranscriptID Organism Organism Delay Correlation
DBT 205369 x at BT.18489.1.A1 AT Bovine -2 0.99
DBT 205369 x at 1449118 AT Mouse -5 0.98
DLAT 211150 s at 1426264 AT Mouse 3 0.92
DLAT 211150 s at 1426265 X AT Mouse 3 0.91
DLD 230426 at BT.27889.1.S1 AT Bovine 4 0.99
DLD 230426 at 1423159 AT Mouse 4 0.9
PDHB 208911 s at BT.2973.2.S1 A AT Bovine -2 0.98
PDHB 208911 s at BT.2973.3.A1 AT Bovine 3 0.97
PDHB 208911 s at 1416090 AT Mouse 3 0.97
DBT 
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Figure 4.8: Acetyl-CoA Biosynthesis I. Displayed is the expression (y-axis) against time (x-axis)
of the four molecules involved in the Acetyl-CoA biosynthesis: dihydrolipoamide branched chain
transacylase (DBT), dihydrolipoamide s-acetyltransferase (DLAT), dihydrolipoamide dehydrogenase
(DLD) and pyruvate dehydrogenase (Lipoamide) beta (PDHB). The colors represent the DynOmics
identified and associated (|cor| > 0.9) orthologous expression trajectories from human (red), mouse
(green) and bovine (blue).
4.4 Discussion
To date, very few methods have been developed to integrate time course ‘omics’ data that are robust to
delays in expression between co-expressed molecules. The integration task is particularly challenging
as the data are often characterised by a high level of noise and measured on a small number of time
points. Our algorithm DynOmics addresses these challenges by modelling time course trajectories,
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identifying delays and re-aligning trajectories to determine the degree of mutual dependency between
reference and query trajectories.
Modelling time course trajectories is an important step in this process, as most methods developed to
integrate time course data, such as DTW4Omics [73] and HMMs [71] require as input only a single
value per time point. In this study we used a data-driven modelling approach based on linear mixed
model splines [128] to summarise the time course data appropriately, reduce noise, and interpolate
additional time points within the time course. We found that while the modelling step may remove
some associations between reference and query trajectories, e.g., in the Lung Organogenesis case
study, it ultimately increased the number of findings by considerably reducing the amount of noise
in the data. In addition, modelling each trajectory as a noisy function of time allows integration of
datasets with different time intervals or numbers of time points, as we demonstrated in the mammalian
embryonic development case study. An additional analytical challenge may occur when the time
series has temporal or cyclic changes and increases or decreases constantly over time. Time dependent
trends are rarely observed in biological time course experiments, as those often lack the sampling
resolution to observe such trends. If a time dependent trend were to be observed it should be removed
prior to DynOmics analysis, for example by extracting residuals from a linear regression analysis of
the expression values against time.
The selection of an appropriate threshold to discriminate between associated and non-associated tra-
jectories is not trivial and often depends on the data characteristic. For our analyses, we arbitrarily
selected a correlation threshold of 0.9 to identify associated co-expressed molecules. It can be argued
that this threshold is very high given the high noise levels characteristically present in gene expression
data. However for our analyses, we were interested only in highly concordant expression trajectories.
In addition we smoothed the trajectories via modelling prior to analysis, which has been shown to
reduce noise [128].
The role of miRNAs as gene expression regulators is an exciting new subject of study, as it is estimated
that they control one-third of the expression of the human genome [182]. Moreover, since miRNAs
appear to be the master switch in biological processes, they are the target of future therapeutic de-
velopment [151, 152]. In the Lung Organogenesis study, the miRNA-mRNA associations that we
identified with DynOmics largely did not agree with the predictions from the databases TargetScan,
microRNA.org and miRDB. One possible reason for the general lack of agreement could be that the
predicted targets were not expressed in the experiment, or were not targeted at all. Those mRNA that
did agree represented subtle delays between miRNA and mRNA trajectories that may indicate high
sequence affinities. The other associations, which included larger delays that were not identified by
standard correlation analysis [154], may not be as similar in sequence and hence were not predicted
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as miRNA targets in the databases [169, 170, 171]. Indeed, our results suggest that sequence informa-
tion alone may not suffice to determine whether miRNAs are expressed and regulate specific mRNA
under certain conditions. Alternately, the large number of miRNA-mRNA associations identified by
DynOmics may represent mRNAs which are indirect targets of miRNAs. Determining whether these
mRNAs are truly direct targets of miRNAs will require further experimental validation, but the enrich-
ment analysis showed that the mRNAs were involved in meaningful biological processes related to
Lung Organogenesis, e.g., lung cell proliferation, lung branching and alveolar development. Thus, in
this context, DynOmics has the potential to identify novel targets of miRNAs to aid in therapeutic de-
velopment. Our study emphasises the importance of jointly studying miRNA and mRNA expression
to understand the mechanisms of miRNA regulation.
Model organisms present a simpler and more convenient alternative to directly study disease in hu-
mans. In the mammalian pre-implantation embryonic development study, we showed that DynOmics
could identify delayed conserved expression between different organisms. This is a challenging task,
as timing differences of expression changes can occur both in metabolic processes and across organs
for different organisms [157]. By correcting for these timing differences, DynOmics can therefore
help to infer gene functions across organisms, and thereby integrate information in whole biological
processes. Such integration may in turn identify which organisms provide suitable models for human
disease and drug discovery due to the conservation in processes [183].
Currently, DynOmics has been used to identify associations between datasets of moderate size (∼ 100
references and ∼ 10, 000 queries). The computational time would increase for large data sets (∼
10, 000 references and queries). One solution could be to cluster profiles prior to applying DynOmics,
to identify specific patterns of interest over time as queries and/or references. As the algorithm is
based on independent pairwise comparisons, parallel computing could also be used to decrease the
computational burden. Alternatively, as shown in the Lung Organogenesis study, the DynOmics
analysis can be performed on a smaller number of queries selected based on prior knowledge or
biological assumptions.
4.5 Conclusion
Delays in molecular expression are an acknowledged and important phenomenon in many areas of
biology. Here we demonstrated the need for and value of methods that are robust to delays, by show-
casing the benefit of accurate delay estimates to interpret response dynamics and identify conserved
molecular mechanisms. DynOmics overcomes the challenge of integrating data with timing differ-
ences of expression changes and therefore presents an effective tool to study time-sensitive molecular
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expression. The integration of multiple time course ‘omics’ data is becoming necessary in order to un-
derstand a biological system’s formation, actions and regulation with high confidence. Our algorithm
DynOmics provides a unique opportunity to study molecular interactions between multiple functional
levels of a single system or multiple organisms, and paves the way to deeper biological time course
studies analyses to investigate or unravel novel biological mechanisms.
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SUPPORTING MATERIAL
LUNG DEVELOPMENT
We compared the average overlap of identified association with correlation smaller than −0.9 be-
tween Pearson correlation of raw data (‘Raw cor’), Pearson correlation on LMMS modelled data
(‘LMMS Cor’) and DynOmics (Table S4.1. We observed that correlation analysis on the modelled
data alone identified on average 85% more associated trajectories than correlation analysis on raw
data. DynOmics had similar numbers as Pearson correlation on modelled data when comparing it to
the correlation analysis on raw data, average of 86% more identified associated trajectories. There
was a big overlap between DynOmics and Pearson correlation on modelled data suggesting that many
associations had no or little time delay (82% and 86%). The on average 18% not identified my Pear-
son correlation on modelled data can be explained by time delay trajectories. The 14% of associations
identified by Pearson correlation that were not identified by DynOmics were likely due to identifying
optimal delays that resulted in positive correlations. These associations however, were not considered
in this analysis, since we only compared negative correlated associations.
Table S4.1: Average percentage of agreement and standard deviation (sd) of the identified as-
sociated mRNAs. For each miRNA we calculated the percentage of agreement of the identified
associations (cor > 0.9) using correlation on raw data (‘Raw Cor’), on LMMS modelled (‘LMMS
Cor’) and DynOmics. The numbers presented are the average agreement and the sd.
Average Percentage % (sd)
m
RawCor ∩m
#RawCor
LMMSCor ∩m
#LMMSCor
DynOmics ∩m
#DynOmics
Raw Cor - 15 (17) 14 (16)
LMMS Cor 79 (24) - 82 (16)
DynOmics 77 (24) 86 (1) -
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Table S4.2: Overlap of predicted miRNA targets from TargetScan associated miRNA-mRNA
expression trajectories. For each miRNA the overall number of identified associated mRNAs is
presented when performing correlation analysis on the raw data (Raw Cor), LMMS modelled data
(LMMS Cor) or DynOmics. In addition, the number of miRNA target predictions in the TargetScan
database (DB) (No. DB prediction) and the overlap with the expression data analysis are presented.
The number of associated miRNA-mRNA trajectories that overlap with the TargetScan DB predic-
tions for correlation analysis on the raw data (Raw Cor) and LMMS modelled data (LMMS Cor).
Finally, the number of overlaps between the miRNAs targets of TargetScan and DynOmics are pre-
sented separated if mRNA expression changes after (delay < 0), simultaneous (delay = 0) or prior
to (delay > 0) miRNA expression.
miRNA Raw Cor LMMS Cor After Simultanious Prior
No. DB 
prediction
Raw 
Cor
LMMS 
Cor After Simultanious Prior
mmu-let-7c 1 3180 327 2572 379 0 0 0 0 0 0
mmu-let-7d 0 94 37 53 5 0 0 0 0 0 0
mmu-let-7e 2 64 8 55 15 0 0 0 0 0 0
mmu-let-7g 0 69 448 50 43 0 0 0 0 0 0
mmu-let-7i 0 109 35 38 7 0 0 0 0 0 0
mmu-miR-100 0 3180 336 2563 379 0 0 0 0 0 0
mmu-miR-106a 241 4338 761 3196 454 0 0 0 0 0 0
mmu-miR-126-3p 2140 3180 808 2058 412 25 0 0 0 0 0
mmu-miR-126-5p 1759 3180 418 2481 379 0 0 0 0 0 0
mmu-miR-127 44 168 25 123 26 21 1 1 0 1 0
mmu-miR-130a 0 4338 368 3622 421 0 0 0 0 0 0
mmu-miR-130b 140 4338 416 3499 496 0 0 0 0 0 0
mmu-miR-133a 362 3180 327 2572 379 0 0 0 0 0 0
mmu-miR-134 159 2347 556 2148 138 249 0 6 2 3 2
mmu-miR-135b 74 214 30 122 37 0 0 0 0 0 0
mmu-miR-136 7 65 8 33 6 369 1 1 0 1 0
mmu-miR-138 1 9 61 9 8 773 0 0 0 0 0
mmu-miR-139-5p 33 391 13 191 112 503 0 1 0 1 0
mmu-miR-140 3 3180 410 2489 379 461 0 15 1 12 3
mmu-miR-142-3p 908 3180 524 2375 379 481 4 16 3 12 1
mmu-miR-145 7 3180 334 2564 380 928 0 20 1 17 2
mmu-miR-146a 1967 3476 475 1184 2007 0 0 0 0 0 0
mmu-miR-146b 1741 3013 286 1100 1699 0 0 0 0 0 0
mmu-miR-149 0 4338 530 3292 589 550 0 14 1 11 2
mmu-miR-150 2384 3180 327 2572 379 379 5 7 2 5 0
mmu-miR-151-3p 4 3180 362 2504 412 0 0 0 0 0 0
mmu-miR-15a 0 3180 332 2567 379 0 0 0 0 0 0
mmu-miR-15b* 0 4338 494 3496 421 0 0 0 0 0 0
mmu-miR-16 564 3180 451 2445 382 0 0 0 0 0 0
mmu-miR-17 142 4338 583 3358 470 1563 2 28 4 24 4
mmu-miR-181a 2 3180 337 2562 379 0 0 0 0 0 0
mmu-miR-182 37 4338 566 3373 472 1471 0 25 5 18 3
mmu-miR-191 276 3180 327 2572 379 98 0 2 0 2 0
mmu-miR-195 850 3180 382 2475 421 0 0 0 0 0 0
mmu-miR-19a 227 2468 319 2238 169 0 0 0 0 0 0
mmu-miR-19b 163 4338 487 3503 421 0 0 0 0 0 0
mmu-miR-200a 687 1719 642 1123 148 0 0 0 0 0 0
mmu-miR-200b 40 542 49 496 19 0 0 0 0 0 0
mmu-miR-200c 37 294 19 277 12 0 0 0 0 0 0
mmu-miR-20a 197 4338 367 3623 421 0 0 0 0 0 0
mmu-miR-21 1407 3180 332 2567 379 421 5 18 0 17 2
mmu-miR-210 4 52 0 38 14 40 0 0 0 0 0
mmu-miR-214 14 4338 607 3382 422 895 0 18 1 16 1
mmu-miR-214* 202 4338 367 3623 421 1316 1 22 1 20 1
mmu-miR-222 1579 3180 390 2445 443 0 0 0 0 0 0
mmu-miR-223 2086 3537 479 3035 146 466 3 7 0 7 0
mmu-miR-24 1181 3180 340 2559 379 824 7 19 3 16 1
mmu-miR-24-2* 752 3180 832 2034 412 0 0 0 0 0 0
mmu-miR-26a 326 3180 369 2530 379 0 0 0 0 0 0
mmu-miR-26b 770 3180 327 2572 379 0 0 0 0 0 0
TargetScan overlap
DynOmicsDynOmics
Overall number of identified associations
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Table S4.2: Overlap of predicted miRNA targets from TargetScan associated miRNA-mRNA
expression trajectories.
mmu-miR-27a 429 3180 328 2571 379 0 0 0 0 0 0
mmu-miR-27b 0 3180 327 2572 379 0 0 0 0 0 0
mmu-miR-28* 0 3180 343 2556 379 0 0 0 0 0 0
mmu-miR-296-5p 21 232 33 166 17 0 0 0 0 0 0
mmu-miR-29a 2006 3180 328 2571 379 0 0 0 0 0 0
mmu-miR-29c 964 2713 2209 535 227 0 0 0 0 0 0
mmu-miR-301a 10 4338 395 3595 421 0 0 0 0 0 0
mmu-miR-301b 25 284 43 197 42 0 0 0 0 0 0
mmu-miR-30a 1529 3180 328 2571 379 0 0 0 0 0 0
mmu-miR-30a* 642 3180 462 2429 387 0 0 0 0 0 0
mmu-miR-30b 138 3180 327 2572 379 0 0 0 0 0 0
mmu-miR-30c 559 3180 446 2423 409 0 0 0 0 0 0
mmu-miR-30d 2021 3180 468 2338 472 0 0 0 0 0 0
mmu-miR-30e 1491 3180 481 2204 593 0 0 0 0 0 0
mmu-miR-30e* 608 3180 328 2571 379 0 0 0 0 0 0
mmu-miR-31 348 3180 635 2255 388 530 2 13 1 12 2
mmu-miR-322 54 219 3 131 13 0 0 0 0 0 0
mmu-miR-322* 5 53 4 39 1 0 0 0 0 0 0
mmu-miR-323-3p 92 4338 927 3054 430 0 0 0 0 0 0
mmu-miR-328 19 3180 334 2565 379 0 0 0 0 0 0
mmu-miR-335-3p 22 84 11 50 4 0 0 0 0 0 0
mmu-miR-335-5p 1 55 2 37 4 0 0 0 0 0 0
mmu-miR-34b-3p 2159 3180 514 2327 437 0 0 0 0 0 0
mmu-miR-351 0 94 5 70 10 0 0 0 0 0 0
mmu-miR-365 529 3180 665 2234 379 0 0 0 0 0 0
mmu-miR-370 13 4338 710 3117 584 547 0 14 3 11 2
mmu-miR-375 0 3180 543 2356 379 292 0 8 2 6 1
mmu-miR-376c 53 190 24 57 32 396 0 1 0 0 0
mmu-miR-379 74 207 23 111 26 133 0 0 0 0 0
mmu-miR-382 12 272 56 214 25 293 0 0 0 0 0
mmu-miR-409-3p 173 295 257 182 91 0 0 0 0 0 0
mmu-miR-410 124 312 159 199 81 856 0 1 0 1 0
mmu-miR-411 41 163 20 107 11 120 0 0 0 0 0
mmu-miR-429 99 226 2670 197 3 0 0 0 0 0 0
mmu-miR-431 97 255 141 198 33 227 0 0 0 0 0
mmu-miR-433 12 4338 380 3610 421 496 0 17 3 12 3
mmu-miR-434-3p 13 85 9 29 14 0 0 0 0 0 0
mmu-miR-449a 147 444 30 214 18 0 0 0 0 0 0
mmu-miR-466d-3p 680 3180 484 2376 418 0 0 0 0 0 0
mmu-miR-467a* 39 433 230 205 238 0 0 0 0 0 0
mmu-miR-486 926 3180 332 2567 379 0 0 0 0 0 0
mmu-miR-503 9 73 4 64 10 477 0 0 0 0 0
mmu-miR-503* 18 224 25 128 20 477 0 1 0 0 0
mmu-miR-532-5p 1 4338 849 2978 584 0 0 0 0 0 0
mmu-miR-539 92 250 148 196 35 936 1 1 2 1 0
mmu-miR-672 21 130 23 69 42 0 0 0 0 0 0
mmu-miR-680 0 3180 368 2531 379 0 0 0 0 0 0
mmu-miR-690 0 4338 737 3253 421 0 0 0 0 0 0
mmu-miR-699 0 4338 376 3614 421 0 0 0 0 0 0
mmu-miR-708 12 80 270 73 9 0 0 0 0 0 0
mmu-miR-709 0 4338 367 3623 421 0 0 0 0 0 0
mmu-miR-805 0 4338 520 3470 421 0 0 0 0 0 0
mmu-miR-877* 0 3180 743 2064 471 0 0 0 0 0 0
mmu-miR-92a 62 4338 766 3188 457 0 0 0 0 0 0
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Table S4.3: Overlap of predicted miRNA targets from microRNA.org and associated miRNA-
mRNA expression trajectories. Presented are the number of miRNA target predictions in the mi-
croRNA.org database (DB) (No. DB prediction), the number of associated miRNA-mRNA trajecto-
ries that overlap with the mircoRNA.org DB predictions for correlation analysis on the raw data (Raw
Cor) and LMMS modelled data (LMMS Cor). Finally, the number of overlaps between the miRNAs
targets of microRNA.org and DynOmics are presented separated if mRNA expression changes after
(delay < 0), simultaneous (delay = 0) or prior to (delay > 0) miRNA expression.
miRNA
No. DB 
prediction Raw Cor LMMS Cor After Simultanious Prior
mmu-let-7c 2659 0 49 4 39 7
mmu-let-7d 2610 0 3 0 3 0
mmu-let-7e 2673 0 1 0 1 0
mmu-let-7g 2596 0 2 8 1 1
mmu-let-7i 2558 0 3 0 0 0
mmu-miR-100 373 0 5 0 5 0
mmu-miR-106a 3621 4 79 14 65 7
mmu-miR-126-3p 87 1 3 1 2 0
mmu-miR-126-5p 0 0 0 0 0 0
mmu-miR-127 420 0 0 0 0 0
mmu-miR-130a 2887 0 66 3 58 9
mmu-miR-130b 2962 4 65 2 56 11
mmu-miR-133a 1780 2 49 1 44 8
mmu-miR-134 2632 4 31 9 26 4
mmu-miR-135b 3433 2 4 1 1 3
mmu-miR-136 3355 0 1 0 0 0
mmu-miR-138 2933 0 0 0 0 0
mmu-miR-139-5p 3154 1 10 0 6 3
mmu-miR-140 2416 0 64 7 52 7
mmu-miR-142-3p 2060 10 47 10 33 5
mmu-miR-145 3220 0 54 5 47 4
mmu-miR-146a 3334 31 55 6 24 32
mmu-miR-146b 3323 30 45 6 18 23
mmu-miR-149 3332 0 74 4 61 12
mmu-miR-150 2643 47 63 10 47 11
mmu-miR-151-3p 0 0 0 0 0 0
mmu-miR-15a 4302 0 88 11 73 8
mmu-miR-15b* 4394 0 97 14 78 9
mmu-miR-16 4232 18 84 13 67 8
mmu-miR-17 3695 5 79 9 68 7
mmu-miR-181a 4517 0 105 12 85 11
mmu-miR-182 3235 0 65 7 54 5
mmu-miR-191 932 2 23 1 21 3
mmu-miR-195 4116 19 81 12 64 9
mmu-miR-19a 3312 3 33 7 28 3
mmu-miR-19b 3195 3 68 8 53 10
mmu-miR-200a 4222 19 46 17 32 4
mmu-miR-200b 3808 2 15 2 14 0
mmu-miR-200c 3794 1 6 0 6 0
mmu-miR-20a 3803 3 78 6 69 8
mmu-miR-21 2340 29 47 4 41 5
mmu-miR-210 839 0 0 0 0 0
mmu-miR-214 3970 0 73 5 60 12
mmu-miR-214* 6310 8 122 9 103 16
mmu-miR-222 2541 26 48 9 37 4
mmu-miR-223 2518 38 58 13 45 4
mmu-miR-24 3371 20 55 6 47 6
mmu-miR-24-2* 0 0 0 0 0 0
mmu-miR-26a 3287 10 69 8 58 6
mmu-miR-26b 3388 15 69 8 58 7
DynOmics
microRNA.org overlap
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Table S4.3: Overlap of predicted miRNA targets from miRNA.org and associated miRNA-
mRNA expression trajectories.
mmu-miR-27a 4060 14 87 13 71 5
mmu-miR-27b 4131 0 84 12 70 4
mmu-miR-28* 2657 0 52 1 44 11
mmu-miR-296-5p 0 0 0 0 0 0
mmu-miR-29a 2871 27 46 3 39 8
mmu-miR-29c 2918 16 38 28 9 2
mmu-miR-301a 3271 0 81 6 69 11
mmu-miR-301b 3238 0 6 0 6 1
mmu-miR-30a 4250 43 74 9 58 14
mmu-miR-30a* 4250 14 74 11 57 14
mmu-miR-30b 4288 8 78 8 62 14
mmu-miR-30c 4350 14 78 11 62 11
mmu-miR-30d 4079 52 72 12 54 13
mmu-miR-30e 4395 44 75 10 57 17
mmu-miR-30e* 4395 12 75 9 59 15
mmu-miR-31 2985 11 66 10 47 15
mmu-miR-322 4334 2 6 0 3 1
mmu-miR-322* 6924 0 2 0 1 0
mmu-miR-323-3p 0 0 0 0 0 0
mmu-miR-328 1864 1 33 1 28 5
mmu-miR-335-3p 0 0 0 0 0 0
mmu-miR-335-5p 3120 0 1 1 0 0
mmu-miR-34b-3p 0 0 0 0 0 0
mmu-miR-351 2210 0 1 0 1 0
mmu-miR-365 1561 13 42 5 34 4
mmu-miR-370 2978 0 55 11 39 8
mmu-miR-375 1006 0 22 10 14 0
mmu-miR-376c 3544 3 5 0 3 0
mmu-miR-379 1493 0 2 0 0 1
mmu-miR-382 3174 1 7 0 5 0
mmu-miR-409-3p 0 0 0 0 0 0
mmu-miR-410 4653 4 9 2 4 4
mmu-miR-411 1741 1 2 0 1 0
mmu-miR-429 3891 3 6 73 4 0
mmu-miR-431 2037 0 0 3 0 0
mmu-miR-433 2651 0 67 10 52 8
mmu-miR-434-3p 0 0 0 0 0 0
mmu-miR-449a 3163 2 11 0 4 1
mmu-miR-466d-3p 0 0 0 0 0 0
mmu-miR-467a* 0 0 0 0 0 0
mmu-miR-486 1750 4 27 3 22 3
mmu-miR-503 984 0 0 0 0 0
mmu-miR-503* 984 0 0 0 0 0
mmu-miR-532-5p 0 0 0 0 0 0
mmu-miR-539 5055 2 9 2 7 2
mmu-miR-672 0 0 0 0 0 0
mmu-miR-680 0 0 0 0 0 0
mmu-miR-690 0 0 0 0 0 0
mmu-miR-699 0 0 0 0 0 0
mmu-miR-708 2757 0 0 6 0 0
mmu-miR-709 0 0 0 0 0 0
mmu-miR-805 0 0 0 0 0 0
mmu-miR-877* 0 0 0 0 0 0
mmu-miR-92a 2168 1 36 9 25 3
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Table S4.4: Overlap of predicted miRNA targets from miRDB associated miRNA-mRNA ex-
pression trajectories. Presented are the number of miRNA target predictions in the miRDB database
(DB) (No. DB prediction), the number of associated miRNA-mRNA trajectories that overlap with the
miRDB DB predictions for correlation analysis on the raw data (Raw Cor) and LMMS modelled data
(LMMS Cor). Finally, the number of overlaps between the miRNAs targets of miRDB and DynOmics
are presented separated if mRNA expression changes after (delay < 0), simultaneous (delay = 0) or
prior to (delay > 0) miRNA expression.
miRNA
No. DB 
prediction
 
Raw Cor LMMS Cor After  Simultanious Prior
mmu-let-7c 0 0 0 0 0 0
mmu-let-7d 0 0 0 0 0 0
mmu-let-7e 0 0 0 0 0 0
mmu-let-7g 0 0 0 0 0 0
mmu-let-7i 0 0 0 0 0 0
mmu-miR-100 0 0 0 0 0 0
mmu-miR-106a 0 0 0 0 0 0
mmu-miR-126-3p 0 0 0 0 0 0
mmu-miR-126-5p 0 0 0 0 0 0
mmu-miR-127 0 0 0 0 0 0
mmu-miR-130a 0 0 0 0 0 0
mmu-miR-130b 0 0 0 0 0 0
mmu-miR-133a 0 0 0 0 0 0
mmu-miR-134 0 0 0 0 0 0
mmu-miR-135b 0 0 0 0 0 0
mmu-miR-136 0 0 0 0 0 0
mmu-miR-138 0 0 0 0 0 0
mmu-miR-139-5p 428 0 1 0 1 0
mmu-miR-140 0 0 0 0 0 0
mmu-miR-142-3p 0 0 0 0 0 0
mmu-miR-145 0 0 0 0 0 0
mmu-miR-146a 0 0 0 0 0 0
mmu-miR-146b 0 0 0 0 0 0
mmu-miR-149 0 0 0 0 0 0
mmu-miR-150 0 0 0 0 0 0
mmu-miR-151-3p 134 0 4 0 4 0
mmu-miR-15a 0 0 0 0 0 0
mmu-miR-15b* 0 0 0 0 0 0
mmu-miR-16 0 0 0 0 0 0
mmu-miR-17 0 0 0 0 0 0
mmu-miR-181a 0 0 0 0 0 0
mmu-miR-182 0 0 0 0 0 0
mmu-miR-191 0 0 0 0 0 0
mmu-miR-195 0 0 0 0 0 0
mmu-miR-19a 0 0 0 0 0 0
mmu-miR-19b 0 0 0 0 0 0
mmu-miR-200a 0 0 0 0 0 0
mmu-miR-200b 0 0 0 0 0 0
mmu-miR-200c 0 0 0 0 0 0
mmu-miR-20a 0 0 0 0 0 0
mmu-miR-21 0 0 0 0 0 0
mmu-miR-210 0 0 0 0 0 0
mmu-miR-214 0 0 0 0 0 0
mmu-miR-214* 0 0 0 0 0 0
mmu-miR-222 0 0 0 0 0 0
mmu-miR-223 0 0 0 0 0 0
mmu-miR-24 0 0 0 0 0 0
mmu-miR-24-2* 0 0 0 0 0 0
mmu-miR-26a 0 0 0 0 0 0
mmu-miR-26b 0 0 0 0 0 0
miRDB overlap
DynOmics
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Table S4.4: Overlap of predicted miRNA targets from miRDB associated miRNA-mRNA ex-
pression trajectories.
mmu-miR-27a 0 0 0 0 0 0
mmu-miR-27b 0 0 0 0 0 0
mmu-miR-28* 0 0 0 0 0 0
mmu-miR-296-5p 462 0 0 0 0 0
mmu-miR-29a 0 0 0 0 0 0
mmu-miR-29c 0 0 0 0 0 0
mmu-miR-301a 0 0 0 0 0 0
mmu-miR-301b 0 0 0 0 0 0
mmu-miR-30a 0 0 0 0 0 0
mmu-miR-30a* 0 0 0 0 0 0
mmu-miR-30b 0 0 0 0 0 0
mmu-miR-30c 0 0 0 0 0 0
mmu-miR-30d 0 0 0 0 0 0
mmu-miR-30e 0 0 0 0 0 0
mmu-miR-30e* 0 0 0 0 0 0
mmu-miR-31 0 0 0 0 0 0
mmu-miR-322 0 0 0 0 0 0
mmu-miR-322* 0 0 0 0 0 0
mmu-miR-323-3p 410 0 8 1 7 0
mmu-miR-328 0 0 0 0 0 0
mmu-miR-335-3p 1190 1 1 0 1 0
mmu-miR-335-5p 410 0 0 0 0 0
mmu-miR-34b-3p 245 1 2 0 2 0
mmu-miR-351 0 0 0 0 0 0
mmu-miR-365 0 0 0 0 0 0
mmu-miR-370 0 0 0 0 0 0
mmu-miR-375 0 0 0 0 0 0
mmu-miR-376c 0 0 0 0 0 0
mmu-miR-379 0 0 0 0 0 0
mmu-miR-382 0 0 0 0 0 0
mmu-miR-409-3p 291 0 1 2 0 0
mmu-miR-410 0 0 0 0 0 0
mmu-miR-411 0 0 0 0 0 0
mmu-miR-429 0 0 0 0 0 0
mmu-miR-431 0 0 0 0 0 0
mmu-miR-433 0 0 0 0 0 0
mmu-miR-434-3p 173 0 0 0 0 0
mmu-miR-449a 0 0 0 0 0 0
mmu-miR-466d-3p 1265 4 23 3 17 3
mmu-miR-467a* 0 0 0 0 0 0
mmu-miR-486 0 0 0 0 0 0
mmu-miR-503 0 0 0 0 0 0
mmu-miR-503* 0 0 0 0 0 0
mmu-miR-532-5p 279 0 4 1 3 0
mmu-miR-539 0 0 0 0 0 0
mmu-miR-672 0 0 0 0 0 0
mmu-miR-680 341 0 8 4 4 1
mmu-miR-690 319 0 8 1 6 1
mmu-miR-699 0 0 0 0 0 0
mmu-miR-708 0 0 0 0 0 0
mmu-miR-709 1494 0 19 1 18 0
mmu-miR-805 0 0 0 0 0 0
mmu-miR-877* 0 0 0 0 0 0
mmu-miR-92a 0 0 0 0 0 0
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Figure S4.1: Summary of miRNA predictions based on co-expression and sequence similarity
Presented is a visual summary of Supporting Tables S4.1-S4.4. In a) we present summarised as
boxplots the number of putative miRNA targets based on co-expression (cor < −0.9) for DynOmics
(grey), Pearson correlation on LMMS modelled data (orange) and on raw data (lightblue). In b) we
depict the number of predictions of putative miRNA targets for databases microRNA.org (green),
miRDB (red) and TargetScan (purple). In c) for each database we present the percentage of overlap
of predicted putative miRNA targets based on sequence similarity with the predictions made based on
co-expression.
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5. NETOMICS - ANALYSIS AND VISUALISA-
TION OF INTEGRATED TIME COURSE ‘OMICS’
DATA
SUMMARY
In the previous chapter I demonstrated how to integrate multiple time course ‘omics’ data from differ-
ent molecular levels to identify and analyse regulatory mechanisms across the layers of metabolism. I
further showed that the same methodology can be used to analyse conserved regulatory mechanisms
across organisms. Approaches that enable the holistic analysis of molecular behaviour under chang-
ing environmental conditions (e.g. disease) are important for drug development; to detect drug targets,
to selected appropriate model organisms for drug testing and to understand disease.
In this chapter I present how I use the information obtained from the methodology developed in
Chapter 4 to build molecule interaction networks in a user-friendly environment. For this purpose I
developed NetOmics an application to analyse and visualise integrated time course ‘omics’ data with
a graphical user interface. First, I enabled the integration and analysis of two data sets with DynOmics
using ‘Shiny’ a web application framework for R, including visualisations to help to understand Dy-
nOmics results. Second, I developed and enabled the visualisation of DynOmics results as interactive
directed relevance networks (RN) using the D3.js JavaScript library.
5.1 Introduction
A system adapts to environmental changes and perturbation via dynamic expression and regulation
of biological molecules through all layers of metabolism. Advances in high-throughput biological
molecule analyses enable us to measure multiple molecular levels of metabolism (e.g. transcripts,
proteins) from the same source. To capture the dynamic response, a time course experimental design
is crucial to study molecules and their interactions that take part in forming the phenotype of the
studied organism. These dynamic biological processes are not driven by a single component but by
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networks of interacting molecules. The hypothesis is that similarities in molecule expression on all
metabolic levels indicate functional relationships. The challenge is to develop an efficient method
to build the underlying molecular regulation network derived from the data. Often these regulation
networks are modelled as a graph with molecules as nodes and interaction between the molecules
as edges. In order to identify these interactions of molecules and to build the network, time course
‘omics’ data can be exploited.
Previous methods developed to build regulation networks with temporal associations have been de-
veloped for gene expression data with genes as nodes and associations between two genes as edges
[81, 83, 84, 85, 86, 87]. Methods developed to model directed gene interaction networks (GINs) from
expression data alone can be separated in methods using bayesian networks (BN) [81] or dynamic
bayesian networks (DBN) [184, 82] and methods using relevance measurements like correlation [85]
or mutual information [87, 78, 185] to create RNs. While there are DBN and RN methods [184,
87] that use time delays in form of lagging the time series to identify delayed associations between
molecules and to infer causality of reactions, none of these methods enable to extract the estimated lag
to use the information in the network visualisation. One big advantage of RN methods compared to
BN and DBN methods is the large number of nodes they can process [80], which is very relevant for
high-throughput data. A drawback in forming biological inferences based on networks derived only
from gene expression data is that it can lead to misinterpretation, as there are numerous regulatory
mechanisms involved in turning a transcript into a fully operative protein. To improve the construction
of gene regulatory networks, researchers integrated experimentally obtained protein-protein interac-
tions (PPI) [9, 97, 98] with gene expression data. While integrating PPI information has shown to
increase specificity of networks built [75], however these PPI maps are considered incomplete [99]
and more importantly PPIs have been found to alter under specific conditions [100]. It is therefore
important to create and analyse conditional specific molecular interaction networks to gain new in-
sights and discover condition specific correlated molecular expression. This is particularly relevant
for perturbation experiments where environmental conditions change dramatically or in patients with
disease.
The purpose of this study was to develop a framework that enables the user-friendly integration of
multiple time course ‘omics’ data and to build molecular networks from multiple molecular levels.
I hypothesised that integrating multiple layers ‘omics’ will increase the understanding of molecular
events under changing environmental conditions and the confidence in observations made. I further
hypothesised that the integration of pathway interaction or gene ontologies information in addition to
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molecule expression data to build the network will increase the biological inference of these networks.
To build the molecular interaction networks I used the associations of molecules derived by my devel-
oped DynOmics approach from Chapter 4. The final output of identified associations of two ‘omics’
experiments using DynOmics was then visualised as RN in order to improve the understanding of
analytical results. The network visualisation was specifically developed to use and display DynOmics
results. The whole approach to integrate and visualise DynOmics results is wrapped into a framework
called NetOmics available on bitbucket https://bitbucket.org/Jasmin87/netomics.
5.2 Material and Methods
5.2.1 Implementation
NetOmics is implemented in R using the web application framework ‘Shiny’ for easy accessibility
and simple usage via a graphical user interface. It adopts methodologies from the dynOmics R
package to identify the associations of molecule expression trajectories within a single data set or
between two data sets. The network tab adopts the force directed layout from the D3.js JavaScript
library. The network library was substantially expanded to display DynOmics’ results. Calculations
run in parallel where possible using the parallel R package [135].
5.2.2 From DynOmics results to networks
The DynOmics algorithm is based on the fast Fourier transform (FFT) [162] and aims to identify de-
lays in the expression changes of two trajectories to realign the trajectories. The relevance measure of
two trajectories is returned as a Pearson correlation coefficient or p-value and those two measurement
were used to build the edges between molecule nodes. Delays between the expression changes of the
two trajectories are used to give RNs directed edges. The directions in the graph helped to form a
hierarchy of molecular events. In the network the direction can be visualised by arrows. The length
of the estimated delays are used to influence the attraction between two connected nodes in depth
described below. Existing network graphs of the D3.js JavaScript library (http://d3js.org/)
are augmented and integrated with Shiny to provide interactive networks.
5.2.3 Force directed layout
A network consists of nodes connected via edges. In NetOmics the nodes represented molecules
and the edges represented the association between two molecules. To form a network of nodes and
edges NetOmics uses a force directed layout algorithm [186]. As the name implies, this algorithms
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uses forces assigned to the nodes and edges to obtain a natural network presentation and to avoid
node and edge overlap. The forces are either in the form of a repulsion as defined by Coulomb’s
law [187] or spring-like attraction based on Hooke’s law [188]. Furthermore, the force directed
layout as implemented in the D3 library uses the position Verlet integration [189] and a quadtree to
improve charge interaction using the Barnes-Hut approximation [186]. The spring-like attraction is
implemented on the edges of the network, and causes the spatial proximity of two nodes in the network
given a connection. To avoid overlapping nodes, every node obtains a repulsion charge. The initial
step to form a force directed layout network, is the random seeding of nodes over the space. Then
nodes are moved iteratively to improve their position based on the desired link attraction or distance
and node repulsion. If the networks nodes and links are far away from their optimal position within the
network, the network has a ‘high temperature’ equivalent to a fast molecule or node movement. The
closer the network layout gets to its optimum the ‘cooler’ it gets and motion stops if the temperature
drops below a defined ‘cooling’ parameter alpha. By default the D3 implementation visualises the
motion of the nodes in the network until it finds a stable layout, but for big networks with many
nodes and edges this is very computational expensive. To increase performance, firstly, I constrained
the number of iterations to form the network to 100 or stopped earlier, if the temperature fell below
0.1. Secondly, I chose not to represent the motion of the molecules to form a stable layout. Instead
the layout is calculated in the background and only the final layout of the nodes’ position estimation
is visualised. In the NetOmics implementation of the force directed layout, my DynOmics model
enabled to use estimated information on association and delay between two molecules to form the
network. The delay information is represented as the link distance between nodes to constrain the
attraction of nodes. In order to visualise and integrate timing differences of expression changes, I
defined nodes as ‘less attracted’ when the absolute delay increased. In this specific network no prior
assumptions on the nodes repulsion to each other were made and therefore every node had the same
charge.
5.2.4 Assessing network structures
The assessment of the modelled networks structure is important in order to infer meaningful biological
results. Molecular networks as well as other networks obtained from social or semantic data have
shown ‘scale-free’ behavior [190, 94, 12]. Scale-free means that not every node has the same number
of connecting edges but the number of edges amongst nodes follows a power-law like distribution.
The theory behind scale-free behavior in molecular networks is that only a few molecules drive the
behavior of other molecules. These molecules have many connected nodes and are also referred to
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as hubs. To allow the user to asses if their networks are scale-free, a connectivity graph for visual
assessment is provided. The connectivity graph visualises the number of nodes with a defined number
of edges or connections (y-axis) in dependency on the number of edges or connections (x-axis).
5.3 Results
The NetOmics web application consists of three tabs ‘Upload’, ‘DynOmics’ and ‘Network’. These
tabs contain the main functionalities to upload data, to identify associations between molecules and
to visualise these associations via networks. In the following section, I first describe the NetOmics
workflows. I then further describe the tabs’ functionalities and visualisations.
5.3.1 Workflow
NetOmics workflow has two alternatives as shown in Figure 5.1. The first option is that given one
or two expression matrices were uploaded, the degree of association between molecules using Dy-
nOmics is estimated in order to build networks (Figure 5.1 A). Alternatively, a network matrix file
can be uploaded which enables the use of the network functionality of NetOmics, only (Figure 5.1
B).
Upload
NetworkDynOmics
B
Upload
NetworkDynOmics
A
Figure 5.1: NetOmics Workflow Overview. A: on upload of expression matrices, associated
molecule trajectories are identified using DynOmics and visualised via networks. Alternatively, B:
upload of a network matrix only enables the network visualisation.
Upload tab. The Upload tab loads the data into the application. One or two expression matrices
with sampled time points as rows and molecules as columns as displayed in Table 5.1 are required. It
is important that the first row contains a unique identifier describing each molecule. Alternatively, a
network matrix as shown in Table 5.2 can be uploaded. The columns named ‘Feature1’ and ‘Feature2’
contain the identifiers of the associated molecules. The column ‘delay’ contains positive or negative
integers and indicates the delay of the expression initiation between the molecules to model the re-
lationship. For example, the delay value is negative if the expression of the molecule in ‘Feature1’
changed expression prior to the expression of molecule in the same row in ‘Feature2’. The delay value
is zero if the molecule in ‘Feature1’ and ‘Feature2’ change expression simultaneous and positive if the
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molecule in ‘Feature1’ changed expression after the molecule in ‘Feature2’. The fourth and fifth col-
umn are association measurements e.g. p-values ‘pAfter’ ranging from 0 to 1 and correlation values
‘corAfter’ ranging from−1 to 1. ‘After’ in the DynOmics context means the correlation/p-value after
realignment using the estimated delay between trajectories, since the R package output also provides
correlation and p-value before delay adjustment. The order of the columns in the network matrix is
not important. However, it is important that the values have the same column descriptions, as shown
in Table 5.2 (first row).
Table 5.1: Example expression matrix. The expression matrix contains molecule expression values,
with the molecules as columns and the measured, comparable time points as rows. The first row
contains the molecules’ identifier.
Molecule ID 1 Molecule ID 2 · · ·
0.5 0.2
...
0.8 0.3
...
...
...
...
Table 5.2: Example network input matrix. An network input matrix consists of five types of infor-
mation: the associated pairs of molecules, whose IDs are in columns with the header i)‘Feature1’ and
ii) ‘Feature2’, iii) the ‘delay’ column containing positive and negative integeres, indicating the causal
relationship between the molecules and vi) a p-value like measurement in column ‘pAfter’ and v) a
correlation like measurement in column ‘corAfter’.
Feature1 Feature2 delay pAfter corAfter
Molecule ID 1 Molecule ID 2 0 0.5 0.5
Molecule ID 1 Molecule ID 3 -1 0.05 0.9
...
...
...
...
...
DynOmics tab. The DynOmics tab identifies and visualises associations between pairs of molecule
trajectories. Depending on the upload of one or two expression matrices on selecting ‘Identify asso-
ciations’ (Figure 5.2 A), DynOmics associates pairs of trajectories within a single data set or between
two data sets. DynOmics returns a table with estimated delays and the measurement of degree of
association (Pearson correlation coefficient and p-value) once the trajectories have been aligned with
DynOmics (Chapter 4). Additionally, a histogram (Figure 5.2 C) displays the data sets number of
estimated delays, for associations with an initial absolute correlation threshold of 0.9 that can be set
from the control panel (Figure 5.2 D). The control panel further enables to chose which molecules
to display in the DynOmics plot (Figure 5.2 E). The detailed description of the DynOmics plot is
described in Section 5.3.2.
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Figure 5.2: DynOmics tab. Displayed is an example of the DynOmics tab. The tab consists of four
parts: A the button triggering the calculation of associations between molecules using DynOmics,
the table containing DynOmics results and B visualisation of DynOmics associated profiles. In C a
histogram displays the number of associations with a certain delay. The associations to be displayed
in the histogram and in the DynOmics plot E are controlled in D.
Network tab. The Network tab takes as an input either the information of the DynOmics associ-
ated profiles from the ‘DynOmics tab’ or the uploaded network matrix information and calculates and
visualises the network. First, appropriate thresholds need to be selected by the user(Figure 5.3 A)
in order to only visualise information of interest (Figure 5.3 B). The detailed description of the net-
work plot follows in Section 5.3.2. A table containing information about the incoming/outgoing and
equal edges for each molecule is displayed as in Figure 5.3 C. Molecules can be sorted by increas-
ing/decreasing number of edges for an easy identification of main regulators/hubs in the network. The
non-randomness of the network can be analysed via a connectivity graph, that displays the number of
edges/connections on the x-axis and the number of nodes with the number of edges/connections on
the y-axis (Figure 5.3 D).
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Figure 5.3: Network tab. The Network tab consists of four components: A the control panel to
select thresholds for the network’s edges, B the visualisation of the network, C a table containing
information about nodes’ number of incoming, outgoing and equal edges, and D a connectivity plot
of the network to assess non-randomness.
Example and Help tab. The Example and Help tab implements the automatic upload of an example
data set to explore NetOmics functionality.
5.3.2 Visualisation
DynOmics visualisation. The DynOmics plot of the identified associations is used to explore the
molecules - sometimes complex expression patterns and their estimated delays. The plot visualises
the reference trajectory of a molecule in association with the identified associated query trajectory
(Figure 5.4 A). The user can chose to visualise all associated query trajectories passing for set p-value
or correlation threshold (Figure 5.4 C). Furthermore, the realigned reference and query profiles can
be visualised as in Figure5.4 BD. The visualisation further uses colors to highlight positive (orange)
and negative (blue) correlated queries.
107
A B
C D
Figure 5.4: DynOmics visualisation. A, when the user selects a row in the DynOmics table, the
reference trajectory of the molcule in the first column ‘Feature Data 1’, is plotted in black as well
as the query trajectory of the molecule in column ‘Feature Data 2’. The query trajectory is colored
according to the Pearson correlation after realignment using the DynOmics estimated delay. Positive
correlations are colored in orange and negative correlations are colored in blue. B, when selecting
the checkbox ‘Show aligned profiles’ the query trajectory is shifted according to the estimatd delay
along the x-axis. When the user selects ‘Plot all features’ the plot displays all query trajectories to the
selected reference trajectory for a given correlation/p-value threshold selected by the user.
Network visualisation. The network I implemented gives a visual overview of the molecule in-
ferred interactions from DynOmics. To further visualise the different molecular levels (e.g. genes,
proteins, NetOmics uses different colors and shapes for the network nodes. Molecules from the data
uploaded first are displayed as grey squares and molecules uploaded second as blue circles. Figure 5.5
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illustrates, the NetOmics visualisation from a DynOmics output. For example, if DynOmics estimated
a negative delay between two molecules this indicates that the molecule’s expression in column ‘Fea-
ture Data 1’ changed prior to the molecule’s expression in column ‘Feature Data 2’. This information
is visualised as an arrow pointing from molecule indicated in ‘Feature Data 1’ towards the molecular
indicated in ‘Feature Data 2’ (Figure 5.5 AB). In the case of a positive delay the arrow is pointing
from molecule in ‘Feature Data 2’ to molecule in ‘Feature Data 1’ (Figure 5.5 CD). In the case of zero
time delay two arrows point to both features in the first two columns (Figure 5.5 E). The length of the
edge is proportional to the absolute delay, however it is also effected by the force directed layout and
will be discussed later. The color of the edges is representative of the trajectories’ correlation, orange
for positive and blue for negative correlation (Figure 5.5 ABC and DE, respectively). The opacity of
the edge color is proportional to the strength of association, measured by the Pearson correlation.
1
0.1
-0.1
-1
Correlation
0
1
2
3
Example Feature Data 1 Feature Data 2 Delay Correlation P-value
A Metabolite 1 Protein 1 -1 0.9 <0.05
B Metabolite 1 Protein 2 -1 0.5 <0.05
C Metabolite 2 Protein 3 1 -0.8 <0.05
D Metabolite 1 Protein 2 0 -1 <0.05
E Metabolite 2 Protein 1 2 0.97 <0.05
… … … … … …
Delay
A
B
C
D
E
Figure 5.5: Network elements. Displayed are examples of how DynOmics’ information are visu-
alised in the network. The table contains an example of DynOmics’ output with information on the
associated trajectories (column ‘Feature Data 1’ and ‘Feature Data 2’), the DynOmics estimated de-
lay, the correlation and the p-values. For each table entry A to E, the presentation in the network
is illustrated. Node colors and shapes indicate different types of molecules. Edge colors represent
negative (blue) or positive (orange) correlation of connected nodes. The opacity of the edge colors is
proportional to the strength of the absolute correlation. Edge lengths are proportional to the absolute
delay.
Regarding the orientation of the network, I implemented various features using the D3.js JavaScript
library. For a large network as presented in Figure 5.6 A, sub-networks can be highlighted by selecting
a node (Figure 5.6 B). The mouse wheel can be used to zoom into or out of the network (Figure
5.6 C). When the mouse hovers over a node, the node’s name along with the number of incoming,
outgoing and equal edges is displayed (Figure 5.6 D). Finally, when the mouse hovers over an edge,
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the correlation and delay of the connection are displayed.
A B C D E
Figure 5.6: Network features. Illustration of the features implemented to improve the navigation in
the network. In A the orginal network is displayed, while B displayes the graph when the user selects
a node. C illustrates the zoom feature and D and E the mouse over node or edge feature.
5.4 Discussion and Conclusion
The proposed framework NetOmics to integrate and analyse multi time course ‘omics’ data uses
DynOmics output to build molecule interaction networks. The DynOmics an algorithm designed to
identify associations between pairs of molecule trajectories using delays. An limitation when using
DynOmics results to visualise networks is that DynOmics likely also identifies indirect associations
between molecules. Indirect associations means that a molecule is not directly responsible for ex-
pression changes of a molecule but mediated through a direct interaction with another molecule. In
networks these indirect edges are unwanted. In order to remove these edges DynOmics delay infor-
mation and the strength of correlation can be used. The removal of indirect edges called pruning will
increase the outcome of the network visualisation and biological inference. Methods like the data
processing inequality for pruning as proposed by Zoppoli et al. [87] or the minimum length principle
as described by Zhao et al. [86] could be adopted for this purpose.
To further increase confidence in identified associations and networks build, the integration of infor-
mation like gene ontologies, pathway maps like KEGG [191] and Reactome [192], or experimentally
verified PPIs like in the String database [193] could be considered.
In Chapter 6, I demonstrate the usefulness of NetOmics in a toxicity study. Further extensive com-
parisons would be needed to compare results to other proposed network reconstruction methods.
Specifically, comparisons to methods that integrate time delay in to their analysis are of interest, like
the DBN method proposed by Rau et al. [184] and the RN method proposed by Zoppoli et al. [87].
NetOmics is specifically developed to instantly access DynOmics results in an interactive network
visualisation, highlighting the most important information. As a consequence it cannot provide ex-
tensive functionalities, such as those proposed in Cystoscape [194]. To circumvent this limitation, my
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graphical user interface enables to save the output compatible for Cytoscape.
NetOmics is a tool for time course ‘omics’ data integration and visualisation of different molecular
levels of an organism using DynOmics. The novelty of NetOmics is that it provides a whole frame-
work for the analysis of multiple time course ‘omics’ data sets. Firstly, it identifies associations across
multiple data sets using DynOmics. DynOmics results can then be analysed via visualising the iden-
tified associations including DynOmics estimated delays between expression changes of molecules.
Finally, it provides a directed RN visualisation, specifically developed to display and analyse Dy-
nOmics and DynOmics-like results. For that purpose I implemented various features in the network
visualisation. Amongst others I weighted the edges of the force directed layout and I also used di-
rected edges.
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6. ANALYSING DELAYS BETWEEN TIME COURSE
GENE EXPRESSION DATA AND BIOMARKERS;
APPLICATION TO A TOXICITY STUDY
ABSTRACT
Associating time course gene expression data to biomarkers can help to understand disease progres-
sion or response to therapy. However, detecting associations between these expression profiles is
not a trivial task. Often expression changes occur not simultaneously but delayed in time and com-
mon used methods to detect correlation will fail to identify these associations. I have developed an
efficient approach, DynOmics, based on Fast Fourier Transform to identify coordinated response dy-
namics between time course omics experiments and specific biomarkers of interest while taking time
delay into account. I applied DynOmics and NetOmics to a rat study investigating molecular response
dynamics to different dosages of acetaminophen (‘paracetamol’). I show how DynOmics can extract
relevant associated molecule expression while NetOmics visualises these associations as networks to
enable a better understanding of the molecular pathways related to toxic dosages of acetaminophen
and resulting renal damage.
6.1 Introduction
A biological system adapts to genetic and environmental changes by dynamic interactions and expres-
sion changes of its components (e.g. transcripts, proteins, metabolites). The components involved in
this adaptation form characteristic profiles over time and similar profiles indicate interactions of com-
ponents. The challenge is to understand how these interactions give rise to the function and behaviour
of that system. One way to reveal molecular responses associated to biological markers is to as-
sociate gene expression profiles to known measured biomarkers. The advantage is that clusters of
molecule response profiles and potential biological function are predefined rather than unsupervised.
The fundamental assumption is that molecules that show similar response profiles are co-regulated,
112
they interact, or they are involved in the same biological processes or molecular functions. The chal-
lenge is to identify associations between profiles. Associated molecule expression profiles often do
not overlap directly [89, 96]. This can be the result of differences in the kinetics of expression between
molecules that lead to profiles that are delayed in time (Figure 6.1).
Figure 6.1: Representation of potential molecule interactions and their quantitative response. Proteins
acting as transcription factors can regulate the expression of multiple genes. Delays occur between
the presences of a protein to the transcription initiation of a downstream target. Proteins functioning
as enzymes will metabolise substrates resulting in a reduction of that substrate while the quantities of
the products increase.
Several authors observed time delays between their expression profiles when integrating transcript and
metabolite data [66], [73]. By incorporating time delays, they could improve on the quality of biolog-
ical inference. Takahashi et al. [66] studied transcript metabolite associations using lagged Pearson
correlation. Lagged Pearson correlation maximises the correlation between two profiles while shift-
ing them along time. However, it does not seem to be very sensitive to a small number of time points.
Similar issues were observed using dynamic time warping (DTW) [73] to identify multi ‘omics’ asso-
ciations. I therefore developed an algorithm based on the fast Fourier transform (FFT). The advantage
of my approach is that it is still very sensitive for low numbers of time points, a commonly encoun-
tered characteristic in time course experiments. It also enables the estimation of time delay between
molecules. This information and the NetOmics approach that visualises DynOmics results as molecu-
lar interaction networks can be used to identify and compare clusters of delayed molecules to find dif-
ferences in response dynamics. Possible applications of DynOmics include the comparison of patients
response to different types of treatment, or monitoring disease progression by associating biomarkers
to gene expression data in time course experiments. In this study, I apply DynOmics and NetOmics
to acetaminophen toxicity time course data from rats. My analysis shows how acetaminophen dosage
has an impact on metabolism and enables a better understanding of acetaminophen toxicity related to
liver and renal damage.
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6.2 Material and Methods
6.2.1 DynOmics algorithm
I have presented DynOmics in Chapter 4. As a brief reminder, the algorithm associates molecule
expression profiles taking delay into account, using FFT. FFT decomposes profiles into circular com-
ponents. This circle information like the frequency (speed), the amplitude (size) and the phase angle
(delay), can be used to compare profiles. To date, people have used information about the frequency
to cluster cell cycle genes [7]. I developed a method to use the phase angle of the dominant frequency
of the profiles to estimate the delay between profiles. This delay was then used to realign profiles and
Pearsons correlation was used to assess their relevance. Profiles identified as associated were then
further analysed via gene enrichment analysis and network representations.
6.2.2 NetOmics network visualisation
NetOmics was presented in Chapter 5 and provided a relevance network (RN) visualisation of Dy-
nOmics results. NetOmics used the force directed layout of the D3.js JavaScript library with mod-
ification made in the layout as described in Chapter 5 to highlight the relationships and dynamics
observed by DynOmics. In the network grey squares represented the BUN marker and blue circles
represented genes. Edges represented identified associations between BUN marker and genes with
an absolute Pearson correlation of > 0.9. Negative correlation values were visualised in blue, while
positive correlations were visualised in orange. Furthermore, the edge distance between two nodes
was weighted by the observed time delay of changes in expression. Edge distance increased with in-
creasing absolute delay. If the arrow points to a molecule this means the molecule changed expression
after expression changed of the molecule the arrow is pointing away from.
6.2.3 Acetaminophen toxicity data
Acetaminophen (‘paracetamol’) is one of the most used pain relievers and fever reducers. However,
acetaminophen overdose has severe consequences like liver and renal damage and liver failure. Here
I examined a study performed by Bushel et al. [195] to analyse the impact of acetaminophen dosage
in association with biomarkers and gene expression in rats. Microarray gene expression data of 3, 316
genes were obtained from four male Fischer rats per dose group exposed to subtoxic levels (50 and
150 mg/kg) and toxic levels (1, 500 and 2, 000 mg/kg) of acetaminophen. Rats were sacrificed to
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obtain the liver samples at time points 6, 18, 24, or 48 hours after treatment. In addition for each rat
clinical chemistry measurements were taken as estimate of acetaminophen damage. Amongst others
a biomarker for renal damage, blood urea nitrogen (BUN) was measured. My analysis focused on
the molecular response dynamics to different doses of acetaminophen in association with the BUN
biomarker. In particular, I asked whether different delays in gene expression can be attributed to
different acetaminophen dosages and whether those delayed genes are involved in relevant molecular
pathways with respect to renal damage and acetaminophen metabolism.
6.2.4 Data pre-processing, modelling and analysis
Data were pre-processed as described in [195]. The low number of time points and high noise ham-
pered the identification of associations of biomarker to the gene expression data. Therefore, I used
my spline modelling approach from Chapter 2 to summarise the profiles for each dose group sepa-
rately and interpolated 14 time points regularly spaced between 6 and 48 hours. As described earlier,
LMMS models profiles depending on their variance structure ranging from simple linear models to
spline models taking subject-specific intersect and slope into account. Trajectories that could only be
modelled by a linear model were removed prior to analysis leaving 401 genes for 50, 910 for 150, 644
for 1, 500, and 960 for 2, 000 mg/kg for subsequent DynOmics analysis. Genes were termed ‘associ-
ated’ if the absolute Pearson correlation of the realigned profiles was above 0.9. Enrichment analysis
of associated genes was performed using QIAGENs Ingenuityr Pathway Analysis (IPAr, QIAGEN
Redwood City, www.qiagen.com/ingenuity). DynOmics results for each dosage merged for
the input in NetOmics to model a directed RN.
6.3 Results and Discussion
6.3.1 Using DynOmics to identify expression dynamics in response to renal
damage induced by acetaminophen
I investigated the molecular response to different dosages of acetaminophen in the acetaminophen
toxicity study. The aim was to detect associations between the BUN biomarker for renal damage
and time course gene expression data. I observed that BUN quantity changed temporarily over time
for all dosages (Figure 6.2), with differences in the rate of change. The rate of change increased
with increasing acetaminophen dosage, indicating severe renal damage with higher dosage and faster
molecular responses. This temporary response indicates only transient renal dysfunction or damage.
Due to the temporary change of the BUN marker I expected to identify associated genes that are
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Figure 6.2: Renal damage marker expression profiles. Presented is the quantity of the BUN renal
damage marker in dependency of time after varying dosages of acetaminophen. Points indicate the
mean response of the biological replicated measurements and error bars the 95% confidence interval.
Table 6.1: Number of genes assosicated BUN renal damage marker identified by DynOmics for
the different dose groups. The table indicates the number of genes associated where + corr and
- corr indicate the number of genes positively or negatively correlated to BUN with a threshold of
0.9. Positive associations indicated the same trend as BUN, therefore these genes were up-regulated.
Accordingly, negative associated genes to BUN indicated a down-regulation.
Dosage in mg/kg ] of genes + corr − corr
2, 000 461 345 118
1, 500 515 440 75
150 575 495 80
50 90 68 22
involved in renal damage but also in the metabolism of acetaminophen.
Application of the DynOmics algorithm to the level of BUN of varying dosage of acetaminophen
resulted in different numbers of associated genes to the renal damage marker BUN.
Using a correlation threshold of 0.9, I obtained different numbers of positively and negatively corre-
lated profiles to the Bun biomarker depending on the dosage (Table 6.1).
Histograms of the predicted delays separated by dosage and correlation indicated that some delays
occurred more often than others (Figure 6.3). I also observed that these prevalent delays are different
for subtoxic (50 and 150 mg/kg) and toxic dosage (1, 500 and 2, 000 mg/kg) of acetaminophen. More-
over, patterns varied between positive (Figure 6.3 A) and negative (Figure 6.3 B) correlated profiles,
suggesting different molecular response dynamics and interactions, with potential different biological
implications.
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Figure 6.3: Histograms of predicted delays of the associated gene expression profiles A) positive
correlated profiles and B) negative correlated profiles to the renal damage marker BUN. The
x-axis presents the delay in standard units where 1 unit refers to 3.2 hours. Negative (positive) delay
indicates the BUN marker changed expression prior to (after) the associated gene.
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6.3.2 Biological relevance of delays and correlation
The biological implication of delayed responses is important to understand signalling pathways and
malfunctions. Information obtained can be used to understand the molecular processes involved in
renal damage caused by acetaminophen or the detection of potential renal damage prior to the actual
event. Therefore, I further investigated the significant enriched pathways (p− value < 0.05) or func-
tions from the toxicity list using IPA (Table 6.2). Associated genes for 2, 000 and 1, 500 mg/kg were
separated into positive or negative associations to the renal damage marker BUN. I also investigated
whether changes in BUN quantity occurred before (negative delay), after (positive delay) or simul-
taneously (no delay) to gene expression changes. The xenobiotic metabolism was clearly activated
through dosages of acetaminophen. Differences in the response dynamics were observed for high
and low dosages. While molecules with a high dosage reacted prior to or simultaneous to the renal
damage marker indicating a fast detoxification of the drug, 150 mg/kg dosage showed late response.
Increased metabolism of acetaminophen can lead to the toxic byproduct N-acetyl-p-benzoquinone
imine (NAPQI) [196]. NRF2 has been shown to play an important role in the regulation of NQO1
which metabolises the hepatotoxic acetaminophen intermediate NAPQI [197]. Majority of molecules
involved in the NRF2-mediated oxidative stress response for toxic dosage of acetaminophen were
positively correlated with the renal damage marker and occurred simultaneously, indicating the acti-
vation of the NRF2 cascade to regulate presence of NAPQI. However, changes for 150 mg/kg occurred
later than changes in the BUN renal damage marker which indicated a delayed response due to less
presence or slower accumulation of NAPQI. The number of genes identified to be associated to the
renal damage marker and known to play a role in ‘Renal Necrosis/Cell Death’ and ‘Long-term Re-
nal Injury Anti-oxidative Response Panel (Rat)’ decreased with decreasing dosage, indicating less
severe damage for lower dosages. The majority of profiles were positively associated but dynamics
varied across the marker. Genes known to increase renal damage only occurred for toxic dosages of
acetaminophen.
6.3.3 Using NetOmics to model dynamic molecular interactions of acetaminophen
treatment
Visualising dynamics of gene expression relative to the BUN renal damage marker is important to un-
derstand the effect of varying dosages of acetaminophen. For that purpose for all dosages associations
with an absolute Pearson correlation higher than 0.9 were extracted. Figure 6.4 A displays the global
BUN-gene interaction network. DynOmics identified many associations between marker and genes
118
Table 6.2: Significant enriched toxicology functions and pathways of associated genes to the BUN
renal damage marker identified by DynOmics for at least one dose group. The table indicates the
number of genes associated their direction and delay. + corr and - corr indicate the number of genes
positively or negatively correlated to BUN. A negative (positive) delay indicates that the BUN marker
changes prior to (after) the change in gene expression, No Delay indicates that BUN and associated
gene changes simultaneously. Dosages without associated genes to the according IPA Tox List were
not listed.
Dosage
in mg/kg
IPA Tox List ] of genes + corr − corr − delay No delay + delay
2,000
Xenobiotic Metabolism
Signalling
14 9 5 1 6 7
1,500 18 13 5 7 7 4
150 20 17 3 16 1 3
50 1 1 − − − 1
2,000
NRF2-mediated
Oxidative Stress
Response
14 12 2 2 7 5
1,500 17 13 4 4 10 3
150 19 17 2 16 − 3
50 4 3 1 1 − 3
2,000
Renal NecrosisCell
Death
16 15 1 8 4 4
1,500 20 18 2 5 9 6
150 19 16 3 17 1 1
50 2 1 1 1 − 1
2,000 Long-term Renal
Injury Anti-oxidative
Response Panel (Rat)
3 3 − 2 − 1
1,500 3 3 − − 3 −
150 2 2 − 2 − −
2,000 Increases Renal
Damage
4 3 1 1 2 1
1,500 2 2 − 1 1 −
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although a strict threshold was applied. Many shared genes between the markers were observed, par-
ticularly for high levels of acetaminophen (1, 500 and 2, 000 mg/kg). Since these genes are all active
across treatment they are likely to be responsible for the drug metabolism. Molecules only identified
for a specific dosage can be either dosage specific or irrelevant for the study performed. If we were
interested in detecting early molecular marker for acetaminophen toxicity it would be more interest-
ing to only visualise molecules that respond prior the actual renal damage. The according network
was modelled only from associations where the gene expression changed prior to the changes in BUN
is visualised in Figure 6.4 B. These genes represent potentially fast responses to the treatment. Asso-
ciations were only observed from acetaminophen dosages 150 to 2, 000 mg/kg. This could mean that
low dosage (50 mg/kg) did not trigger any fast responding genes associated to the BUN marker and is
concordant with low toxicity observed. I further observed increasing number of molecules associated
to the BUN marker with increasing dosage. This potentially reflected the fast accumulation of toxic
byproducts and the resulting molecular response. Only a few genes appear to be common between
the different treatments, which is likely due to the dosage dependent response dynamics. The final
network in Figure 6.4 C, illustrates genes that change expression after expression changes in BUN
occurred. Only a few genes have the same response dynamic across dosages, while there are many
genes for each individual dosage. These genes may be activated as consequence of renal damage and
we observe fewer genes for low dosage than high dosages of acetaminophen.
Presenting DynOmics results as networks has the clear advantage of conveying information quickly
about response dynamics across different treatments. Dynamic interaction networks can be compared
to infer common genes and pathways activated during treatment and those which are unique for toxic
levels. This can ultimately help to identify candidates for predictive biomarkers of acetaminophen
overdosage.
6.4 Conclusion
Associated molecular events often do not change simultaneously but are delayed in time. I presented
my methods DynOmics and NetOmics as a useful and important tool to identify time delayed asso-
ciations and to understand pathophysiological events. In this case study I showed gene expression
changes caused by acetaminophen and associated to renal damage showed different response dynam-
ics depending on the dosage. My approaches enabled the identification of relevant activated pathways
and genes that were delayed in time, giving insights into acetaminophen metabolism. These associa-
tions would have been not detected if an analysis disregarding time delays was performed. This Chap-
ter therefore illustrate the benefits of modelling with LMMS, analysing time delays with DynOmics
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and visualising the resulting detected associations with NetOmics. Such information is undoubtedly
useful for early detection of acetaminophen over-dosage and prevention of renal damage.
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AB C
Figure 6.4: Network visualisation of the BUN maker and associated genes. Displayed as grey squares
are the BUN renal damage marker for the different dosages of acetonaminophen (50, 150, 1, 500 and
2, 000 mg/kg) and blue circles are genes. Lines represent associations between BUN and genes with
an absolute correlation higher than 0.9. Line colors indicate if two nodes are positively (blue) or
negatively (orange) correlated. In A the global network is presented while in B the network is limited
to only display associations where genes change expression prior to expression changes in the BUN
marker and C displays only associations where genes change expression after the BUN marker.
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Part III
General discussion
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7. GENERAL DISCUSSION
Capturing small biological molecules that are expressed during adaption to environmental changes is
the future to understand molecule interactions and functions that drive a system’s behaviour. Time
course ‘omics’ technologies like microarrays, RNA sequencing and mass spectrometry are the best
current available tools to quantify the entity of these molecules. The main hypothesis of this thesis
was that a sophisticated framework for the integration and analysis of time course ‘omics’ data will
aid to fully exploit these data and also gain confidence in observations. Hence, in this thesis I proposed
novel frameworks based on linear mixed effect model splines and fast Fourier transform, for filtering,
modelling, differential expression and co-expression analysis.
7.1 Development of statistical methods to analyse single time course
‘omics’ data
The first aim was to develop a sophisticated framework for the analysis of time course ‘omics’ data
derived from a single high-throughput platform. Chapter 2 showed how removing molecules with
noisy expression as well as data-driven modelling of trajectories before clustering and differential
expression analysis reduced the noise and benefited the biological interpretation of the data.
In time course ‘omics’ experiments thousands of molecules are quantified, however only a small pro-
portion of these molecules will be of interest for the biological study performed. I hypothesised that
removing non-informative molecules characterised by noisy or no expression will magnify the inher-
ent signal through increasing statistical power in clustering and differential expression analysis.
My developed approach extended the standard deviation filter [106] to time course ‘omics’ data and
provided a computational efficient approach accompanied by useful visualisations. I showed that my
filtering approach was effective at discriminating informative from non-informative profiles by com-
paring the values of our filtering statistics with the test statistics from differential expression analysis
over time.
Despite the fact that I discovered a clear relationship between differential expression and filtering
statistic, I found the selection of a threshold to be challenging. The threshold choice was observed to
be affected by the amount of missing data and the number of replicates per time point. In my analy-
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sis I found 2-cluster model-based clustering on the filter statistics helpful to discriminate informative
from non-informative molecule expression. However, I also investigated and implemented filtering
via conservative threshold selection.
One main drawback of this approach is that it is only applicable to replicated time courses with the
same sampling time points. If time points are adjacent for repeated measurement it may be necessary
to group time points into bins prior to analysis in order to obtain sufficient data density.
This filtering approach is the only filtering approach to date that specifically uses the variance struc-
ture of the time course as opposed to the variance of the samples. I see here the opportunity to further
investigate filters that are less constrained on the sampling time points.
Until now, modelling approaches for time course ‘omics’ data fitted the same statistical model for
each molecule [38, 39]. However, I hypothesised that effects of environmental and genetic factors
on expression vary for individual molecules. An important question at this time was, whether a data-
driven modelling approach is of relevance for time course ‘omics’ data.
My developed LMMS approach improved upon existing methods by allowing the data to drive the
complexity of the models rather than having a single fixed model. By applying LMMS to a range of
time course transcriptomics and proteomics data from organisms with different genetic complexity,
and different genetic and environmental backgrounds, I observed heterogeneous variance structures
on a molecule to molecule basis. This was a significant observation since using a single variance
structure for all molecules in an experiment would therefore lead to over- or under-smoothing of the
data [39].
I further found that clustering on data-driven modelled data could increase biological findings and
could also enhance sensitivity compared to commonly used linear models to identify differential ex-
pressed molecules on simulated data. For some data sets this approach was of particular importance
since I solely identified differential expressed molecules when applying the data-driven modelling
approach.
While I showed the importance of taking subject-specific noise into account, there is also the variance
caused by differences in analysis techniques. Technical variance across samples is caused for example
because high-throughput platforms can only analyse a few hundred samples at a time. As machines
are often newly calibrated between runs or chemicals are exchanged, quantities vary between batches.
Similar issues were observed when researchers pooled data from different laboratories or different
technical platforms, as the data come in different scales and noise levels [198]. These batch effects
are a serious concern in the analysis of high-throughput data [199] since they have a large impact on
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biological findings and on their reproducibility [198, 199]. The benefit of linear mixed effect models
is that they can account for these batch effects in the model. I have not implemented it in the model
yet but I am certain that accounting for batch effects or other confounding factors will significantly
improve the biological inference and reproducibility of pooled data.
Clustering of molecules with similar expression over time is important to explore the intrinsic patterns
that shape molecular responses. It is also believed that we can derive functions of molecules by com-
paring the expression patterns with other molecules. The question was how to identify the clusters of
molecular response. The difficulty was that the performance of clustering algorithms used to identify
the distinctive molecular response patterns depended on the data property and structure. Therefore,
no single clustering algorithm was superior for all data. Recognising this limitation I implemented
exploration of clustering algorithm performance based on an assessment methods for cluster stability.
With this approach I could also identify the number of distinct patterns in the data.
In the past decade microarray techniques were commonly used to quantify gene expression, but are
limited in identifying low abundant transcript or novel splice variants [200]. Therefore, researchers
move towards novel platforms for the quantification of transcripts. For example, RNA sequencing has
been shown to find more low abundant transcripts and novel splice variants [200]. Data obtained from
RNA sequencing platforms are different from data obtained from microarray or mass spectrometry
platforms. Biases arise from the chemical composition and the length of the transcript [201, 202]. The
abundance of a transcript is derived by counting parts of a transcript’s sequence called ‘read counts’.
Read counts do not represent the full length of the transcript but are fragments of the original tran-
script. Consequently, longer transcripts are more likely to have higher read counts [201]. Counts as
opposed to quantities derived from microarray or mass spectrometry technologies are of discrete na-
ture leading to a poisson-like or negative binomial distribution assumption of the data [203, 204, 205].
My developed data-driven modelling approach however, assumes a normal distribution of the data.
Therefore, the framework as it stands is not suitable for analysing RNA sequencing data. However,
the LMMS framework can be expanded to a generalised linear mixed effect model framework with
a negative binomial distribution assumption. My hypothesis is that a generalised LMMS approach
will prove to be equally valuable for RNA sequencing data, as LMMS is for microarray and mass
spectrometry data. RNA sequencing data are also prone to environmental and genetic differences of
the studied subjects. Furthermore, transcript expression is a systematic process. Therefore, observed
read counts can be described as a noisy realisation of a function of time. Using generalised LMMS
modelling to obtain this function will reduce the noise and enhance biological inference.
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The significance of this research is that we need to be aware that organisms come with their own
noise components. My proposed LMMS framework recognises the variance structure and therefore
enhances analytical results and biological inference. It is a framework that enables comprehensive
modelling of complex time course ‘omics’ data to fully exploit their wealth of information.
7.2 Development of statistical methods to analyse co-expression
across multiple time course ‘omics’ data
Chapter 2 addressed the development of a sophisticated framework to filter, model and analyse time
course ‘omics’ data from a single molecular level, whereas the main question of the thesis was, how
to integrate time course ‘omics’ experiments from multiple molecular levels. The challenge was to
extract biologically relevant information from high-dimensional and noisy data with functionally re-
lated molecules observed to change expression at different time points. Since available methods had
difficulties identifying these co-expressed molecules, I presented in Chapter 4 an algorithm based on
the fast Fourier transform. The algorithm receives two trajectories to identify delayed changes of
expression and uses this delay information to determine their degree of association.
The power of this approach was seen clearly when applying and comparing this approach on sim-
ulated data. DynOmics increased sensitivity to identify associated trajectories by 8%, compared to
available methods using dynamic time warping or correlation analysis. DynOmics could further es-
timate the correct simulated delays in up to 76-99% of cases (depending on the noise level). These
results gave me confidence that my approach was well suitable for the integration and analysis of
disparate types of time course ‘omics’ data.
Given that the analysed biological studies were measured to different time points and also came with
noise and missing values, I was interested if my developed LMMS framework (Chapter 2) was suit-
able for pre-processing the data prior to integration. I could show that LMMS could reduce the noise
and interpolate time points and therefore increased findings by over 80%.
My next hypothesis was that the integration of biological molecules from different molecular levels or
organisms at comparable time points presented a systematic way to study molecular processes. Miss-
ing information in any single data type could be compensated and false positives could be reduced,
when multiple observations pointing to the same biological function. To validate this hypothesis, I ap-
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plied DynOmics to a variety of biological data sets (Chapter 4). The first data set showed the potential
of integrating multiple types of molecular levels measured over time in order to examine their regula-
tory relationships. When applying DynOmics, I found that the prediction of miRNA targets based on
expression and sequence similarity varied vastly. I further identified some miRNAs that were highly
correlated with molecules that changed expression delayed in time and whose functions was in line
with the study performed. These targets would have been missed if not taking delays into account.
Since correlation analysis is currently used for identifying miRNA-mRNA pairs based on expression,
applying DynOmics to these kind of data will bring novel insights into molecular processes regulated
by miRNAs and provide potential therapeutic targets.
The goal of the second study was to identify conserved molecular mechanisms across organisms using
time course ‘omics’ data measured to comparable time points. The identification of conserved molec-
ular mechanisms and their dynamics is relevant for phylogeny, appropriate model organism selection
for drug testing and to study disease. Using DynOmics, I identified a variety of molecular mecha-
nisms relevant to the study performed, that showed differences in the timing of expression changes.
This knowledge is very important for the appropriate comparison of molecular mechanisms.
The third study was a comparison of the molecular dynamics across different types of treatment in
response to a specific biomarker. The aim was to find biomarkers for the early prediction of drug
overdoses and onset of kidney damage. The analysis and comparison of different treatments helped
to discriminate and study the general response to the drug treatment and responses unique to toxic
dosages. I am confident that this study will prove useful for toxicity biomarker selection and under-
standing response dynamics to drug treatment.
DynOmics was developed to identify linear relationships of molecule expression that can be delayed
in time. Another research area, where this kind of analysis is of interest is when studying the compo-
sition of microbial communities. The analysis of the microbiome has many applications in medicine
[206, 207]. Quantities of microbes are measured using high-throughput sequencing techniques [208].
In these metagenomics experiments researchers observe apart from co-existence of microbes also
other more complex relationships between microbes [209]. One example is the ‘non-coexistence’
relationship, meaning that the presence of one bacteria is only measured in the absence of another
bacteria [210, 211]. DynOmics was developed to identifies (time delayed) linear relationships be-
tween two entities and will potentially not identify non-coexistence relationships. If one wants to
identify non-coexistence I refer to tools using the maximum information coefficient [209] or mutual
information [87, 185], as they were shown to be able to identify these kind of relationships.
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The integration of multiple time course ‘omics’ data can deliver information to systematically model
unbiased, information-based biochemical networks. A major challenge of systems biology is the dif-
ficulty to extract biochemical interactions from large-scale observations, between disparate types of
data and visualise them for analysis. Currently, there is a lack of approaches that can integrate and
visualise multiple time course ‘omics’ data. In Chapter 5 I proposed the use of the output generated
by the DynOmics algorithm developed in Chapter 4 to model data-driven molecule networks. These
networks can help to understand a biological system’s response to external environmental changes.
I used relevance networks, as they have been shown to perform well in the high-throughput case
[80]. Nodes in the reconstructed networks represented the different integrated ‘omes’ variables and
edges the connection of ‘omes’ (between and within ‘omes’). I used the information obtained from
the DynOmics algorithm to generate edge directions used for inferring causal relationships between
molecule expression. Using time delay information in the network, can model causality or discover
altered interaction affinities in different molecular settings [18].
While the network visualisation implemented here is not as sophisticated as tools specifically devel-
oped to display networks like Cytoscape [194], the network visualisation provided in NetOmics is
specifically implemented to display and analyse DynOmics results.
Since DynOmics was developed to identify pairs of associated trajectories from multiple time course
‘omics’ experiments, these results require further processing in order to model biological relevant net-
works of interacting molecules. In network analysis, one is not interested if a molecule is indirectly
involved in the change of a molecule through the interaction of another directly involved molecule.
All connections in the graph should represent direct interactions of molecules. Therefore, DynOmics
results require additional filtering approaches to remove these indirect connections. The removal of
these ‘irrelevant’ parts of a network before invoking inference is called ‘network pruning’. Common
approaches for network pruning are to use the data processing inequality [87] or minimum length
principle [86]. I hypothesise that networks modelled from DynOmics results after the removal of
indirect connections will be more biological relevant. I further believe that including PPI informa-
tion from the BioGRID [212] or STRING [193] database and metabolic pathway information from
MetaCyc database [213], KEGG [191] or Reactome [192] to weight the edges derived by the data
will allow to gain confidence in the networks built. Further extensions that will be beneficial for the
assessment of the quality of the networks are the test for gene ontology (GO) enrichment (e.g. bio-
logical processes) of hubs and their connected molecules. A permutation test to validate that the GO
enrichment observed is significant compared to a random association will further give confidence in
findings.
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The importance of this research is that many functional dependent molecular processes show differ-
ences in timing of expression changes. My proposed DynOmics algorithm estimates this expression
delay and therefore increases analytical results and biological inference. In addition, Dynomics re-
sults can be visualised through data-driven dynamic molecular networks. This enables the integration
of multiple time course ‘omics’ data to study molecule interactions that drive a system.
7.3 Development of user-friendly tools to analyse time course ‘omics’
data
Knowledge sharing of best-practice approaches for the analysis of high-throughput data is important
to enhance the research field. I wanted to enable the developed frameworks for molecular biologists
to answer key biological questions. I therefore developed graphical user interfaces called TimeOmics
and NetOmics. Both tools are easy to install and use and require no programming skills. Filter ratios,
clustering, differential expression and co-expression analysis can be performed and their results can
be explored via interactive tables and graphs, that will increase the understanding of analytical results.
The high-dimensional nature of these data comes with the challenge of keeping the computation time
low. Both the data-driven modelling and the pairwise comparison to identify associated trajectories
are not very efficient and increases with number of molecules analysed. However, the analysis can run
independently for each molecule. In order to speed up the calculations I implemented both LMMS
and DynOmics approaches to run in parallel on CPU cores using the R package parallel [135].
The run time can further be improved by running the methods on parallel on a cluster or a more effi-
cient implementation in another programming language than R.
TimeOmics and NetOmics are open source software projects for the integration and analysis multiple
‘omes’ expression measured over time as unified frameworks. They are the interface to state-of-the-
art statistical approaches for the analysis and integration of time course ‘omics’ data. I hope the
availability of such tools will open new avenues in biomarker discovery, and a better understanding
of the dynamics of disease and treatment.
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1 TimeOmics in a Nutshell
TimeOmics is a user-friendly application to filter, visualize and analyse high dimensional time course
‘omics’ data. TimeOmics enables a variety of functions (Fig. 1), for molecule expression experiments
measured on multiple biological replicates over multiple time points to enable:
• Filtering of not expressed or noisy molecules.
• Modelling of time course expression profiles.
• Clustering of modelled expression profiles.
• Analysing differential expression over time (between groups and time and group interaction, if
two groups are available).
Figure 1: Overview of the TimeOmics analysis framework. The proposed framework consists
of three stages: quality control and filtering; serial modelling of profiles; and analysis with clustering
to identify similarities between profiles or with hypothesis testing to identify differences over time,
between groups, and/or in group and time interactions.
1.1 Data requirements
TimeOmics does not provide tools for normalizing and transforming the data. You should make sure
your data is appropriately normalized and transformed prior to analysis. Also make sure that you do
not observe any batch effects that may effect the analysis.
Access to the full functionality of TimeOmics requires the data to have:
• A minimum of four time points.
• A minimum of three biological replicated measurements per time point.
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1.2 Citing TimeOmics
The TimeOmics software can be cited as:
Straube J, Bernard A, Huang BE and Lê Cao K-A (2015)
TimeOmics: Web application for interactive time course ‘omics’ data analysis
Submitted
The R package lmms can be cited as:
Straube J, Lê Cao K-A, and Huang BE (2015)
lmms: Linear Mixed Effect Model Splines for Modelling and Analysis of Time Course Data.
R package version 1.3
The statistical method can be cited as:
Straube J, Gorse A-D, Huang BE and Lê Cao K-A (2015)
A linear mixed model spline framework for analyzing time course ‘omics’ data.
PLoS ONE 10(8): e0134540. doi: 10.1371/journal.pone.0134540
1.3 How to get help?
The user guide and references will hopefully answer most questions about TimeOmics. However,
additional questions can be directed to j.straube[at]qfab.org. We appreciate bug reports in the software
or R functions and welcome any suggestions or comments for improvements.
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2 Quick start
2.1 Downloading R, RStudio and TimeOmics
TimeOmics version 1.0 functionality was tested on R version 3.2 and RStudio version 0.99. Follow
the subsequent steps to install R (≥ 3.2), RStudio (≥ 0.99) and TimeOmics:
1. Download and install the latest version of R for your machine from here.
2. Download and install the latest version of RStudio Desktop for your machine from here.
3. Once you have R and RStudio running, download TimeOmics from GitHub here.
4. You will also need to install the R package shiny in order to run TimeOmics. Open RStudio
and type into the RStudio console:
> install.packages(‘shiny ’)
2.2 Run TimeOmics
Run TimeOmics by typing the following commands in the console:
> library(shiny)
> runApp(‘C:/filepath/to/TimeOmics ’)
Note: The first time you launch TimeOmics may take time as many package dependencies need to
be automatically installed.
2.3 Workflow
TimeOmics can analyse data with either a single biological sample or multiple biological samples.
Figure 2 displays the different analysis workflows.
Upload
Model
Cluster
Differential 
Expression
Filter
Multiple samples time course
with filteringA
Upload
Model
Cluster
Differential 
Expression
Filter
Multiple samples time courseB
Upload
Model
Cluster
Differential 
Expression
Filter
Single sample time courseC
Figure 2: Workflows. Presented are the possible workflows using TimeOmics. WorkflowA and B are
for multiple samples time course experiments. In workflow A after uploading the data, you perform
filtering prior to modelling the expression profiles and clustering or analysing for differential expression.
In workflow B you can perform modelling, clustering and analysing for differential expression without
filtering. Workflow C is for single sample time course experiments, where only the upload and the
clustering functions are provided.
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2.3.1 Multiple samples time course experiment
In time course studies multiple biological replicates are measured at multiple time points and the ex-
perimental design looks similar to table 1. With these kind of experiments all functions of TimeOmics
are enabled. You can analyse your data following workflow A or B from Figure 2.
Sample ID Time Group
1 1 1
1 2 1
1 3 1
1 4 1
2 1 1
2 2 1
2 3 1
2 4 1
3 1 1
3 2 1
3 3 1
3 4 1
Table 1: Workflow A or B: Multiple samples experimental design.
2.3.2 Single Sample time course experiment
In the case where you only measure one source or use a different approach to summarize and model
the time trajectories using the median or the mean, the experimental design looks like table 2. You
can only use the functionality provided in the ‘Upload’ tab and ‘Cluster’ tab.
Sample ID Time Group
1 1 1
1 2 1
1 3 1
1 4 1
Table 2: Workflow C: Single sample experimental design.
2.4 Download Images and Tables
All images generated in TimeOmics can be easily saved with a right click on the image -> save image.
Tables can be downloaded through the ‘Download’ button in a .csv format.
2.5 Run an Example
You can run TimeOmics with data provided in two ways, either by uploading the example data
available from the ExampleData folder in the downloaded TimeOmics application or on the user
interface itself by going to the ‘Example and Help’ tab and check the ‘Run example’ check box. You
can now follow workflow A or B from Figure 2 to get familiar with TimeOmics functionality.
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3 Upload
The ‘Upload’ tab provides an interface to upload data and assess the quality via data distribution
plots. Moreover you will select what groups in your data you further want to analyse. Example data
is available in the downloaded TimeOmics application folder ‘ExampleData’.
3.1 Input, Format and Workflow
The Upload step requires four files:
• An expression data set in a matrix with samples in rows and molecules in columns (Fig. 3 I).
The matrix can contain a header and the delimiter in your file can be either comma, semicolon
or tab.
• A numeric vector indicating the time point of each sample (Fig. 3 II). The vector is comma
separated and does not have a header. The time vector needs to match the samples from the
expression matrix.
• A character or numeric vector indicating the source of the sample (e.g. sample ID) (Fig. 3
III). The vector is comma separated and does not have a header. The sampleID vector needs to
match the expression matrix rows.
• A numeric or character vector indicating the sample groups (Fig. 3 IV). The vector is comma
separated and does not include a header. The sample group vector needs to match the samples
from the expression matrix.
• Optional, a character vector of molecule annotation (Fig. 3 V). The molecule annotation file
can either contain gene symbols or protein identifier (IPI). The vector is comma separated and
does not include a header. The molecule annotation vector needs to match the molecules from
the expression matrix.
1. Upload the file molecule expression matrix by clicking on the ’Choose File’ button and select
your file.
2. Indicate whether your data file has a header by selecting the ‘Header’ check box.
3. Indicate the delimiter in your file either: comma, semicolon or tab.
4. Upload the files containing information about the sampled time point (Time vector), the source
of the sample (Sample ID vector) and the according group (Sample Group vector).
5. Select the groups you further want to investigate.
6. Choose to visualize the density distribution of the histogram or boxplot by ticking the ‘Show
density’ check box.
3.2 Graphical outputs
The plots generated when uploading the files aid the user to check the quality of the uploaded data.
The first plot generated is a histogram plot of the whole uploaded expression matrix (combining
all samples and molecules, Fig. 3B). Optionally, the data can be visualized as density distribution
by ticking the check box above the histogram plot ‘Show density’. Data should appear bell shaped
(normally distributed) since samples are assumed to be normalized. If you observe strong deviations
from a normal distribution, we recommend to normalize the data prior to using TimeOmics. If the
data is not normally distributed TimeOmics may not produce valid results.
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Figure 3: Upload. The ‘Upload’ tab is the user interface to upload the data to be analysed.
TimeOmics requires an expression matrix I, a vector indicating the sample time point II, a vec-
tor indicating the sample source II, a vector indicating the grouping IV and optionally the molecule
annotation V. Select the groups you want to analyse A. The data histogram B and sample boxplot
C are visualized upon uploading the data.
On uploading group information the histogram plot will change appearance if more than one group
is available. The histogram and density will display multiple histograms coloured by the according
groups in the sample.
The second plot displays the sample wise boxplot (Fig. 3C). Optionally, the density for each sample can
be displayed by ticking the ‘Show density’ check box above the sample boxplot. The data distribution
should be roughly the same for all samples (homogeneously distributed). If sample boxes show strong
deviations it may indicate technical difficulties or batch effects and analysis should proceed with
caution.
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4 Filter
‘Omics’ experiments measure the intensity of thousands of molecules at the same time. However, only
a few molecules will respond to treatment or perturbation. Molecules that do not change expression
over time or are noisy (non-informative) can be removed prior to analysis.
The method provided is specifically developed for time course data. It is based on the time to molecule
standard deviation ratio (RT ) and the subject to molecule standard deviation ratio (RI) as described
in [1] and implemented in the lmms R package [2]. High filter ratios indicate non-informative molecules.
However, filter ratios can be affected by high number of missing values. Therefore, the filter ratios
are visualized along with the proportion of missing values and enable to filter molecules with a lot
of missing data. We suggest to first remove molecules with a high number of missing values prior to
filtering on the filter ratios.
Figure 4: Filter. The ‘Filter’ tab allows you to filter for proportion of missing values and fold changes
I. Moreover, you can filter molecules based on their filter rations II. The filter ratio plots help you to
identify appropriate threshold for the proportion of missing values A the fold changes B. Filter ratio
plot C shows the classification using a model based clustering algorithm and helps to discriminate
between informative and non-informative profiles.
4.1 Graphical outputs
After uploading your data click on the ‘Filter’ tab. TimeOmics automatically visualizes the filter
ratios RT and RI for each molecule. The filter ratios should guide the user to identify molecules
that are not expressed or do not have a consistent response across subjects over time. The ratios are
visualized with three different types of information:
• Proportion of missing values (Fig. 4 A)
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• Fold change (Fig. 4 B)
• Model based clustering results with two clusters (Fig. 4 C)
If multiple groups are available the data of only one group will be visualized. You can switch
between groups by selecting ‘Choose a group’ drop down menu.
4.2 Filter Workflow
4.2.1 Missing Values/Fold Change
You can filter the data by proportion of missing values or fold change (Fig. 4 I).
1. Select the fold change or proportion of missing values cut-off using the slider.
2. Select the check box of the variables you wish to filter for.
3. Check the ‘Use filtered data for further analysis’ check box to remove all molecules that do not
meet the criteria.
Note: the data is by default assumed to be log transformed for the fold change calculation. Hence,
the fold change is the difference between the maximum average time point value and the minimum
average time point value. If your data is not log transformed, deselect the check box below Figure 4
B. The fold change will then be updated to the ratio of the maximum average time point value and
the minimum average time point value.
4.2.2 Filter Ratios
You can remove molecules with no expression changes over time or noisy (non-informative) profiles
by filtering molecules with high filter ratios (RT , RI) using two approaches.
• Use the classification of a model based clustering algorithm [8] to discriminate informative from
non-informative profiles.
1. Select the radio button ‘Model based clustering’.
2. Molecules are removed that are in the cluster with the high RT and RI coloured red in the
plot of Figure 4 C.
3. Check the ‘Use filtered data for further analysis’ check box to keep working on the filtered
data set.
• Alternatively, use fixed RT and RI to filter molecules.
1. Define RT and RI (Default values are RT = 0.9 and RI = 0.3).
2. Select the radio button ‘Fixed R_T and R_I’.
3. Molecules are removed that have higher RT and RI values as defined.
4. Check the ‘Use filtered data for further analysis’ check box to keep working on the filtered
data set.
4.2.3 Filtering data with two groups
You can not select different criteria (proportion of missing values, fold change or classification of model
based clustering) for different groups. Moreover, molecules are only filtered if they do not pass the
defined criteria for both groups.
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5 Model
Modelling a representative expression profile for molecules from multiple subjects measured over time
is not a trivial task. Subjects can have the same expression for some molecules, while for other
molecules they have different levels of expression or even change expression at different rates. Using
the mean or median to obtain a representative expression profile for all subjects is simple but often
sensitive to outliers and missing data. A better solution is to model expression profiles as smooth
function of time. To model this representative expression profile for each molecule we used our data
driven method Linear Mixed effect Model Splines (LMMS) [1]. LMMS has many advantages. It can
handle unbalanced designs and missing data. It also takes into account the variance structure of the
subjects, which was shown to prevent over or under smoothing of the profiles.
TimeOmics offers a range of splines to be selected by the user namely ‘cubic’, ‘p-spline’ and ‘cubic
p-spline’. The difference between these splines is the basis function and the way they select the knots
or break points. The ‘cubic’ spline basis as proposed by [3], uses all inner time points of the measured
time interval as knots. The ‘p-spline’ and the a ‘cubic p-spline’ basis use the quantiles of the measured
time interval as knots as proposed by [4]. Cubic splines are preferred if the number of time points
are small. However, with increasing number of time points this basis can get very computational
expensive. The alternative is to use either the ‘p-spline’ or the ‘cubic p-spline’. The models applied
to the data are a linear model (0), a LMMS (1), a LMMS with subject-specific random intercept (2)
and a LMMS with subject-specific random intercept and slope (3).
5.1 Model Workflow
After you uploaded and optionally filtered the data you can model the representative molecule ex-
pression profiles (Fig. 5 I). If you selected more than one group in the ‘Upload’ tab the molecules will
be modelled for each group individually.
1. Select the spline basis.
2. Click on the ‘Model’ button. When the modelling is completed, a table of each molecule with
the model used (linear model (0), a LMMS (1), a LMMS with random intercept (2) and LMMS
with random intercept and slope (3)) appears.
Then several options are available:
• Sort the table by molecule name or by model.
• Search for a molecule name or model by typing into to the ‘Search’ field at the top right of the
table.
• Select a molecule in the table to visualize the modelled profile along with the expression data.
• Download the LMMS modelled profiles (provided as a comma separated file) or proceed with
the clustering of the modelled molecular profiles.
By default TimeOmics outputs the fitted time points observed in the experiment. The lmms R
package provides further functionality, that allows the prediction of more time points within the
measured time interval.
5.2 Graphical outputs
Once the modelling step is completed a table appears (Fig. 5A) and you can visualize the expression
of each molecule with respect to time (Fig. 5B) by clicking on the molecule in the provided table. The
fitted profile is the default visualization. You can smooth the fitted profile or add the mean profile to
the plot by selecting the corresponding check boxes.
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Figure 5: Model. The ‘Model’ tab (Section 5) enables the modelling of multiple samples time course
experiments. You can select the spline basis to be used to model the data I. After modelling is
completed you obtain a summary with the number of models used to model your data II. Moreover,
you obtain a table with each molecule and the model used A. You can also visualize the modelled
profiles together with the measured data and the mean B.
6 Cluster
Clustering of the molecular profiles can give valuable insights into a systems molecular behaviour.
Molecule profiles with the same pattern are believed to be co-regulated, have similar functions or are
involved in the same biological processes. The analysis of the individual clusters for biological en-
richment can therefore be more informative than analysing all differentially expressed molecules over
time. We provide the choice of cluster analysis on the LMMS modelled profiles euclidean distance or
on the Pearson correlation matrix.
Clustering on the Pearson correlation may perform better if you wish to cluster profiles according to
their shape. Clustering on the euclidean distance will rather lead to clustering on the distance and
same shaped profiles with different expression levels may not be clustered together.
The data used for the clustering input is either modelled profiles using the ‘Model’ tab provided func-
tions, alternatively it can be a single sample experimental design.
The ‘Cluster’ analysis consist of three parts:
1. Cluster stability assessment (Fig. 6 I).
2. Expression profile cluster visualisation (Fig. 6 II).
3. GO enrichment analysis of clusters (Fig. 6 III).
The following clustering algorithms are provided:
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• Hierarchical Clustering (HC) with Ward agglomeration method [5]
• Kmeans [5]
• Partitioning Around Medoids (PAM) [6]
• Self-Organizing Maps (SOM) [7]
• Model based clustering (Mclust) [8]
Figure 6: Cluster. The ‘Cluster’ tab enables the stability assessment of clusters given different
algorithms and number of clusters I. A boxplot helps you to choose the algorithm and number of
clusters that predicts the most stable clustering A. Then you can choose the cluster algorithm and
the number of clusters II to visualize the clustered profiles B.
6.1 Cluster Stability Assessment Workflow
In order to perform the cluster stability assessment do the following steps:
1. Select if you wish to perform the assessment on the correlation matrix.
2. Select the cluster algorithms you wish to assess.
3. Choose the range of numbers of clusters you wish to assess.
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4. Finally, press the ‘Update View’ button to perform the analysis.
5. You can download a table with the molecules and the cluster they fell into by clicking on the
‘Download classification’ button.
6.1.1 Cluster Proportion of Non-overlap
The Cluster Proportion of Non-overlap (CPN) is provided to assess cluster stability via leave-one-out
cross-validation. We modified the implementation of the CPN as proposed by [9] to obtain a CPN
per cluster. The CPN measures the proportion of observations not placed in the same cluster with a
clustering based on the full data and a clustering based on the data with a single time point removed.
Let Ci represent the cluster containing observation i using all of the available data and Ci,−t represent
the cluster containing observation i, where the clustering is based on the dataset with time point t
removed. Then T is the number of different time points, and N is the number of different observations
in the data, the CPN is given by:
CPN = 1
TN
N∑
i=1
T∑
t=1
1− C
i,−t ∩ Ci
Ci
The CPN is in the interval [0; 1], with values close to zero corresponding to highly robust clustering
results.
6.1.2 Graphical outputs
The stability measurement is calculated as the Cluster Proportion of Non-overlap (CPN). The CPN
for each algorithm and number of clusters is visualized as a boxplot (Fig. 6 A). The algorithm and
number of clusters with the smallest and lowest box should be chosen.
6.2 Expression Profile Clustering Workflow
In order to cluster the expression profiles:
1. Select the clustering algorithm.
2. Select the number of clusters.
3. Click the ‘Update View’ button to perform the analysis. The clustered profiles will be visualized
as soon as the analysis was successfully performed.
4. You can choose to color the profiles by group.
6.2.1 Graphical outputs
The cluster plot visualizes the modelled profiles grouped by the predicted cluster (Fig. 6 B). The
black line is the mean profile of the predicted cluster. The header gives the information about the
cluster number and the number of profiles that were predicted in that particular cluster.
6.3 GO Enrichment Analysis
To validate the biological relevance of the clustered profiles, you can perform a size based enrichment
analysis. To use this function you need to
1. Provide gene symbols of protein identifier (IPI) in the ‘Upload’ tab.
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2. Cluster your profiles as described in the ‘Expression Profile Clustering Workflow’ section. Once
the analysis was successful, you receive a table with the following information:
• Cluster of the enriched GO term (Cluster)
• Number of molecules in your data in the GO category (Counts)
• Overall number of molecules in the GO category (Num.Mols)
• Size of the cluster (Cluster.size)
• GO ID (GO)
• GO description (GODescrip)
• Ontology (Ontology)
• P-value of the hypergeometric distribution (p.value)
• FDR adjusted p-value (adj.p)
3. Sort the table by any of the above mentioned table entries either alphabetically or numerically
decreasing/increasing by clicking on the according table name.
4. Search for anything in the table by typing into to the ‘Search’ field at the top right of the table.
Note: The GO enrichment analysis is currently only available for human using the org.Hs.eg.db
R package [10].
How is the GO enrichment analysis performed? The enrichment is computed using the hy-
pergeometric distribution based on the number of molecules in the set of interest. Let p be the total
number of unique molecules observed in the experiment, pf the total number of molecules that are in
the GO category of interest, and gc the number of molecules assigned to a given cluster C. Based on
the hypergeometric distribution the p-value of seeing pGO molecules in the intersection of the category
of interest and cluster C can be computed as
min(gc,pf )∑ (pf
i
)(
p−pf
gc−i
)(
p
gc
)
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7 Differential Expression
Differential expression analysis is a mean to identify differentially expressed molecules between groups
and/or over time. Here we use the Linear Mixed effect Model Spline (LMMS) approach as described
in [1] and implemented in the lmms R package.
You can select the spline basis as described in Section 5. Given two groups you can define the ‘Type’
of differential expression analysis to be performed either over time, between groups or time and group
interaction. You can also perform all three of them at the same time. If you only have one group you
can only test for differential expression over time.
Moreover, you can define the type of ‘Experiment’ to restrict the modelling to one model for each
measured molecule. We discriminate between ‘Time course’, ‘Longitudinal 1’ and ‘Longitudinal 2’
models. ‘Time course’ models each molecule with a LMMS. You select this model if you don’t ex-
pect much variation across biological replicates (e.g. cell cultures). ‘Longitudinal 1’ models a LMMS
subject-specific intercept. Select this model if you expect subject-specific expression levels. ‘Longi-
tudinal 2’ models each molecule with a LMMS and a random intercept and slope. Select this model
if you expect your the subject-specific molecule expression to vary in expression levels and speed of
expression change. However, each molecule expression can be differently affected by environmental
or genetic factors. Choosing one model for all molecules may lead to over- or under-smoothing of the
data. A solution is to let the data drive the modelling process. TimeOmics provides this functionality
if you select ‘All’ in the ‘Experiment’ drop down menu. All three models are considered and for each
molecule the model that has the best goodness of fit is selected. The analysis returns p-values as well
as False Discovery Rate (FDR) adjusted p-values as proposed by [11].
7.1 Differential Expression Workflow
1. Select the basis for modelling (Fig. 7 I).
2. Define the ‘Type’ of the differential expression analysis by selecting in the drop down menu (Fig.
7 II).
3. Define the ‘Experiment’ performed (Fig. 7 III).
4. Click the ‘Analyse’ Button to perform the analysis.
5. Once the analysis is done a table appears for each molecule with the p-value for the test per-
formed and the FDR adjusted p-value (Fig. 7 A). The table can be sorted by each of the above
mentioned table entries either alphabetically or numerically decreasing/increasing by clicking
on the table name of choice. You can also search for anything in the table by typing into the
‘Search’ field at the top right of the table.
6. Click on the molecule in the table to visualize the expression data along with the modelled
profiles (Fig. 7 B).
7. Download the results by clicking on the ‘Download DE analysis’ button.
7.2 Graphical outputs
After the analysis is completed you can click on it in the provided table (Fig. 7 A) and visualize
the expression of each molecule depending on time (Fig. 7 B). Given you performed all differential
expression types you can visualize all models at once by clicking the ‘Show plot’ radio button ‘All’.
Alternatively you can visualize only the ‘Time’, ‘Group’ or ‘Group and time interaction’ fit. Moreover,
you can visualize the expression data and the LMMS fitted data along with the mean profile or a
smoothed fit by selecting the according check boxes.
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Figure 7: Differential expression. The ‘Differential Expression’ tab enables the differential ex-
pression analysis. You can select the basis of the spline I, define the type of differential expression
analysis II and the kind of experiment performed III. Once the analysis is done a table appears for
each molecule with p-value and FDR adjusted p-value A. By clicking on the molecule in the table you
can visualize the expression data with the modelled profiles and the mean expression profile B.
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